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Abstract i 
Abstract 
Chronic hepatitis B virus (HBV) infection has been strongly associated with 
hepatocellular carcinoma (HCC). The hepatitis B virus X protein (HBx) is reported to 
mediate diverse cellular changes that are thought to cause cancer development. 
Recently, isolation of the HBx integrants from HCC tissue reveals the truncation of 
this viral gene at its C-terminus. In this study, we hypothesized that C-terminal 
truncated HBx mutant should retain the potential carcinogenic effect of wild-type 
HBx through different mechanisms. Thereby we studied and compared several 
cellular functions of wild-type HBx and a truncation mutant HBxAC44. 
We have demonstrated that wild-type HBx and mutant HBxAC44 have 
different subcellular localization in liver cell-lines. However, the difference in sites of 
localization does not affect their similar function in cell cycle pattern and both of 
them cause an increase in S-phase distribution and DNA synthesis. Nevertheless, the 
underlying molecular regulation mechanism of cell cycle by HBxAC44 deviates from 
that of HBx, with a different effect on cycle protein expression. Their effects on 
mRNA expression of p53, c-myc and RhoC are also different. The 
regulation of p2iwaf如pi expression is mediated in a wild-type p53-dependent manner 
which is activated by the HBx variants. Besides, both wild-type HBx and HBxAC44 
mutant potentiate the Ras/Raf/MEK/ERK phosphorylation in a similar way which 
may also account for 卩21柳『如卩1 and wild-type p53 expression regulations. 
Apart from the comparative study on wild-type HBx and HBxAC44 using a 
transient transfection system, we have also constructed a Tet-On inducible cell-line 
TOXDCl that stably expresses HBxAC44 upon doxycycline induction. This cell-line 
serves as an excellent platform for future study on this truncated, clinically relevant 
• HBx mutant. 











者皆提升細胞週期在DNA合成期（S，DNA synthesis phase)的分佈，因而提升 
DNA合成。然而，從基本的分子控制方面來說，HBXAC44突變體所採取的控 
制機制與原生X蛋白並不一樣。他們對細胞週期蛋白的表達產生不同的影響。 
他們對於 p2lwaf/eipi，p2/ipi，p53，om_yc 和 RhoC 信使 RNA(mRNA)表達的影響 
也不相同。我們發現p2iwaf/eipi的表達可由原生品種的p53蛋白透過受X蛋白 
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CHAPTER 1 Introduction 1 
CHAPTER 1 
Introduction 
1.1 Hepatitis B Virus 
1.1.1 General information 
Hepatitis B Virus (HBV) is one of the major etiological agents responsible for 
development of chronic liver diseases including cirrhosis and hepatocarcinogenesis 
(Szmuness et al, 1978). The HBV-mediated hepatocarcinoma development is among 
the top 10 most common cancers in the world. Currently, there are more than 3,000 
million people infected by HBV worldwide among which about 400 million are 
chronic carriers. One quarter of these chronic carriers will develop hepatocellular 
carcinoma (HCC) in their lives (Beasley et al, 1981; Zhang et al” 2005). Endemic 
areas of HBV infections include south-eastern Asia, some of the western Pacific 
islands, and sub-Saharan Africa where there are also high incidence of HCC (Zhang 
et al., 2005). China including Hong Kong shares the greatest portion of HBV chronic 
carriers in the world with a number of about 130 millions, estimated to be one in 
every ten people (Parkin et al, 1999). 
HBV is a blood-borne virus. Its infection can be classified into transient 
infection (or called acute infection), and chronic infection. The majority of 
hepadnaviruses infection in adults is transient that the infected cells are killed by the 
host immunological responses before virus production can initiate. However, about 
90% of perinatal infections are chronic that the babies fail to remove the virus 
antigen even at 6 months after the infection (Seeger and Mason, 2000). An effective 
vaccine has been used for about 20 years. However, some people escape vaccination 
and the prevalence of hepatitis B mutants has been increasing several years after the 
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vaccination program started. For instance, in vaccination-escaped children in Taiwan, 
the prevalence of mutant hepatitis B surface gene increased from 7.8% to 19.6% at 
five years after the vaccination program. It became 28.1% and 23.1% at ten years and 
fifteen years after respectively (Hsu et al, 2004). Current treatments of chronic HBV 
include interferon alpha and nucleoside/ nucleotide analogues (Dusheiko et al, 2007). 
Approved nucleoside/ nucleotide analogues include lamivudine (Boni et al., 1998; 
Lai et al., 2005), adefoir (Hadziyannis et al, 2003 and 2005), telbivudine (Standring 
et al, 2001) and entecarvir (Chang et al, 2006). Some herbal medicines in the 
traditional Chinese community have also been used for years in treating HBV 
infection. Our group has also previously reported the anti-HBV effect of the 
ethanolic extract of a herb called Phyllanthus nanus (Lam et al., 2006). 
1.1.2 Classification 
Hepatitis B virus (HBV) is the only DNA virus found in the Hepatitis Viridae 
family which also contains RNA viruses including hepatitis A, C, D, E or G viruses. 
、 
An important development in hepatitis B research was the discovery of human HBV 
as the prototype for the virus family called Hepadnavihdae. Closely related HBV 
can be found in apes, woodchucks (woodchuck hepatitis virus [WHV]) (Summers et 
al., 1978) and ground squirrels (ground squirrel hepatitis virus [GSHV]) (Tennant et 
al.’ 1991; Testut et al, 1996). Together with other viruses of DNA sequence 
homology and similar genome organization and hosts, human HBV is further 
grouped into the genus Orthohepadnavirus, which infect mammals. A distantly 
related group is called Avihepadnavirus which contains viruses that infect avians 
such as ducks (duck hepatitis B vims [DHBV]) (Mason et al, 1980)，geese (goose 
、hepatitis B virus) (Urban et al, 1998). 
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Presence of hepatitis B surface antigen (HBsAg) in the serum of infected 
individuals reflects the presence of viral particles, which defines infection. Detection 
of pre-S in serum reflects presence of live viruses. If no pre-S but surface antigen is 
detected, it may reflect chronic infection such that the viral genes have been 
integrated into the host genome and they replicate with the host genes without 
producing live viruses. Based on the serological tests using subtype-specific 
antibodies against HBsAg, nine different subtypes of HBV are defined, naming aywl, 
ayw2, ayw3, ayw4, ayr, adw2, adw4, adrq+ and adrq- (Swenson et al., 1991; Blitz et 
al, 1998). Genotypically, HBV genomes have been classified into eight groups A-H, 
based on an inter-group divergence of 8% or more in the complete nucleotide 
sequence (Norder et al., 1994; Stuyver et al, 2000; Chan et al, 2005). These 
genotypes show a geographical ethnical distribution. For example, genotype A is 
pandemic but mostly found in north-west Europe, North America and Central Africa. 
Genotype B and C are prevalent in Asia. Genotype C can be further divided into Cs 
subgroup that is prevalent in Southeast Asia and Ce subgroup that is predominantly 
、 
found in far East Asia (Lee et al, 2003; Chan et al, 2005). Genotype D is 
predominant in the Mediterranean area and the Middle East while genotype E is 
typical in Africa. Genotype F is found in American natives and in Polynesia (Norder 
et al., 1994; Van Geyt et al, 1998). Some of the genotypes are suspected to be 
associated with more severe disease outcome. For example, some reports indicate 
that genotype C has the highest carcinogenic activity (Kao et al., 2000; Lee et aL, 
2003; Thakur et al, 2002; Yuen et al, 2007). 
1.1.3 Virus life cycle and genome 
、 • In spite of being the largest virus in Hepatitis Viridae with a diameter of 42 nm, 
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the HBV genome is only about 3.2 kb in length (Robinson et al., 1974). The 
hepadnavirus genome is a partially double-stranded relaxed-circular DNA (rcDNA) 
structure encapsidated within the enveloped viral particles. It contains four genes, 
namely the polymerase gene, core gene, surface gene and a fourth gene unique to 
Orthohepadnavirus, called the X gene (Fig. 1.1) (Toillais et al, 1985). 
Direction" 
V 
Figure 1.1 A schematic diagram of the transcriptional and translational map of 
HBV (modified from Fig.l, Feitelson M.A., 1998). The genome is a double-stranded 
circular DNA (3.2 kb). The minus strand has a nick at a unique position in the 
genome whereas the plus strand has a unique 5' end but variable 3，end whose 
position is different in individual virus particles. There are four open reading frames 
coding for different viral proteins. The outer circle indicated the heterogeneous start 
sites of HBV transcripts, of which the pregenome, serves as the mRNA for the 
synthesis of core protein and the viral reverse transcriptase. The subgenomic RNAs 
are used in the synthesis of S, M and L surface proteins and X protein. 
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Upon infecting hepatocytes which is the primary site of viral DNA replication, 
the viral rcDNA is transported into the nucleus where it is converted into a covalently, 
closed, circular, double-stranded DNA (cccDNA) (Fig. 1.2). The cccDNA serves as 
the template for transcription of viral mRNA including a pregenomic RNA and three 
subgenomic mRNAs including the S & M (pre-S2/S) mRNA, the L (pre-Sl) mRNA 
and the X mRNA. The preC/ pregenome serves as the mRNA for the synthesis of 
core viral capsid protein that is known as the HBV core antigen (HBcAg) and the 
viral polymerase which is also responsible for the reverse transcription of its own 
pregenome (Bartenschlarger and Schaller, 1988). The reverse transcriptase is then 
packed with its own mRNA template into the nucleocapsids where viral DNA 
synthesis occurs. The subgenomic mRNAs includes the small and middle (S & M) 
and large (L) mRNA which together encode for three envelope components called S, 
M and L hepatitis B surface antigens (HBsAgs) which are essential for the 
development of nucleocapsids. The small surface protein (S) contains the S-domain 
which is highly hydrophobic and consists of four trans-membrane spanning regions 
(Stirk et al., 1992). They contain the antigenic epitope of HBV which is greatly 
synthesized in the early infection. This is also the reason why it is used to define 
different HBV subtypes (Peterson et al, 1984; Okamoto et a!., 1998). The middle 
surface protein (M) contains an extra preS2 region which contributes to its 
hydrophilic property and allows it to locate in extracellular space. It is thought to be 
responsible for viral attachment to cells (Brus et al, 1998). The large surface protein 
(L) consists of preSl, preS2 and the surface domains. Its dual topological structure 
allows them to move across the cell membrane (Goo and Pugh, 1997). The presence 
and expression of X mRNA that encodes for the HBx polypeptides (HBx) of 
unknown function is unique to Orthohepadnavirus. An additional product expressed 
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during natural infections is hepatitis e-antigen (HBeAg) with unknown function. It is 
expressed from the core gene and is proposed to suppress host cell immune response 
upon HBV infection (Seeger and Mason, 2000). 
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Figure 1.2 Life cycles of hepadnaviruses (modified from Fig. 2，Seeger and Mason, 2000). 
During the initiation of infection, the viral reverse transcriptase (polymerase) is 
attached to the 5'-end of the minus strand while a short RNA is attached to the 5'-end 
of the plus strand, that the viral genome is converted into covalently closed circular 
double-stranded DNA (cccDNA). During this process, the viral proteins and RNA are 
removed. The cccDNA serves as the template for transcription of viral mRNA. The 
pregenome is the mRNA template for the synthesis of viral reverse transcriptase. The 
reverse transcriptase binds to the 5'-end of its own mRNA template and the complex 
is then packaged into nucleocapsids where DNA synthesis occurs. After maturation 
of the nucleocapsids, the virus is transferred into the endoreticulum (ER) through 
budding motion. These cccDNA may also migrate into the nucleus to increase the 
copy number of cccDNA. 
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1.1.4 Hepatitis B virus X protein (HBx) 
HBx is a multifunctional protein. It is essential for natural or established 
infection of woodchuck hepatitis virus (WHV) in woodchucks (Zoulim et al, 1994). 
It is important but possibly nonessential in human HBV replication in vivo and in 
vitro (Kodama et al., 1985; Melegari et al., 1998). 
Genetic features 
Genetically, X gene is the fourth gene of HBV that is unique to 
Orthohepadnaviruses but not found in Avihepadnaviruses. The designation of the X 
gene/protein originally reflected its unknown function and lack of homology with 
known proteins (Miller and Robinson, 1986). The X gene includes the smallest open 
reading frame (ORF) of the mammalian hepadnaviruses that encodes the HBx 
peptide. The X open reading frame is located downstream to the enhancer I (En 1) 
and is partially overlapped by the polymerase (P) ORF at the N-terminus and the by 
the PreCore (PreC) ORF at the C-terminus (Tiollais et al., 1985). The X ORF 
consists of a coding region of 462 bp and the enhancer 2 (En 2). Transcription of the 
0.8 kb HBx mRNA is controlled by its own promoter which is regulated by En 1, that 
is located upstream of the promoter. Several cellular transcription factors are found 
as the regulators of X gene transcription such as the hepatocyte nuclear factor 1 
(HNF 1)，hepatocyte nuclear factor 3 (HNF 3), retinoid X receptor (RXR) and HBx 
itself (Guo et al, 1991; Garcia et al.’ 1993). 
Protein structure 
HBx peptide is 154 amino acids in size, with a molecular mass of 
approximately 17.5 kDa. Its three-dimensional structure is still known. HBx defies 
high resolution crystallization, probably due to its high flexibility at the C-terminus. 
Besides, purification of HBx is not easy as HBx is a mostly hydrophobic molecule 
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with poor solubility that it easily aggregates with itself or other proteins. 
Nevertheless, sequence comparison analysis shows that HBx is well conserved 
among different mammalian hepatitis viruses such as human HBV, squirrel hepatitis 
virus (GSHV), woodchuck hepatitis virus (WHV), with a presumptive helical 
domain in the amino and carboxy-terminal regions (Kodama et al., 1985), together 
with a potential coiled-coil motif (Colgrove et al, 1989; Kodama et al, 1985). Some 
evidence shows that the N-terminus and C-terminus may be linked with disulphide 
bonds with the cysteine residues (Lin et al.’ 1989; Urban et al, 1997). As shown in 
Figure 1.3，the HBx sequence contains a serine/proline rich region at the N-terminus 
and Kunitz peptidase inhibitory domains-like regions at the C-terminus (Takada and 
Koike, 1990c). Kunitz inhibitory (KI) domains are inhibitor sequences that can be 
found among serine proteases (Laskowski and Kato, 1980). Unlike the typical KI 
domains, the one in HBx has a longer intermediate amino acid residues and is richer 
in helical content instead of beta-sheet structure, thus HBx is unlikely to be a serine 
protease (Kim et al., 1993). Two well-characterized transactivation domains lie on 
the central region and the C-terminus. Deleting the N-terminus up-regulates the 
transactivation activity of HBx suggesting that the N-terminus may act as a negative 
regulatory domain. However, the mechanism of such negative regulation is unknown 
(Murakami et al, 1994). Using yeast two hybrid system, several interacting partners 
of HBx are identified. HBx has been shown to interact with proteasome complexes 
19S, 20S and 26S. It can function as a substrate as well as an inhibitor of proteasome 
(Hu et al., 1999). 
Protein modification 
Phosphorylation of HBx has been demonstrated by several groups in insect 
cells (Urban et al., 1997) or in mammalian cells HepG2 (Schek et al., 1991) and 
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Hep3B through extracellular signaling-regulated kinase (ERK) 1/2 phosphorylation 
pathway (Noh et al.’ 2004)，and may affect its subcellular distribution. Acetylation, 
though not well supported, has been reported when HBx is over-expressed in insect 
cells (Urbane/a/., 1997). 
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Figure 1.3 A schematic presentation of the basic structural properties of 
hepatitis B virus X protein (HBx). HBx contains a serine/ proline rich region at the 
N-terminus and a Kunitz inhibitory (KI) domain like region near the C-terminus. 
Two transactivation domains have been well-described and a p53 binding site was 
proposed to be at the C-terminus. The N-terminus and the C-terminus are thought to 
be linked with disulphide bonds. 
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1.2 Enigmatic functions of HBx 
1.2.1 HBx as a transactivator 
HBx is an atypical transactivator in that it does not bind to DNA but functions 
via protein-protein interaction. The transcriptional transactivation function is 
important for the virus replication (Tang et al, 2005). Throughout the past two 
decades, numerous transactivation targets of HBx have been reported. The ability of 
HBx to activate transcription is likely through stimulation of transcription 
components or activation of cytosolic signal transduction pathways. These molecular 
targets include NF-KB (Mahe et al, 1991; Lucito et al, 1992), AP-1 (Benn et al, 
1996), AP-2, c-EBP, ATF/CREB (Maguire et al, 1991; Williams et al., 1995), 
calcium-activator factors NF-AT, TNF-a (Gonzalez-Amaro et al, 1994) or Oct-1 
(Autunovic et al., 1993) and p53 (Wang et al, 1994). HBx can interact with all major 
forms of NFKB , including those with Rel A (p65), c-Rel, p52, p50 and pl05 (Su and 
Scheneider, 1996). Through binding with the IB subunit of the NFKB complex, HBx 
is able to enter the nucleus (Siddiqui et al., 1989). Activation of NF-KB is important 
for HBx-mediated apoptosis (Su et al., 2001). HBx can also stimulate RNA pol-I and 
pol-III dependent promoters through interacting with the RPB5 subunits (Cheong et 
aL, 1995; Wang et al, 1997 and 1998). It interacts with TFIIB，TFIIH, and the 
TATA-binding protein (Haviv et al, 1998). 
HBx transactivates plethora pathways in cells such as ras/raf/MAPK, JAK/STAT, 
PI3K/Akt and Wnt pathways (Cross et al., 1993; Benn and Schneider, 1994; Natoli et 
aL, 1994; Lee and Yun, 1998; Shin et al., 2000; Cha et al.，2004; Liu et al., 2006). 
Ras is the prototype member of the low-molecular-weight family of GTPase, cycling 
between an inactive GDP-bound state (ras-GDP) and an active GTP-bound state 
(ras-GTP). Activated ras converts upstream activating signals into downstream 
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phosphorylating events by recruiting the kinase Raf to the plasma membrane. Raf 
activates MAP kinase kinase kinase (MAPKKK/MEK), which in turn activates the 
family of MAP kinases, including the extracellular-signal-regulated kinases (ERKs) 
(Klein et al, 1997). HBx strongly elevates the level of GTP-bound Ras and thus 
activates the down stream pathways (Benn and Schneider, 1994). Such stimulation 
effect may be direct, by increasing GTP uptake to Ras (Park et al, 2001; Ganem et 
al, 2001). The interaction between HBx and activated Ras has been suggested to 
determine the functional switch of HBx on apoptosis, transformation and 
tumourigenesis in vivo that HBx together with Ras can induce programmed cell 
death (Wei et al, 2006). On the other hand, HBx can indirectly stimulate this 
pathway by activating the focal adhesion kinase (FAK) (Bouchard et al, 2006) and 
then the non-receptor tyrosine kinase of the Src family and thus activates Ras (Klein 
et al., 1997). HBx was suggested to deregulate cell cycle checkpoints by activating 
this pathway (Benn and Scheneider, 1995; Doria et al., 1995). This also causes cell 
transformation in cooperation with c-myc. However, in most cell-lines with a high 
Ras activity, over-expression of HBx often leads to apoptotic cell death. 
Activation of the Janus activated kinase pathway (JAK/STAT) signaling by HBx 
is associated with increased hepatocyte proliferation which is mediated by Src family 
kinase (Klein and Schenneider, 1997). The JAK/STAT involves the activation of cell 
surface receptors, then phosphorylation of the JAK protein, as well as the receptor 
components to create docking sites for STATs. STATs are phosphorylated to form 
dimers that translocates to the nucleus to bind to the target DNA elements. The STAT 
binding sties are often in close proximity to motifs for other transcriptional factors 
that are activated by HBx (Arbuthnot et al, 2000). Through this pathway, HBx 
regulates cell proliferation, differentiation and apoptosis. 
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HBx also activates phosphoinositide-3-kinasesl-3-kinase (PI3K) dependent 
pathway, causing phosphorylation of Akt and Bad and suppression of caspase-3 
activation for cell protection from apoptosis (Lee et al, 2001). It is also suggested to 
stimulate Wnt signaling as P-catenin is activated in HBx-positive liver cell-lines. The 
HBx-mediated P-catenin activation stimulates the Wnt singaling which is likely to 
contribute to pathogenesis of HCC (Cha et al, 2004; Feitelson et al., 2006). The 
p-catenin accumulation in the cytoplasm is suggested to be caused by an HBx 
stimulated decrease in E-cadherin, the suppressor protein of p-catenin, in a 
Src-dependent manner (Liu et al, 2006; Lara-Pezzi et al, 2001). These massive 
activation roles of HBx are suggested to be regulated by cytosolic-mitochondrial 
calcium dependent modulation as inhibition of the mitochondrial transition pore by 
cyclosporine A blocks the activation of Pyk2 and Src kinases (Bouchard et al, 2001 
and 2006). 
1.2.2 HBx as a cell cycle regulator 
Aberrant regulations of cell cycle by HBx have been reported. Studies on cell 
cycle using established cell-lines, primary mouse liver cells and HBx transgenic mice 
have demonstrated that HBx can induce cell proliferation by increasing DNA 
synthesis and speeding up cell-cycle progression. HBx can induce arrested cells to 
exit Go to re-enter the cell cycle more rapidly than cells without HBx with elevated 
activation of cyclin-dependent kinases CDK2, CDC2, and cyclin E, A or B (Benn et 
al, 1995). HBx can also cause cells to stall at Gi/S border in the absence of serum 
(Bouchard et al, 2001). It also alters expression of CDK inhibitors pir^^^'P' and 
p27kipi, thus regulates the cycle gene expression (Leach et al, 2003). HBx can 
repress p2iwaf/cipi expression via ERK-mediated phosphorylation to promote cell 
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growth (Ahn et al., 2001; Han et al, 2002; Noh et al, 2004). However, some studies 
showed opposing results that HBx up-regulates p2iwaf/cipi 丈。protect cells against 
apoptosis (Park et al., 2000). Suppression on promoter is independent of 
the presence or absence of p53. Indeed, wild-type p53 has been shown to bind to 
p2iwaf/cipgene to block its expression. These suggest that can be regulated 
by HBx via both p53-dependent and p53-independent pathways. The contradictory 
results may also be explained by the variants of HBx used (Kwun et al, 2004) or the 
status of cellular p53 (Ahn et al., 2002). In vitro binding of HBx to CDK2-cyclin E/A 
has demonstrated that the complex destabilizes (Mukherji et al., 2006). 
However, in vivo study with HBx transgenic mice suggested that HBx exerted strong 
growth arrest and imbalanced cell-cycle progression (Wu et al, 2006). 
1.2.3 HBx as an apoptosis modulator 
There is an enormous amount of scientific evidence reporting the pro-apoptotic 
and anti-apoptotic effect of HBx in vitro and in vivo. HBx has initially been 
demonstrated to counteract p53-dependent apoptosis (Wang et al, 1995); while other 
groups reported a proapoptotic effect in both p53-dependent or p53-independent 
manner (Chirillo et al., 1997; Bergametti et al., 1999; Terradillos et al., 1998). HBx 
exerts a spontaneous pro-apoptotic effect on primary culture and in mice (Pollicino et 
.. al, 1998; Koike et al, 1998). The apoptotic effect is likely related to the 
transactivation activity of HBx (Elmore et al., 1997; Bergametti et al, 1999) or 
caused by HBx-mediated sensitization of the cells to tumour necrosis factor-a 
(TNF-a)-induced apoptosis (Su and SChneider.，1997). Another potential pathway 
may be through DDBl-binding (Bontron et a!., 2002; Leupin et al., 2003). Inhibition 
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of apoptosis by HBx has been reported with caspase 3 activity inhibition and 
protection cells against TGF-p-induced and anti-Fas-mediated apoptosis (Gottlob et 
a l , 1998; Shih et aL, 2000; Pan et al, 2001). The discrepant effect on apoptosis of 
HBx may be due to different cell systems used for the study and is dependent on the 
status of other cellular proteins. But more importantly, it may be due to the different 
cellular status in which HBx is expressed. In differentiated resting hepatocytes where 
the negative growth regulatory pathway can by stimulated resulting in apoptosis. 
However, in some cases like that in rapidly growing cancer cells, as the negative 
growth pathway is inactivated by mutations, promoter methylation etc., then the 
stimulation to grow by HBx may not trigger apoptosis, by the development of HCC. 
1.3 Etiology of HBV-mediated hepatocarcinogenesis 
Chronic HBV infection was shown to be strongly associated with HCC but the 
pathogenesis of such virus mediated malignant transformation is yet to be resolved. 
Like many other viruses, HBV integrates its DNA into the genome of hepatocytes 
and is often detected in HBV-related liver tumour tissues (Brechot et al, 1981; 
Sharfritz and Kew, 1981; Takada et al., 1990a). Such integration takes place in about 
85% of HCC patients (Robison et al., 1994). However, unlike other retroviruses, 
integration is not needed for HBV replication. Viral DNA integration is suggested to 
result in chromosomal instability which contributes to poor outcome of the diseases. 
Some examples of endogenous genes of integrated viral sequence are retinoic acid 
p-receptor, cyclin A, TRAPl genes or a sarcoendoplasmic calcium 
ATPase-dependent pump (SERCA 1) are also the hot spots of integration (Chami et 
al, 2000; Dejean et al, 1986; Wang et al., 1990). 
Another proposed mechanism of HBV-mediated HCC is by modulation of 
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cellular pathways through the expression of HBx protein. HBx has long been thought 
to play a central role in HCC development as infection of mammalian HBV which 
encodes an HBx protein is associated with the HCC development, whereas infection 
of avian hepatitis viruses that do not have an X gene, does not (Popper et al, 1987). 
A direct correlation between HBx and the severity of chronic liver diseases has been 
found in chronic carriers. In addition, the association between HBx and HCC was 
addressed in the first in vivo study with a transgenic mouse that expressed HBx in the 
liver and developed liver tumours (Kim et al., 1991). Such results are further 
supported by other groups that knocking down of HBx can reduce the 
tumourigenicity of HCC cells (Yu et al., 1999; Chan et al, 2006). However, HBx 
alone was found to fail to induce oncogenesis in many other groups (Lee et al, 1990; 
Slagle et al., 1996). On the other hand, some report that HBx may need to be above a 
threshold for the development of HCC (Koike et al, 1994). Indeed, HBx-induced 
changes are suggested to be mediated through cooperation with proto-oncogenes 
such as c-myc (Terradillos et al, 1997)，p53 (Shimamura et al.’ 1996)，the Ras family 
(Ng et al, 2004) or transgenes like SV40 large T antigen and epidermal growth 
factor receptor (Hohne et al, 1990; Luber et al., 1996; Oguey et al, 1996). Due to its 
subtle effect on cellular physiology, HBx was suggested to work as an assisting, 
weakly proto-oncogenic factor that leads to detrimental consequences for 
hepatocytes when mutations accumulated (Bouchard et al, 2004). Recently, HBx has 
been suggested to promote hepatocellular remodeling prior to tumour formation and 
aids metastasis by down-regulating E-cadherin (Liu et al., 2006). E-cadherin is an 
important cell adhesion protein that suppresses tumour by inhibiting cellular growth, 
transformation and invasiveness (Christofori and Semb，1999). 
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1.4 Clinical mutants of HBV 
While the precise role of HBV integration in hepatocarcinogenesis remains 
uncertain, the HBV integrates are usually rearranged or partially deleted in the host 
genome. Point mutations in the X gene have been reported by Tu in 2001 and Huo in 
2001 but the effect of these mutations are not yet elucidated. Interesting, several 
deletion breakpoints within X gene are found at the 3’-end thus consequently 
resulted in C-terminal truncated mutants (Takada et al, 1990b; Wei et al., 2000). 
Similar C-terminal deletion was further reported by Tu, 2001 in patients in France 
and Wang, 2004 in a study with Chinese HCC patients. The deleted sequences range 
from a few amino acids to the full C-terminus which include the p53-dependent 
transcriptional repression binding site, Spl binding site and cell growth-suppressive 
effect domain. However they retain the activity in hepatocarcinogenesis (Poussin et 
al., 1999). The truncated HBx seemingly has lost part of its transactivation activities 
thus causes a decrease in transactivating the Early Growth Response Factor 1 (Egr-1) 
(Chen et al, 2000). The C-terminal truncated mutants were shown to have a stronger 
tumourigenic effect by increasing colonies formed. These truncated mutants may 
provide a tool for finding an explanation on the contradictory properties of HBx 
found in various studies. 
1.5 Hypothesis and aims of the research 
Tumours are thought to be the results of an uncontrolled cell proliferation, 
deregulated cell cycle through disruption of normal cellular pathways. It may also be 
the result of activation of oncogenes/proto-oncogenes or inactivation of tumour 
suppressor genes. Throughout the past decades, many research studies have been 
> carried out on HBx of different subtypes. A single search of PubMed using the 
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keyword HBx gave 519 items (done in May, 2007). HBx has long been reported to 
have diverse cellular functions among which some are contradictory and unexpected 
from the view of oncogenesis. On the other hand, clinical knowledge reveals a strong 
association between the truncation pattern of integrated HBx at the C-terminus and 
tumour development. 
In the present study, we aimed to study the effect of C-terminus truncation in 
hepatocarcinogenesis. In the process of carcinogenesis, several cellular changes can 
be named. They include the induction of cell proliferation, repression or destruction 
of tumor suppressors or stimulation of oncogenes. Hereby, we hypothesized that 
C-terminal truncated HBx should enhance the detrimental effects of wild-type HBx; 
that it should enhance the cell proliferation effect of wild-type HBx on liver cells. 
Moreover, it can activate the carcinogenesis pathways in order to transform the 
normal cells, and eventually cause tumour formation. Specifically, the C-terminal 
truncated mutants should be capable to transactivate oncogenes c-myc and 
proto-oncogenes RhoC and Rabl4. It should also be capable to repress the tumour 
suppressor gene p53 via the ras-signaling pathway and potentiate cells to 
carcinogenic changes. We hypothesize that the cellular and molecular changes 
stimulated by the C-terminal truncated mutant should be in a different way from that 
of the wild-type HBx. Thus, we studied and compared the potential differential 
cellular functions of C-terminal truncated mutants and wild-type HBx. More 
specifically, we aimed to elucidate the effect of the mutant and the wild-type HBx on 
subcellular localization, cell cycle regulation and transactivation pathways (including 
the ras-signaling pathway) behind which eventually cause the differential effects. 
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1.6 Basis of Tet-On System 
The Tet-On gene expression system is a tightly regulated system that expresses 
genes of interest at high level upon induction. It uses a chimeric transactivator to 
regulate transcription from a silent promoter. The transactivator itTA is expressed 
from the constitutive CMV promoter (Gossen et al., 1992). In the Tet-On system, the 
gene expression is turned on when doxycycline, a tetracycline derivative, is added 
into the system. The degree of gene expression can be controlled by varying the 
doxycycline concentration and the maximum expression level is comparable with 
that from strong, constitutive CMV promoter (Yin et al, 1996). The system is highly 
specific to doxycycline induction and the background gene expression level is kept to 
a minimum. It is thought to be a good system for maintaining toxic genes such as 
viral genes, in a cell-line or a transgenic organism. 
In the Tet-On system, two basic plasmids pTet-On and pTRE2 were introduced 
into the target cell-line at different stages (Fig. 1.4). The pTet-On regulatory plasmid 
encodes a regulatory protein called reverse tetracycline-controlled transactivator 
(rtTA), a fusion protein of reverse Tet repressor (rTetR) with the Herpes simplex 
virus VP 16 activation domain. The rTetR protein consists of 1-207 amino acid 
residues of the Tet repressor protein (TetR) of E. coli with changes in four amino 
acids. The VP 16 domain contains 127 amino acids at the C-terminus, which can 
convert the rTetR from a repressor to an activator. The responsive plasmid pTRE2 
contains the Tet responsive element (TRE) for the regulation of the gene of interest. 
The TRE is derived from the tet operator sequence in E. coli and is located upstream 
of the minimal CMV promoter (PminCMV). In the presence of doxycycline, the rtTA 
fusion protein is able to bind to the TRE in the responsive plasmid. The VP 16 
subunit in the rtTA complex then activates the transcription of the gene. 
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Viral proteins such as HBx in our project, has various functions that may 
deviate from our prediction. This system allows the expression of HBx at controlled 
time points and allows 'switching off' the gene expression. Such tight control avoids 
the selection of a pool of cells resistant to the toxicity of viral proteins, as that found 
in typical stable cell-line constructions. Moreover, viral protein integration is often a 
problem that should be taken into account for consideration of its effect on the cells. 
As mentioned in section 1.3, the integration sites of viral genes may be some 
essential genes; thus, the cellular changes may be due to these integrations but not 
the effect of the viral proteins. Tet-On system allows study of the effect of viral 
proteins alone by using the uninduced cells that contain an HBx integrant (but a 
silent gene) as the control. It eliminates the potential effect caused by the HBx 
integration. 
In this project, besides studying the C-terminal truncated HBx in cell growth 
and transformation, we also constructed inducible cell-lines using Tet-On system 
which serves as a cell model system for long term study of this viral gene. 
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Figure 1.4 A schematic diagram of Tet-On inducible gene expression system. The 
pTet-On plasmid expressed rtTA complex which is a fusion protein of reverse Tet-On 
repressor (rTetR) and Herpes simplex virus VP 16 activation domain. In the presence 
of doxycycline, the rtTA fusion protein is able to bind to the Tet responsive element 
(TRE) in the response plasmid which then turns on the expression of the gene of 
interest. 
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CHAPTER 2 
Experiment Materials 
2.1 Cell culture 
2.1.1 Cell-lines 
Two cell-lines were used in the study. One is human liver cell-line and the 
other is human hepatocarcinoma cell-line. Both cell-lines were purchased from the 
American Type Culture Collection (ATCC) and cultured in different media. The cells 
were cultured in a 37°C, 5% carbon dioxide incubator with humidified atmosphere. 
Cells were passed at 1:5 ratio every 3-4 days. For each passage, the spent medium 
was discarded and cells were washed twice with I X phosphate buffer saline (PBS) 
before trypsinization. The trypsinized cells were rinsed out with culture medium and 
subjected to centrifugation at 1000 x g for 3 minutes to remove the dead cells debris. 
The cell pellet was then resuspended in complete medium and cultured in desired 
culture flasks (IWAKI). 
1. W R L 6 8 human liver cell-line 
Human liver cell-line WRL 68 (ATCC number CL-48) was a cell-line derived 
from hepatocytes of Homo Sapiens origin. It was reported to be contaminated with 
some HeLa cells and some HPV DNA sequences and was purchased from American 
Type Culture Collection. They exhibited adherent characteristics and were 
maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 
3.7 g/L sodium bicarbonate (Sigma), 10% (v/v) fetal bovine serum (HyClone) and 
1% (v/v) penicillin-streptomycin (HyClone). All experiments described in this thesis 
were performed on WRL68 unless specified. 
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2. HepG2 human hepatocarcinoma cell-line 
Human hepatocellular carcinoma cell line HepG2 (ATCC number HB-8065) 
was derived from a 15 years old Caucassian male. These cells were adherent with 
epithelial morphology. They were maintained in RPMI 1640 medium (Invitrogen) 
supplemented with 3.7 g/L sodium bicarbonate (Sigma), 10% (v/v) fetal bovine 
serum (HyClone) and 1% (v/v) penicillin-streptomycin (HyClone). 
2.1.2 Culture medium 
All the media mentioned were purchased in powder form with the same 
preparation method suggested by the supplier. A pack of culture medium powder was 
dissolved in one liter nano pure water with 3.7g /L sodium bicarbonate supplied and 
adjusted to pH 7.2 (0.2 below desire pH value 7.4). The medium was sterilized by 
filtering with 0.22 \xM bottle-top filter (Millipore). Addition of 10% (v/v) fetal 
bovine serum (HyClone) and 1% (v/v) Penicillin-streptomycin (10,000 units/ml, 
HyClone) afterwards gained the complete culture medium. 
1. Dulbecco's modified Eagle's medium (DMEM) 
Dulbecco's modified Eagle's medium (DMEM), consisting phenol red, 4 mM 
L-glutamine and 4.5 g/L glucose, was used in culturing human liver cell-line WRL68. 
Liquid medium of DMEM was made by dissolving packs of DMEM powder in nano 
pure water at 1 pack to 1 liter ratio. 
2. Rosewell Park Memorial Institute (RPMI) 1640 Medium 
RPMI 1640 (Rosewell Park Memorial Institute tissue culture medium 1640) 
was used for culture of both HepG2 cell-lines. Liquid medium of RPMI was 
prepared as described in 2.1.2(1). 
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2.1.3 Culture medium supplements 
1. Fetal bovine serum (FBS) 
Heat inactivated fetal bovine serum (FBS) was purchased from HyClone Thermo 
Fisher Scientific Inc. It was thawed and inactivated at 55°C and stored as 50 ml 
aliquots and kept at -20°C until use. FBS was added to 450 ml plain medium and 
made to 10% for use. 
2. Penicillin-streptomycin (PS) 
Penicillin-streptomycin (PS) antibiotic lOOX solution was purchased from 
Gibco BRL Life Technologies, Inc. (Carlsbad, C.A., U.S.A.). It contained 10,000 
unitls/ml penicillin G (sodium salt) and 10,000 |ig/ml streptomycin sulphate in 
0.85% saline. It was thawed at 37°C and stored as 5 ml aliquots at -20°C until use. 
The aliquot was added to 500 ml complete culture medium and made to 1% to 
prevent contamination of cell culture. 
3. Phosphate-buffer saline (PBS) 
Phosphate-buffer saline Tablet was purchased from Sigma Aldrich. To prepare for 
IX PBS, one tablet was dissolved in 200 ml nano pure water and autoclaved at 
120。C for 20 minutes with high pressure. It was stored at 4。C and warmed to 3TC 
before use. 
4. Trypsin-EDTA solution 
Trypsin-EDTA solution was purchased from Invitrogen Life Technology Ltd. It 
contains 0.25% trypsin and 1 mM EDTA-4Na in Hanks' Balanced Salt Solution 
(HBSS) without CaCb and MgCh. It was stored at -20°C as 40 ml aliquots and 
warmed to 3TC before use. 
5. Transfection reagents 
• L i p o f e c t a m i n e ™ Reagent and Plus™ Reagent were purchased from Invitrogen 
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Life Technology Ltd. Lipofectamine™ Reagent is a liposome formulation suitable 
for transfection of DNA into cultured eukaryotic cells. Plus™ Reagent is an 
enhancing reagent that can increase the transfection activity of Lipofectamine™ 
Reagent. 
2.2 Reagents for subcloning 
2.2.1 Reagents for polymerase chain reaction (PGR) 
1. DNA/y i / polymerase and lOX Pfu reaction buffer 
Pfu polymerase and lOX reaction buffer were purchased from Promega 
Biosciences. Both were stored at -20°C until use. The lOX reaction buffer was used 
at I X concentration which then contained 10 mM KCl, 10 mM (NH4)2S04, 20 mM 
Tris-Cl (pH 8.75 at 25。C)，2 mM MgS04，0.1% Triton X-100, 100 \xg/m\ BSA. 
2. DNA Ducan Tag polymerase and lOX MgCh-free PGR buffer 
Tag polymerase (5 U/ul) (Thermus aquaticus) and lOX MgCli-free PGR buffer 
were purchased from Amersham Biosciences. Both of them were stored at -20。C 
until use. The PGR buffer was used at I X concentration which contained 10 mM 
Tris-HCl (pH 9.0)，50mM KCL It was supplemented with 200 uM MgC^ solution 
(Amersham Phramacia) to facilitate the polymerase action. 
3. Deoxyribonuleoside triphosphate (dNTP) mix 
The stock 100 mM dNTP mix was purchased from Promega. It was diluted to 2 
• mM dNTP using sterile nano pure water and kept in aliquots at -20°C. 
2.2.2 Reagents for restriction enzyme digestion 
1. Restriction Enzymes 
、Sal I (20,000 U/ml) was purchased from BioLabs® Inc. (New England). EcoRI 
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(15 U/ |il) and EcoRV (10 U/ |il) were purchased from Promega. They were stored at 
-20°C and kept in ice during usage. 
2. One-Phor-All Plus (OPA+) buffer 
One-Phor-All Plus (OPA+) buffer was purchased from Amersham Biosciences. It 
was supplied at lOX concentrate which contained 100 mM Tris-acetate (pH 7.5), 100 
mM magnesium acetate and 500 mM potassium acetate. The function of the buffer 
was based on the concept that enzymes are more likely to retain activity when 
buffered with salts that are normally present in cells. Enzymatic digestion with single 
or double enzymatic reaction was performed in OPA+ buffer at I X or 2X 
concentration according to the restriction enzymes used. 
2.2.3 Reagents for ligation 
1. T4 DNA ligase and T4 DNA ligation buffer 
T4 DNA ligase (400 units/^il) and lOX T4 DNA ligase reaction ligation buffer 
was purchased from BioLabs® Inc. (New England). They were stored at -20°C until 
use. The T4 DNA ligase was kept on ice during usage while the reaction buffer was 
made to I X final concentration which then contained 50 mM Tris-HCl, 10 mM 
MgCli, 10 mM Dithiothreitol, 1 mM ATP, 25 |ig/ml BSA with pH 7.5. 
2.2.4 Reagents for electrophoresis 
1. Tris-Acetate-EDTA (TAE) electrophoresis buffer 
The 5OX TAE electrophoresis buffer stock was prepared by dissolving 242 g 
Tris-base in nano pure water. Then 57.1 ml acetic acid and 100 ml EDTA (pH 8.0) 
was added and made to 1 liter with water. The TAE buffer was used at I X 
concentration by diluting at 1:50 ratio with water. Both stock and working buffer 
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were stored at room temperature. 
2. Agarose gel 
Agarose gel was prepared by dissolving agarose powder in I X TAE buffer. The 
agarose powder was purchased from Invitrogen Life Technology Ltd. The powder 
buffer mixture was heated to boil until the powder completely melted. Ethidium 
bromide was added into the gel mixture at 0.7 |xg/ml for DNA staining. 
3. Ethidium bromide (EtBr) 
Ethidium bromide (EtBr) was purchased from Invitrogen Life Technology Ltd. 
It was kept in the dark at room temperature and used at a concentration of 0.7 |ig/ml 
in DNA agarose gels. 
4. Gel loading solution 
Loading dye was prepared by mixing 0.25% (w/v) bromophenol blue 
(Amerchsm Biosciences), 0.25% (w/v) xylene cyanol EF (ICN BioMedicals) and 
40% glycerol (USB) in autoclaved nano pure water. 
5. DNA ladder markers 
100 Base Pair Ladder Markers (1 and 1 kb DNA Ladder Markers (0.1 
l^g/jil) were purchased from Amersham Pharmacia and Fermentas respectively. 
2.2.5 Reagents for E. coli DH5a preparation 
1. R F l buffer 
RF1 buffer was prepared by dissolving 12 g of Rubidium Chloride (RbCl，Sigma), 
9.9g Manganese (II) Chloride Tetrahydrate (MnCl2.4H20, Sigma), 2.9g Potassium 
Acetate (BDH AnalaR)，1.5g Calcium Chloride Dihydrate (CaCb^HiO, Sigma) and 
150g glycerol (USB) in nano pure water for every liter of final solution. The solution 
was adjusted to pH 5.8 by 0.2 M acetic acid (BDH AnalaR) which was then sterilized 
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by filtration through 0.2 ^im filter (Millipore). It was stored at 4。C. 
2. RF2 buffer 
RF2 buffer was prepared by dissolving 2.1g MOPS (USB), 1.2 g RbCl，44g 
CaCl2.2H20 and 150g glycerol in nano pure water. The solution was adjusted to pH 
6.8 by sodium hydroxide (NaOH) and then sterilized by filtration. It was stored at 
2.2.6 Materials for bacterial culture work 
1. Luria broth (LB) medium and LB agar 
Both Luria broth (LB) medium and LB agar powder were purchased from USB 
Corporation. LB medium was prepared by mixing 20 g LB medium powder with 1 
liter double distilled nano water and autoclaved to melt and sterilize at 120°C for 20 
minutes. It was then kept at room temperature. LB agar plates was prepared by 
mixing 17.5 g/ml in 500 ml nano pure water and autoclaved at 120°C for 20 minutes. 
The LB agar mixture was cooled to around 55°C. Appropriate antibiotics were added 
and the agar mixture was poured into 90 mm petric dishes (Sterllin). The plates were 
kept at room temperature for two weeks or at 4°C for longer time. 
2. Ampicillin 
Stock solution of ampicillin (100 mg/ml) was prepared by dissolving the 
ampicillin powder (Amersham Biosciences) in nano pure water. The stock solution 
was kept at -20°C and diluted at a ratio of 1:1000 in LB medium/ LB agar. 
3. Kanamycin 
Stock solution of kanamycin (30 mg/ml) was prepared by dissolving the 
kanamycin powder (Invitrogen) in double distilled nano water. It was stored at -20°C 
、and -diluted at a ratio of 1:1000 in LB medium or LB agar. 
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4. Rapid Plasmid Miniprep System 
Plasmid DNA extract kit Rapid Plasmid Miniprep System was purchased from 
Marligen Biosciences. The procedure involves modified alkaline lysis and binding to 
high capacity silica membranes followed by elution with sterile nano pure water. 
5. HiSpeed Plasmid Midi Kit 
QIAGEN HiSpeed Plasmid Midi Kit was used for purification of up to 500 ug 
transfection grade plasmid or cosmid DNA. Its procedures were similar to that of 
mini plasmid kit but at a larger scale. 
2.3 Reagents for subcellular localization study 
2.3.1 Reagents for cell staining 
1. Hoechst 33342 
Hoechst 33342 was a nucleus stain purchased from Molecular Probes. It was 
supplied as a 10 mg/ml water-based solution and was used at a concentration of 25 
|ag/ml for staining cell nuclei. 
V 
2. MitoTracker®Red CMXRos 
Mitochondria staining dye MitoTracker Red CMXRos (C32H32CI2N2O) was 
purchased from Invitrogen Life Technologies Inc. It was a red-fluorescent dye that 
stains mitochondria in live cells and its accumulation is dependent upon membrane 
potential. This dye is well-retained after fixation with paraformaldehyde. It allows 
-excitation wavelength at 558 nm and emission wavelength at 583 nm. The stock 
powder was dissolved in 99.5% DMSO (LabScan) to a stock concentration of 250 
|iM and stored at -20。C in the dark. The working solution of MitoTracker Red was 
prepared by diluting the stock solution at 1:1000 ratio into culture medium and 
allowed to incubate at 37°C, 5% CO2 humidified atmosphere for 30 minutes. 
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2.3.2 Reagents for mounting slides 
1. Mounting reagent 
The mounting reagent Mowiol was purchased from Calbiochem, EMD 
Biosciences. It was prepared by dissolving 100 g Mowiol in 400 ml I X PBS with 
stirring for 16 hours at room temperature. When the powder was dissolved, 50 ml 
glycerol (Amersham Biosciences) was added to the mixture and stirred for another 
16 hours. It was adjusted to pH 8.0 and then centrifuged at 9,000 r.p.m. for 30 
minutes. The mixture was stored at 4°C in 50 ml aliquots. 
2.3.3 Materials for site-directed mutagenesis 
In vitro site-directed mutagenesis was performed with QuikChange® II 
Site-Directed Mutagenesis Kit from Stratagene. It was used to generate specific 
mutations in double-stranded plasmids. 
2.4 Reagents for cell cycle analysis and cellular proliferation 
、 
2.4.1 Reagents for cell cycle analysis 
1. Propidium iodide (PI) staining solution 
The stock propidium iodide (PI) solution (1 mg/ml) was purchased from 
Molecular Probes. It was made to the working PI staining solution by mixing 2 ml PI 
solution (1 mg/ml) with 100 Triton X-100 (Sigma), 400 0.5M EDTA (USB) and 
•• 4 ml 0.2 mg/ml RNase A (Amersham Biosciences) in a total volume of 100 ml in I X 
PBS. It was kept in the dark at 4°C. 
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2.4.2 Reagents for cellular proliferation study 
1. BrdU proliferation assay kit 
The Cell Proliferation ELISA, 5-bromo-2‘ -deoxyuridine (BrdU) colourimetric 
immunoassay kit was purchased from Roche Applied Science. It was used to assess 
the relative degree of cell proliferation by labeling the newly synthesized DNA. 
2.5 Reagents for protein expression study 
2.5.1 Cell lysis buffer 
Radio Immunoprecipitation Assay (RIPA) lysis buffer was prepared with 50 mM 
Tris-HCl (pH 7.5), 150 mM NaCl，1 mM EDTA, 1% Triton X-100, 1% Sodium 
deoxycholate, 0.1% SDS. It was stored at 4。C before use. Before using RIPA lysis 
buffer, one Complete Protease Inhibitor Cocktail Tablet (Roche Applied Science) 
was dissolved in 20 ml of the lysis buffer to inhibit the proteases and therefore to 
protect the protein samples. 
2.5.2 Reagents for SDS-PAGE 
1. Acrylamide / Bis solution 
The ready-to-use 40% PlusOne Ready lEF solution was purchased from 
Amersham Biosciences. It contained 40% acrylamide/ N,N'-methylene-bis-
acrylamide for a total monomer to cross-linker ratio of 19:1. It was stored in the dark 
at 4°C until use. 
2. Sodium dodecyl sulphate (SDS) solution 
Sodium dodecyl sulphate (SDS) was made to 10% (w/v) solution by dissolving 
10 g electrophoresis-grade SDS (Amersham Biosciences) in 100 ml nano pure water 
and kept at room temperature. 
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3. Stacking gel buffer 
The stacking gel buffer was a 0.5 M Tris-HCl buffer made by dissolving TRis 
base powder (USB) in nano pure water and adjusted to pH 6.8 using HCl . It was 
stored at 4°C until use. 
4. Running gel buffer 
The running gel buffer was a 1.5M Tris-HCl buffer made from Tris base powder. 
It was adjusted to pH 8.8 using HCl and kept at 4°C until use. 
5. Ammonium Persulphate (APS) 
Ammonium Persulphate (APS) was purchased from Bio-Rad Laboratories. It was 
made to 10% (w/v) by dissolving in nano pure wate. It was stored as 400 |il aliquots 
at -20'C. 
6. N,N,N',N'-Tetramethylethylenediamine (TEMED) 
TEMED was purchased from Amersham Biosciences. It was the last-added 
reagent in setting running or stacking gel to initiate the polymerization of the 
SDS-polyacrylamide gel. It was stored in the dark at room temperature. 
V 
7. Tris-glycine SDS gel loading dye 
Tris-glycine SDS gel loading dye (6X) without p-mercaptoethanol (Bio-Rad 
Laboratories) was prepared with with 300 mM Tris-HCl (pH 6.8)，200 mM 
dithiothretiol, 4% SDS, 0.2% bromophenol blue and 20% glycerol. It was kept at 4。C 
for long term storage. Before usage, 1ml p-mercaptoethanol was added to every 9 ml 
. . o f the loading dye mixture and kept at room temperature. 
8. Rainbow marker standard 
SeeBlue Plus® 2 Pre-stained standard marker was purchased from Invitrogen Life 
Technology Ltd. It was supplied in 60% formamide and stored at -20°C until use. 
« The standard proteins in the marker mixture were summarized in Table 2.1. 
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Table 2.1 The apparent molecular weights of the protein bands in SeeBlue® 
Plus2 Pre-Stained Standard in Tris-Glycine system. 
Proteins Molecular weight (kDa) Colour 
Myosin 250 Blue 
Phosphorylase 148 Orange 
BSA ^ Mue 
Glutamic Dehydrogenase 64 Blue 
Alcohol Dehydrogenase 50 Purple 
Carbonic Anhydrase 36 Blue 
Myoglobin Red 22 Pink 
Lysozyme 16 Dark blue 
Aprotinin 6 Blue 
Insulin, f> Chain 4 ^ 
9. Running buffer 
V 
SDS-PAGE running buffer was first prepared in 5X concentration. It was made 
with 15.1 g Tris-Base (USB), 4 g Glycine (USB) and 5 g SDS (Amersham 
Biosciences) in 1 liter nano pure water and stored at room temperature. The 5X 
running buffer was diluted with nano pure water to IX working concentration before 
use. 
10. Coomassie blue staining solution 
Coomassie blue staining solution was prepared by dissolving 1.25 g Coomassie 
Brilliant Blue R-250 (Bio-Rad) in 50 ml acetic acid (Sigma), 225 ml methanol, 225 
ml nano pure water for 500 ml final solution. The mixture was stirred to dissolve at 
room temperature for 2 hours and stored at room temperature. It was ready to be used 
for staining the protein on SDS-PAGE acrylamide gels. 
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11. Destaining solution 
Destaining solution was used to remove the excess Coomassie blue staining 
solution from acrylamide gels. It was prepared by mixing 1 volume of acetic acid, 3 
volumes of methanol with 6 volumes of nano pure wate. The prepared solution was 
stored at room temperature. 
2.5.3 Reagents for Western blot 
1. Transfer buffer 
Transfer buffer was prepared by dissolving 3.03 g Tris-base, 14.4 g Glycine in 
nano pure water and made to 850 ml final volume. To the Tris-Glycine mixture, 150 
ml methanol was added. The buffer was kept at 4。C until use. 
2. Polyvinylidene fluoride (PVDF) Western blot transfer membrane 
Immobilon丁M-P transfer membrane, a microporous polyvinylidence difluoride 
(PVDF) membrane with a pore size of 0.45 |Lim was purchased from Millipore. It was 
cut into the size that fitted the SDS-PAGE for use. 
V 
3. Tris-buffered saline-Tween (TBST) 
Tris-buffered saline (TBS) lOX concentrate containing 0.2 M Tris-HCl, 1.5 M 
NaCl (usb) per liter was prepared, autoclaved and stored at room temperature. 
TBS-Tween washing buffer was prepared by diluting the lOX TBS buffer to I X 
concentration, to which 1 ml Tween 20 (Sigma) was added. The prepared TBS-0.1 % 
Tween washing buffer was ready to be used for washing membranes. 
4. Blotting reagent 
Blotting reagent was used at 10% (w/v) concentration. It was prepared by 
dissolving the Blotting-Grade Blocker Non-Fat Dry Milk powder (BioRad) in I X 
TBST washing buffer. 
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5. Western blotting luminal reagents 
Western Lightning™ Chemiluminescence Reagent Plus was purchased from 
Perkin Elmer. It includes an enhanced luminol reagent and an oxidizing reagent 
which were stored in the dark at 4°C. Equal volume of both reagents was mixed well 
which worked as a substrate for horse radish peroxidase (HRP). 
6. X-ray film 
The Super R X X-ray film was purchased from Fuji Photo Products Co. Ltd. It 
was kept at a dark area at room temperature. 
2.5.4 Antibodies 
1. Primary antibodies 
a. Anti-GFP antibody 
Mouse monoclonal IgGia Living Colors® A.v. antibody was purchased from 
Clontech. It was produced by hybridoma cells against full-length Aequorea victoria 
green fluorescent protein (GFP) which recognizes native and denatured forms of 
wild-type GFP and different variants in bacterial and mammalian cell lysate. It could 
be used in WB and IP and was stored at -20°C. 
b. Anti-Cyclin A antibody 
Rabbit polyclonal anti cyclin A IgG was purchased from Santa Cruz 
Biotechnology and stored at 4。C. It contains 200 |ig/ml rabbit IgG epitope 
corresponding to amino acids 1 -432 representing full length cyclin A of human origin. 
It is recommended for the detection of cyclin A and cyclin A l of mouse, rabbit and 
human origin by Western blot (WB), immunoprecipitation (IP), immunofluorescence 
(IF) and immuno-histochemistry (IHC). It was used at 1:500 dilutions for WB. 
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c. Anti-Cyclin E antibody 
Rabbit polyclonal anti cyclin E IgG was purchased from Santa Cruz 
Biotechnology and stored at 4°C. It contains 200 |ig/ml rabbit IgG epitope 
corresponding to the C-terminus of rat cyclin E. It is recommended for the detection 
of cyclin E of mouse, rabbit and human origin by Western blot (WB), 
immune-oprecipitation (IP), immunofluorescence (IF) and immuno-histochemistry 
(IHC). It was used at 1:500 dilutions for WB. 
d. Anti-p actin antibody 
Mouse monoclonal anti p-actin IgG was purchased from Sigma-Aldrich and 
stored at -20°C. It was raised against an epitope located on the N-terminal end of the 
p-isoform of actin and could be used for WB, IF, IHC and indirect ELISA. It was 
used at 1:10,000 dilution. 
e. Ant i-pERK antibody 
Mouse monoclonal antibody anti pERK antibody was purchased from Santa 
Cruz Biotechnoloty, Inc. and stored at 4。C. It contains 200 \xg/m\ IgGia epitope 
corrrescponding to a sequence containing phosphorylated Tyr 204 of ERK of human 
origin. It is recommended for detection of ERK 1 and ERK 2 phosphorylated at Tyr 
204 of mouse, rat and human origin by WB, IP, IF and IHC. 
f. Anti-ERK antibody 
Rabbit polyclonal antibody anti ERK 1 antibody was purchased from Santa 
Cruz Biotechnoloty, Inc. and stored at 4。C. It contains 200 fig/ml IgG epitope 
corrrescponding to a peptide mapping subdomain X I of ERK 1. It is recommended 
for detection of ERK 1 p44 and to a lesser extent ERK 2 p42 of mouse, rat and 
human and other animals origin by WB, IP, IF and IHC. 
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2. Secondary antibodies 
a. Anti-mouse immunoglobulins/HRP 
Polyclonal Rabbit anti-mouse IgG/Horse Radish Peroxidase (HRP) was 
purchased from DakoCytomation. It was purified from rabbit antiserum conjugated 
with HRP and can react with all mouse IgG subclasses. It was stored at 4°C. 
b. Anti-rabbit immunoglobulins/HRP 
Polyclonal goat anti-rabbit IgG/Horse Radish Peroxidase (HRP) was purchased 
from DakoCytomation and stored at 4°C. It was purified from goat antiserum 
conjugated with HRP and can react with all rabbit IgG subclasses. 
2.6 Reagents for gene expression study 
2.6.1 Reagents for RNA extraction 
1. Diethyl pyrocarbonate (DEPC) 
DEPC was purchased from Sigma Aldrich. It was stored at 4。C. It inactivates 
RNase in water or I X PBS at 0.1-0.2% (v/v), thus protecting RNA against 
degradation. 
2. DEPC-treated water 
DEPC was added to nano pure water at 1:1000 ratio to give 0.1% DEPC-water 
and it was then shaken overnight at 37°C for 150 r.p.m. to disperse the DEPC. The 
solution was then autoclaved at 120°C for 30 minutes to degrade the remaining 
DEPC and then stored at room temperature. 
3. DEPC-treated PBS 
DEPC was added to 1 liter nano pure water at 1:1000 ratio together with 5 PBS 
tablets to give 0.1% DEPC-IX PBS and shaken overnight at 37°C for 150 r.p.m. to 
disperse the DEPC. The solution was then autoclaved at 120°C for 30 minutes to 
CHAPTER 2 Experiment Materials 37 
degrade the remaining DEPC and then stored at room temperature. 
4. TRIzol® reagent 
TRIzol® reagent was purchased from Invitrogen Life Technology Ltd. It was a 
ready-to-use reagent stored in the dark. 
5. RNeasy Mini Kit 
RNA isolation from the cell-lines was performed using RNeasy Mini Kit which 
was purchased from QIAGEN. It was a ready-to-use kit which was stored at room 
temperature. 
2.6.2 Reagents for fist strand cDNA synthesis 
1. High-Capacity cDNA reverse transcription kit 
High-Capacity cDNA Reverse Transcription Kit was purchased from Applied 
Biosystems. It uses the random primers scheme for initiating cDNA synthesis which 
takes the advantage that random primers ensure that the synthesis occurs efficiently 
with all species of RNA molecules present. It was stored at -20°C. 
V 
2. Reagent for RNase H digestion 
Ribonuclease H (RNase H), 10 U/|il was purchased from Applied Biosystems 
and stored at -20°C. 
2.6.3 Reagents for real-time PGR 
1. Power SYBR Green PGR Master Mix 
Power SYBR® Green PGR Master Mix was purchased from Applied Biosystem. 
It is a modified formulation of SYBR Green PGR Master Mix that contains the 
enzymes, dNTP mix and buffer necessary for the PGR and works with a higher 
sensitivity than the original SYBR Green PGR master mix. 
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2.7 Reagents for establishment of Tet-On inducible stable cell-lines 
2.7.1 Reagents for MTT assay 
(MTT) ultrapure powder was purchased from USB Corporation and is stored in 
the dark at room temperature. The MTT solution was prepared by dissolving the 
powder in nano pure water and made to 3 mg/ml. The solution was protected from 
light and kept at 4。C. 
2.7.2 Reagents for selection of stable clones 
1. Geneticin 
Geneticin® Selective Antibiotic (50 mg/ml, C2oH4oN40io.2H2S04) was 
purchased from Invitrogen Life Technology Ltd. It was a selection agent commonly 
used for the selection of mammalian, plant, or yeast cells. It was stored as aliquots at 
-20°C and diluted in culture medium prior to use for selection of Tet-On transfected 
cells. 
2. Hygromycin 
Hygromycin B (50 mg/ml), an amino glycosidic antibiotic produced by 
Streptomyces hygroscopicus and kills microorganisms by inhibiting protein synthesis, 
was purchased from Invitrogen Life Technology Ltd. It is used to select the Tet-On 
cells successfully transfected with pTK-Hyg vector that contains a hygromycin 
resistant gene. 
3. Doxycycline 
Doxycycline (Dox, C22H24N2O8.HCI.I/2C2H5OH.I/2H2O), the Tet system 
inducer, is a derivative of tetracycline purchased from Clontech. It was in powder 
form and was stored at 4。C in the dark. Stock doxycycline solution was prepared by 
dissolving in nano pure water to 1 mg/ml and filtering in a culture hood to sterilize. 
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The solution was stored at 4°C in the dark for not more than 4 weeks or at -20。C for 
long-term. The Tet-On system in our study was induced by 400 ng/ml doxycydine 
which was freshly diluted into culture medium in individual experiments. 
2.8 Vectors used in the project 
2.8.1 Vectors for subcellular localization study 
1. pEGFP-Cl 
pEGFP-Cl (Clontech) encodes a red-shifted variant of wild-type EGFP which 
has been optimized for bright fluorescence and higher expression in mammalian cells 
with an excitation maximum at of 488 nm and emission maximum of 507 nm. It 
contains a kanamycin/ neomycin resistant gene of Tn5 while the gene cloned into the 
multiple cloning sites (MCS) will be expressed as fusion to the C-terminus of EGFP 
(Fig. 2.1a). 
2. pDsRed2-Mito 
pDsRed2-Mito (Clontech) is a mammalian expression vector that encodes a 
fusion of Discosoma sp. Red fluorescent protein (DsRed2) and the mitochondrial 
targeting sequence from subunit VIII of human cytochrome c oxidase. The expressed 
Mito sequence targets the Mito-DsReds fusion protein to the host cell's mitochondria. 
It was used as the plasmid vector for locating mitochondria (Fig 2.1b). 
‘ 2.8.2 Vectors for establishment of Tet-On inducible cell-lines 
1. Tet-On® 
The pTet-On® Vector is used to develop stable Tet-On cell lines. It expresses the 
reverse tet-responsive transcriptional activator (rtTA) which is a fusion of amino 
acids 1-207 of the tet repressor (TetR) and the negatively charged C-terminal 
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activation domain (130 amino acids) of the VP 16 protein of herpes simplex vims. 
After a vector that contains a gene under the control of a tet-responsive element 
(TRE) is transfected into a Tet-On cell line, the rtTA binds to the TRE, thus 
activating transcription in the presence of doxycycline (Dox) (Fig. 2.1c). 
2. pTRE2 
pTRE2 is a response plasmid that can be used to express a gene of interest in 
Tet-On or Tet-off systems. It has a MCS where foreign gene sequence with an 
initiating ATG codon can be placed. It dose not consist of an antibiotic resistant gene 
that the pTRE2-gene plasmid must be cotransfected with the pTK-Hyg for stable 
transfectants (Fig. 2.Id). 
3. pTRE2-Luc 
pTRE2-Luc contains the gene encoding firefly luciferase cloned into the Bam 
HI and Nhe I sites in the pTRE2 MCS. The luciferase construct adds 1.65 kbp to 
pTRE2. 
4. pTK-Hyg 
pTK-Hyg is a selection vector with hygromycin resistance in mammalian cells. 
It is especially useful for selection of double-stable cell lines using the Tet-On™ or 
Tet-OfFM Gene Expression Systems because the absence of an enhancer element on 
pTK-Hyg prevents the unwanted activation of pTRE- and pBI-derived plasmids upon 
cointegration into the host cell's genome. pTK-Hyg can be cotransfected into the host 
- cell line with an expression plasmid which contains a gene of interest (Fig. 2.1 e). 
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Figure 2.1 Vectors used in the project, (a) pEGFP-Cl vector for making 
EGFP-gene constructs, (b) pDsRed2-Mito used as a positive control for locating cell 
, mitochondria, (c) Tet-On vector, (d) pTRE2 vector for subcloning the target gene, (e) 
pTK-Hyg for hygromycin selection. 
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2.9 Primers used in the project 
2.9.1 Primers used for subcloning 
Subcloning primers were designed based on the sequence of HBx adwl, 
genotype A (NCBI nucleotide: AF462041). Each of the primers includes a GC clamp 
sequence TAGGGC, restriction sites, an initiating or stop codon and extra bases to 
make the sequence in frame to the reading sequence of the vector (Table 2.2). 
Table 2.2 Subcloning primers for HBx and mutants designed for various vectors 
Sequence ^ ^ ^ ^ Orientation Sequence 5'->3' 
1 GFP-C1-HB» Forward 5' TAGGGCGAATTC i ATG GCT GCT AGG CTG TAC TGC 3' £cqR 1 
HBx pEGFP-Cl Reverse 5' TAGGGC GTCGAC H A GGC CTC AAG GTC GGT CGT 3' Sail 
2 GFP-Cl-HBxAC44 
HBxdC44 pEGFP-Cl Revei^e 5' TAGGGC GTCGAC I 1A GGC CTC AAG GTC GGT CGT 3' Sail 
3 GFP-CI-HBxAN60 Forward 5' TAGGGC GAATTC T ATG TGT GCC TTC TCA TCT GCC GG 3' EcoR I 
HBxdN60 pEGFP-Cl 
4 GFP-Cl-HBxAClO Forward 5' TAGGGCGAATTC l ATG GCT GCT AGG CTG TAC TGC 3' EcoR 1 
HBxdClO pEGFP-Cl Reverse 5' lAGGGC GTCGAC TTA TGCGCAGACCAATTTATG 3' Sail 
5 GFP-Cl-HBxAC20 Forward 5' TAGGGCGAATTC i ATG GCT GCT AGG CTG TAC TGC 3' £coR 1 
5' TAGGGC GTCGAC n A TAA TAC AAA GAC CTT TAA CCT 
HBxdC20 pEGFP-Cl Reverse AAT CTC 3' Sal \ 
6 GFP-Cl-HBxAC30 Forward 5' TAGGGCGAATTC i ATG GCT GCT AGG CTG TAC TGC 3' EcoR I 
HBxdC30 pEGFP-C 1 Reverse 5' TAGGGC GTCGACTIA CCC CAG CTC CTC CCA GTC 3' Sail 
7 GFP-Cl-HBxAC37 Forward 5' TAGGGCGAATTC i ATG GCT GCT AGG CTG TAC TGC 3' EcoR i 
HBxdC37 pEGFP-C 1 Reverse 5' TAGGGCGTCGAC T TA AAA CAC ACA GTC TTT GAA 3' Sa/1 
8 GFP-Cl-HB»l-60 Forward 5' TAGGGCGAATTC 1 ATG GCT GCT AGG CTG TAC TGC 3' EcoR 1 
HBx 1-60 pEGFP-Cl Reverse 5' TAGGGC G T C G A C H A GAC GGG GAG ACC GCG TAA 3' Sal\ 
9 GFP-Cl-HBx61-110 Forward 5 'TAGGGC GAATTC .I. AT(丨 TGT GCC TTC TCA TCT GCC GG 3' EcoR] 
HBx61-110 pEGFP-Cl Reverse 5' TAGGGC GTCGACTI A GGC CTC AAG GTC GGT CGT 3' 5a/1 
10 GFP-Cl-HBxl l l-lS4 Forward 5' l AGGGC GAATTC I TAC TTC AAA GAC TGT GT 3' EcoR I 
HBxl 11-154 I pEGFP-Cl Reverse 5' TAGGGC GTCGAC H A GGC AGA GGT GAA AAA GTT GCA 3' Sail 
J J TRE-HB» Forward 5' TAGGGC GTCGAC ATG GCT GCT AGG CTG TAC TGC 3' Sail 
HBx pTRE2 Reverse 5' TAGGGC GATATC TTA GGC AGA GGT GAA AAA GTT GCA 3' EcoR V 
12 TRE-HBxAC44 
HBxdC44 pTRE2 Reverse 5' l AGGGC GATATC T I'A GGC CTC AAG GTC GGT CGT 3' EcoR V 
13 TRE-HBxAN60 Forward 5'TAGGGC GTCGAC ATG TGT GCC TTC TCA TCT GCC GG 3' Sail 
HBxdN60 pTRE2 
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2.9.2 Primers for site-directed mutagenesis 
Primers for site-directed mutagenesis were designed as instructed by the kit. The 
mutagenic primers (Table 2.3) contained the desired mutations and anneal to the 
same sequence on opposite strands of the plasmid. 
Table 2.3 Primers used for in vitro site-directed mutagenesis 
Name Mutation Orientation Sequence 5,-->3, 
1 H B x Y l l l A Tyrosine Forward accgaccttgaggccGCTttcaaagactgtgtg 
Reverse cacacagtctttgaaAGCggcctcaaggtcggt 
2 HBxF112A Phenylalanine Forward gaccttgaggcctacGCTaaagactgtgtgttt 
Reverse aaacacacagtctttAGCgtaggcctcaaggtc 
3 HBxK113A Lysine Forward cttgaggcctacttcGCTgactgtgtgtttaag 
Reverse cttaaacacacagtcAGCgaagtaggcctcaag 
4 HBxD lMA Aspartate Forward gaggcctacttcaaaGCTtgtgtgtttaaggac 
Reverse gtccttaaacacacaAGCtttgaagtaggcctc 
5 HBxC115A Cysteine Forward gcctacttcaaagacGCT gtgtttaaggactgg 
Reverse ccagtccttaaacacAGCcgtctttgaagtaggc 
、 
6 HBxV116A Valine Forward tacttcaaagactgtGCTtttaaggactgggag 
Reverse |ctcccagtccttaaaAGCacagtctttgaagta 
2.9.3 Primers used for real-time PGR 
Primers for real-time PGR were designed using Primer Express 3.0 program 
which is specified for real-time PCR primer design. They are listed in Table 2.4. 
5IVDI5VVVDD55I55VOVID5|SSLAXIY、>I-3OIM 
1D0VV0VVVDDD1VV00130 ~PJ 删 oj J-Ooq^ 沖AZJO—WM DOilH 
IDIVVVDDIDDOIOIDIDIDIVD isIdXiy 
1V1D1001V1131D0V000D0 PJ 则 oj FWW 乙•O—WM H^ ^ 
VVV0VD1131DD10VV3VVD0D ~3SJ9A3"a 
10V100VVD3DD3D0VVVV0 ~P 皿 JOj J-。人 W 乙 9 乙OOO—WNL 。加-A ^ 
D011D1101D0130V00V0V00001 ~ssjiXi^ >1-丄"H 
Ii5iv5IoI5555ddI55I55555pj観oj i-i-a"esci r^sooo—WM ^esdi 
V 丄 0 丄 OOOO 丄丄丄 DO 丄 OVOOD ^-eiH^^aD 
VOO 丄丄丄 VVOD 丄 DVVOOODV PJBAVJOJ J-aiM^iaD wo 甘 00_WM LZ^ f 
0 丄 0 丄 VVVOV 丄 90 丄 DVDO 丄丄丄 000 3SJ3A3>I I^-VINDIGD 
VVVOOIDDDVOIOIOVDVDOL pJBAVJOj i'VlN^iaD 68e000~WN. IZ^ £ 
VV 丄 VVOD 丄 DO 丄 VDD 丄 0 丄 OOOV 3SJ3A9>I ^-HMDD 
VVVOOOVll丄OODOOVO丄VO pJBAUOj d-RHDO 8e^l00~PMNL 3 z 
丄 OVOVOOJVO 丄 0：)丄 OVO 丄 0 丄丄 O >I-IVM33 
：)丄 0 丄丄丄 DVOOVVOOVOOVVDDV pmmo^ J-IVM33 l7l6e00~IAIlS[ IV i 
, jsquinu 
.e<".S 33U3nb3S UOIJBJUaUO ^^m ®O 
U0IPB3J 3SCJ[3UlX|0d UI pSSIl SJ9UIUJ p'Z 3[qBX 
PP SIBU9JBIAJ juaiuuadxH z -aaidVHD 
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CHAPTER 3 
Research Methods 
3.1 Subcloning of HBx and mutant genes into a green fluorescence 
protein (GFP) expression vector 
3.1.1 Amplification of HBxWt, HBxAC44 and HBxAN60 genes 
Pairs of primers were designed flanking the full length or partial sequences of 
HBx open reading frame (ORF) with the addition of a start or stop codon, Sal I and 
EcoR I restriction sites and 5' end clamp sequences (TAGGGC) to facilitate 
restriction enzyme digestion, as listed in Table 2.2. Primers were designed to frame 
the full-length and the sequences that did not include the N-terminus or the 
C-terminus. The determination of region of termini was based on a publication in 
1997 (Elmore et al., 1997) which described the interaction between p53 tumor 
suppressor and different regions of HBx protein. The primers were designated as 
GFP-Cl-HBx-F/ GFP-Cl-HBx-R for wild-type HBx gene (HBxWt), 
GFP-Cl-HBx-F/ GFP-Cl-HBxAC44-R for C-terminal truncation mutant (HBxAC44) 
and GFP-Cl-HBxAN60-F/ GFP-Cl-HBx-R for N-terminal truncation mutant 
(HBxAN60), respectively. 
Polymerase chain reaction (PGR) was performed in a 50 fxl mixture with 200 
nM each of the each of the primers, Ix Pfu buffer, 200 fiM dNTP mixture, 2.5 Units 
Pfu polymerase (Promega), sterile nano pure water, and together with 1 |il diluted 
pTRE2-HBx plasmid template, which contained full-length HBx gene in the pTRE2 
vector that was obtained from previous research on HBx (Ng et al., 2004). The 
original HBV clone was purchased from ATCC and belongs to subtype adw2 and 
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genotype A. PGR reaction was performed using PTC-200 DNA Engine (Petlier 
Thermal Controller) by denaturing at 94°C for 5 minutes, followed by 35 cycles of 
amplification at 94°C for 36 seconds, 58。C for 36 seconds, 72°C for 36 seconds, with 
a final extension at 72°C for 10 minutes. 
The PGR product was analyzed on a 0.2 % TAE agarose (Invitrogen) gel with 
0.7 |xg/ml ethidium bromide (Invitrogen). The gel was visualized and photographed 
under ultra violet light, using a UVitec DNA gel machine. 
3.1.2 Purification of PCR products 
Electrophoresis separates the PCR products according to the sizes. The desired 
PCR products were visualized on a 2UV™ Transilluminator and then excised out 
and weighed. Purification of PCR product from the gel was performed using 
QIAquick® DNA Extraction Kit (QIAGEN). The excised gels were dissolved in 3 gel 
weight/volumes of QC buffer at 55。C for 15 minutes, with occasional shaking. One 
gel weight/volume of isopropanol was added to the dissolved mixture to maximize 
the yield of small DNA less than 500 base pairs. The mixture was then loaded into a 
QIAquick spin column and put on a 2 ml collection tube. The column was then 
subjected to centrifugation at 13,000 r.p.m. for 1 minute. The flow through in the 
collection tube was discarded. The DNA bound to the column membrane was then 
washed once with 700 |il PE buffer. The column was centrifuged at 13,000 r.p.m. for 
1 minute. After disposing of the flow through, the tube was re-centrifuged at 13,000 
for 2 minutes, followed by 3 minutes air-drying to remove the residual ethanol in the 
buffer. The DNA was eluted from the membrane by applying 30 |il 65°C sterile nano 
pure water and incubated at room temperature for 2 minutes. The purified DNA 
products were obtained by centrifugation at 13,000 r.p.m. for 2 minutes. 
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3.1.3 Restriction enzyme digestion 
Restriction enzyme digestion of the purified PCR product was performed in a 
20 \i\ reaction mixture containing 2X One-Phor-All PLUS buffer (Pharmacia), 12 
Units of Sal /，12 Units of EcoR /，10 pi purified PCR product, and sterile nano pure 
water. The reaction mixture was incubated at 37°C for 3 hours for restriction 
digestion followed by heat termination at 85。C for 20 minutes. Restriction digestion 
of the pEGFP-Cl (Clontech) vector was performed in parallel using the same 
restriction enzymes. The digestion products and pEGFP-Cl vector were analyzed on 
a 1% TAE agarose gel. The target bands were excised out and subjected to 
purification as described in section 3.1.2. 
3.1.4 Ligation of gene products with pEGFP-Cl vector 
Ligation of the purified and digested gene products into pEGFP-Cl vector was 
performed in a 20 |il reaction mixture containing I X ligation buffer, 10 ng Sal // 
EcoR I digested pEGFP-Cl, 30 ng purified DNA insert, 5 units of T4 DNA ligase 
(Invitrogen) and sterile nano pure water. A control reaction was performed in parallel 
by replacing the DNA insert with water. The reaction mixture was incubated at 16°C 
for 16 hours for ligation. 
3.1.5 Preparation of chemically competent bacterial cells E. coli strain 
DH5a 
Preparation of chemically competent bacterial cells for transformation was 
based on the Hannahan method (Hanahan, 1983) which took about three days. On 
day one, LB agar (USB) plate without antibiotics was prepared as a solid platform 
for bacterial growth. E. coli strain DH5a was streaked onto the LB plate and 
incubated overnight at 37°C to obtain single colonies. On day two, a single colony of 
E. coli was inoculated in 10 ml LB medium (USB) and the culture was incubated at 
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37°C for 16-20 hours with shaking at 250 r.p.m. to obtain a starter culture. On day 
three, 5 ml overnight culture was sub-cultured into 250 ml LB medium and further 
incubated and shaken for about 2-3 hours until its absorbance at wavelength ⑷ 600 
nm reached 0.4-0.6. Bacterial cells were harvested by centrifugation at 6,000 r.p.m. 
at 4°C for 10 minutes. The supernatant was decanted and the cell pellet was 
resuspended in 83 ml (1/3 of the original culture volume) RF l buffer by pipeting up 
and down. The suspension was incubated in ice for 15 minutes before centrifugation 
at 6,000 r.p.m. at 4°C for 10 minutes to harvest the cells. The supernatant was 
discarded and the cell pellet was resuspended in 20 ml (1/25 of original culture 
volume) RP2 buffer by pipeting up and down. The suspension was incubated in ice 
for further 15 minutes and then aliquot to 200 |il fractions into pre-chilled 1.5 ml 
microcentrifuge tubes. The aliquots were frozen immediately in liquid nitrogen and 
then stored at C. 
3.1.6 Transformation of the ligation product into competent cells 
The frozen competent cells E. coli strain DH5a cells were thawed on ice for 10 
minutes. Ligation mixture was then mixed with 200 |il competent cells and incubated 
in ice for 20 minutes. The cells were heat shocked at 42°C for 90 seconds and then 
chilled immediately in ice for 3 minutes. To the cell mixture, 800 |il LB medium was 
added, followed by incubation at 37°C for 1 hour with shaking at 250 r.p.m. The cells 
were centrifuged down at 9,000 r.p.m. for 3 minutes and resuspended in 150 |xl LB 
medium. All the cell suspension was spread onto LB agar plate containing 
kanamycin (30 |ag/ml) and incubated at 37°C for 16 hours in an inverted position. 
3.1.7 P G R confirmation of successful ligation 
Single colonies of the transformants were picked up from the LB-kanamycin 
plates and seeded onto another LB-kanamycin plate grid to assign a number to each 
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colony and incubated at 37°C for further 16 hours. Some of the cells were picked for 
PCR insert checking in parallel. PCR mixture was prepared using Ducan DNA Taq 
polymerase in a 10 mixture with IX MgCb free PCR buffer, 200 ^M dNTP 
mixture, 200 |xM Mg2Cl2,2.5 units Ducan Taq polymerase , 200 nM of gene specific 
forward primer and vector specific reverse primer pEGFP-Cl-R and sterile nano pure 
water. The reaction was performed on a PTC-200 DNA Engine (Petlier Thermal 
Controller) by denaturing at 94°C for 5 minutes, followed by 30 cycles of 
amplification at 94°C for 1 minute, 58°C for 1 minute, 72°C for 1 minute, with a final 
extension at 72°C for 10 minutes. The PCR products were analyzed on a 1% TAE 
agarose gel. 
3.1.8 Small scale preparation of bacterial plasmid DNA 
The clones that gave a desirable PCR product were inoculated in 5 ml LB 
medium containing kanamycin (30 |ig/ml) and incubated at 37°C overnight with 
shaking at 250 r.p.m. The overnight culture was harvested by centrifugation at 6,000 
X g for 5 minutes. The plasmid DNA was isolated by using Rapid Plasmid Miniprep 
System (Marligen Biosciences) with recommended procedures of the kit. The 
supernatant was discarded and the cell pellet was resuspended in 250 4。C Cell 
Suspension Buffer by vortexing. Then 250 pi Cell Lysis Buffer was added to the cell 
suspension and mixed by inverting the tube up and down for five times. Lysis was 
performed by incubating at room temperature for 5 minutes. To the lysis mixture, 
350 |il Neutralization Buffer was added and mixed immediately by inverting up and 
down the tubes. The suspension was centrifuged at 13,000 r.p.m. for 10 minutes to 
remove the cell residues. The clear supernatant was loaded into a spin cartridge that 
was put into a 2 ml collection tube and centrifuged at 13,000 r.p.m. for 1 minute. The 
flow through was discarded and 700 jil Wash Buffer that contained ethanol was 
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added to the spin cartridge and centrifuged at 13,000 r.p.m. After disposing of the 
flow through, the tube was recentrifuged at 13,000 r.p.m. for 2 minutes and then 
air-dried for 3 minutes to remove the residual buffer and ethanol. The plasmid DNA 
was eluted with 40 fil 65°C sterile nano pure water. 
3.1.9 DNA sequencing of the cloned plasmid DNA 
DNA sequencing for the cloned plasmid DNA was performed by the 
commercial sequencing service TechDragon Company with a vector specific forward 
primer and gene specific reverse primers. 
3.1.10 Large scale preparation of target recombinant plasmid DNA 
After verification of the insert sequences by DNA sequencing, clones with 
interesting inserts were picked up from the steaked plates and inoculated into 150 ml 
LB medium containing kanamycin (30 |ig/ml). The culture was incubated at 37°C 
overnight with shaking at 250 r.p.m. The overnight culture was harvested by 
centrifugation at 6,000 x g at 4。C for 10 minutes. The plasmid DNA was isolated by 
using HiSpeed Plasmid Midi Kit (QIAGEN). The supernatant was discarded and the 
V 
pellet was resuspended in 6 ml resuspension Buffer PI by vigorous vortexing. Then 6 
ml lysis Buffer P2 was added and mixed gently. The mixture was incubated at room 
temperature for 5 minutes cell lysis. After cell lysis, 6 ml neutralization Buffer P3 
was added to the lysate and mixed gently immediately. The neutralized lysate was 
then transferred into the barrel of a QIAfilter™ Midi Cartridge that was closed by a 
cap, and allowed to incubate at room temperature for 10 minutes. During the 
incubation, a Hispeed™ Midi Tip was equilibrated with 4 ml Buffer QBT. After 
incubation, the neutralized lysate was filtered into the equilibrated Hispeed™ Midi 
Tip with the aid of a plunger. The lysate was allowed to enter the resin of the Midi 
, T i p by gravity flow. The Midi Tip was then washed with 20 ml Buffer QC by gravity 
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flow. The bound DNA was eluted with 5 ml Buffer QF. To the eluted DNA, 3.5 ml 
isopropanol was added to precipitate the DNA. The content was mixed and incubated 
at room temperature for 5 minutes. During the incubation, a QIAprecipatator^'^ Midi 
Module was fixed to a 20 ml syringe. The eluate/isopropanol mixture was transferred 
into the syringe and filtered into the Midi Module with a matched plunger. The 
QIAprecipatator™ Midi Module was removed from the syringe outlet nozzle before 
pulling out the plunger. The QIAprecipatator^^ was reattached to the syringe and 2 
ml 70% ethanol was applied to the syringe. The 70% ethanol was filtered through the 
QIAprecipatator™ by inserting the plunger. The bounded DNA was air dried to 
•-pik * 
remove the residual ethanol by pressing air through the QIAprecipatator . The 
QIAprecipatator™ was reattached to a 5 ml syringe and 500 |il 65。C sterile nano 
pure water was applied. The matched plunger was inserted and pressed to transfer the 
eluted DNA into a 1.5 ml microcentrifuge tube. The quantity of plasmid DNA and 
protein was measured by a UV-Vis spectrophotometer at 260 nm and 280 nm 
respectively. The quality of the plasmid DNA was analyzed on a 1% TAE agarose 
V 
gel. 
3.2 Subcellular localization pattern study 
Subcellular localization pattern study is the study of protein distribution in a cell. 
It can be made possible by conjugating an enhanced green fluorescence protein 
' (EGFP) tag to the target protein which when expressed, emits green fluorescence 
upon X-=488 nm excitation and X = 5 0 7 emission. 
3.2.1 Cell Transfection 
A square glass slip (MARIENFELD) was flamed to sterilize which served as a 
、seeding platform. Cells were counted and 2 x 10^ (60% confluent) per well were 
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seeded onto a glass slip put in a 6-well plate before the day of transfection. 
Transfection was performed according to the instructed procedures of 
LipofectamineTM Reagent (Invitrogen). One the day of transfection, 0.8 p^ g plasmid 
pEGFP-Cl-HBxWt or pEGFP-Cl-HBx mutants as well as pEGFP-Cl vector were 
diluted in 100 \x\ serum-free DMEM or RPMI 1640 according to the cell type of 
interest. The diluted plasmid was then mixed with 6 Plus™ Reagent (Invitrogen) 
and allowed to incubate at room temperature for 15 minutes. Meanwhile, 4 fil 
LipofectamineTM was diluted by 100 \x\ serum-free medium. After incubation, the 
DNA-Plus pre-complex and the diluted L i p o f e c t a m i n e T M reagent were mixed 
together and further incubated for 15 minutes at room temperature. During the 
incubation, the complete culture medium on the 6-well plate was replaced by 1 ml 
serum-free plain medium. The DNA-Plus-Lipofectamine complexes were added to 
the cells and incubated at 37°C, 5% CO2 for 3 hours. After 3 hours incubation, the 
serum-free medium with the transfection mixture was replaced by 2 ml 10% serum 
medium and allowed to grow. Co-transfection with pDsRed2-Mito vector which 
expressed a mitochondrial targeting sequence with the subunit VIII of human 
cytochrome c oxidase, was performed for confirmation of localization. 
3.2.2 Mitochondria and nucleus staining 
At 36 hours post-transfection, cells were ready for cell staining for subcellular 
localization observation. To stain the mitochondria (if the cells were not transfected 
- with pDsRed2-Mito), 250 nM MitoTracker Red (Molecular Probes) was added to the 
medium and incubated at 37°C, 5% CO2 in darkness for 30 minutes. After the 
incubation, cells were washed three times with I X PBS and then fixed with 3.7% 
paraformaldehyde solution for 20 minutes in darkness. Cells were washed for three 
‘ t imes with I X PBS after fixation. Then 1 ml 2.5 }ig/ml Hoechst 33342 (Molecular 
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Probe) nucleus staining dye was added to each well and incubated for 10 minutes. 
The staining solution was washed away with I X PBS for three times. The glass slips 
with cells were mounted onto glass microscope slides using 150 |j.l mounting reagent. 
After air drying of the excess mounting reagent in darkness, the glass slips were 
briefly wiped with a kimwipe paper with distilled water for microscopy viewing and 
storage. 
3.2.3 Epi-fluorescence microscopy 
The fluorescence signal from the cells successfully transfected with 
EGFP-tagged plasmids was visualized using NIKON TE2000-U fluorescence 
microscope. The images were captured using the SPOT Advanced software program. 
3.2.4 Analysis of fluorescence images 
The captured fluorescence images were analyzed using the SPOT advance 
program. Brightness and contrast of the images were adjusted to give a clear image. 
A calibration bar was added to indicate the relative size. The images from difference 
fluorescence were overlapped using the same program to show different organelles in 
V 
a single picture. 
3.2.5 In vitro site-directed mutagenesis 
In vitro site-directed mutagenesis was performed with QuikChange® II 
Site-Directed Mutagenesis Kit (Stratagene). Primers with the desired mutation in the 
middle were designed according to the guideline in the kit, as listed in Table 2.3. A 
, reaction mixture of 50 \i\ was set up which contained I X reaction buffer, 125 ng of 
forward primer, 125 ng reverse primer, 1 |al dNTP mix and 20 ng of dsDNA template. 
A control reaction using pWhitescript plasmid and matched primer pairs was set up 
in parallel to estimate the mutation efficiency. To each of the reaction mixture, 2.5 
、units of Pfu Ultra HF DNA polymerase were added. The mixtures were then 
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subjected to a thermal cycling of DNA denaturation at 95°C for 30 seconds, followed 
by 16 cycles of 95°C for 30 seconds, 55°C for 1 minutes and 68°C for 5 minutes. The 
reaction was cooled down to <37°C when completed. The nonmutated parental 
dsDNA templates were then digested by Dpnl restriction enzyme which selectively 
digested the methylated or semi-methylated templates. The reaction was performed 
by directly adding 10 units of Dpn I to the amplification reaction mix and incubating 
at 37。C for 1 hour. Transformation into the XL 1-Blue Supercompetent cells were 
performed by adding 1 [x\ Dpn /-treated DNA from each control and sample reaction 
to 50 (il of the supercompetent cells. The mixture was kept on ice for 30 minutes. 
The transformation reaction was heat shocked for 45 seconds at 42°C and then placed 
on ice for 2 minutes. To each reaction tube, 0.5 ml 42°C pre-heated LB medium was 
added and incubated at 37°C for 1 hour with shaking at 250 r.p.m. A transformation 
control was set up by transforming 0.1 ng pUC18 plasmid into 50 |J.1 supercompetent 
cells in parallel. At the end of incubation, 250 |il pWhitescript mutagenesis control 
and 5 \i\ pUC transformation control was spread onto LB-ampicillin agar plates 
containing 80 fig/ml X-gal and 20 mM IPTG. Each mutated sample was spread onto 
two LB-ampicillin plates with 125 ]i\ for each plate. The plates were incubated at 
37°C for 16 hours in an inverted position. The mutagenesis efficiency (ME) and 
transformation efficiency were calculated for the pWhitescript 4.5-kb control plasmid 
and pUC-18 plasmid respectively as the standard to estimate the number of colonies 
‘ to pick up. Colonies from the mutation sample plates were picked up and cultured. 
Sequencing for the target of interest was performed after obtaining the plasmid using 
Rapid Plasmid Miniprep System (Marligen Biosciences) as described in section 
3.1.8. ‘ 
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3.3 Cell cycle phase analysis with flow cytometry 
3.3.1 Cell transfection 
WRL-68 cell-lines were counted and approximately 3x10^ cells were seeded 
onto a 60 mm dish. At 16-24 hours after seeding, synchronization was performed by 
replacing the complete culture medium with serum-free medium and allowed to 
incubate for another 24 hours. Cells were then transfected with GFP-Cl or 
GFP-tagged plasmids as described in section 3.2.1 by scaling up the plasmids to 2.0 
|ig per dish. 
3.3.2 Cell staining 
Propidium iodide is a red-fluorescent dye for nuclei and chromosome staining. 
By detecting the fluorescent signal, the phase of cell cycle of individual cell can be 
estimated. Cells were transfected with GFP-tagged plasmids in 60 mm dishes as 
described in section 3.3.1. At 24 hours and 48 hours post-transfection, cells were 
subjected to staining for cell cycle analysis. Both floating and adherent cells were 
collected by trypsinization, washed once with I X PBS, and fixed with 70% ethanol 
for 2 hours. After fixation, cells were washed with I X PBS once and stained with 
Propidium Iodide (PI) staining solution (20 \ig/m\ PI, 8 }ig/ml RNase A in IX PBS) 
for 30 min at 37°C under subdued light. Stained cells were then analyzed using a 
Flow Cytometer FACSCanto (Becton Dickinson). 
3.3.3 Flow cytometry 
‘ Cell cycle analysis was performed using a Flow Cytometer FACS Canto. 
Successfully transfected cells were gated out in the cytometer for cell cycle analysis. 
A schematic diagram was used to illustrate the procedures of cell gating (Fig 3.1). 
Cells were selected and gated with PI using parameters SSC against FSC. The gated 
cells were further analyzed with the PI intensity against PI-W, which measured the 
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Figure 3.1 A schematic diagram of the gating procedures in flow cytometry, (a) 
Cells were screened for the size. Cell duplexes were avoided while single cells were 
gated for further analysis, (b) Single cells were analyzed with EGFP expression. 
Cells with successful transfection which gave green signals were gated for cell cycle 
analysis, (c) Cell cycles analysis of transfected cells. 
V 
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width of the cells. Cell duplexes with twice the width of single cells were not 
selected while single cells were gated by P2 for further analysis. The P2 gated cells 
were analyzed with green fluorescence (FITC) against the PI signal (PE-A). Two 
separate plots were used to analyze the cell cycle phase of cells transfected or 
untransfected with EGFP-tagged plasmids. Cells with positive PE but negative FITC 
signals were gated with P3 for cell cycle analysis of mock transfection cells. Cells 
with positive FITC and PE signal were gated with P4 for GFP-fusion protein 
expressed cells for cell cycle analysis. Cell cycles of a total of 10,000 cells of target 
signal were recorded. The percentages of DNA content at different phases of a cell 
cycle were analyzed with Modfit 3.0 software provided by BD Bioscience. 
3.4 Cellular proliferation quantification by BrdU proliferation assay 
A non-radioactive colourimetric immunoassay for the quantification of cell 
proliferation was performed using the Cell Proliferation BrdU ELISA kit (Roche). 
The quantification was based on the measurement of incorporation of the pyrimidine 
analogue 5 -bromo-2 ‘ -deoxyuridine (BrdU) instead of thymidine into the DNA of 
proliferating cells. 
3.4.1 Cell transfection 
On the day before transfection, WRL68 cell-lines were seeded onto a 
96-well plate with 1x1 O^  cells per well. Synchronization was performed 24 hours 
‘ after seeding the cells. Transfection was performed as described in section 3.3.1 
using 0.03 |j,g/well plasmid DNA in 6 wells repeats. Cells were supplied with 100 |il 
complete medium for further incubation. 
3.4.2 BrdU ELISA measurement 
、 At 24 or 48 hours post-transfection, BrdU ELISA measurement was 
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performed to determine the degree of cellular proliferation. To each well, 10 |j.l 1:100 
diluted BrdU labeling solution was added in a culture hood. The cells were allowed 
to incubate for additional 3 hours at 37°C, 5% CO2. After incubation, the culture 
medium with BrdU labeling solution was tapped off. To each well, 200 jiil FixDenat 
solution was added and allowed to incubate for 30 min at room temperature. In the 
process, the cells were fixed while DNA was denatured to improve the accessibility 
of the incorporated BrdU for the detection by the antibody. The FixDenat solution 
was then removed thoroughly flicking off and tapping. To each well, 100 
anti-BrdU-POD working solution was added and further incubated for 90 minutes at 
room temperature. The antibody conjugate was removed by flicking off and the wells 
were washed three times with 200 |j,l I X washing solution. The washing solution was 
removed by tapping. To each well, 100 |LI1 substrate solution was added and incubated 
in darkness at room temperature for 10 minutes for the yellow colour development. 
After incubation, 25 \x\ I M sulphuric acid (H2SO4) solution was added to stop the 
reaction. The product colour was changed to blue by the stopping solution. The 
mixture was shaken immediately for 15 seconds on an ELISA plate reader and the 
absorbance was measured at 450 nm. 
3.5 Protein expression 
3.5.1 Cell lysate collection 
Cell number was counted and approximately 3x10^ cells were seeded in 60 
mm dishes on the day before. Synchronization in serum-free medium at 37°C for 24 
hours was performed with the assumption that cells are "force" to stay at 
non-replicating state afterwards. Transfection was performed with 2 [ig plasmids as 
described in section 3.3.1 after the synchronization. FBS was replenished at three 
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hours after transfection. At desired time post-transfection, cells were washed with 
ice-cold I X PBS twice before treating with 70 |il modified Radio 
Immunoprecipitation Assay (RIPA) lysis buffer with proteinase inhibitors (Roche) on 
ice for 5 minutes. Cells and the lysate were removed with a cell scraper and 
transferred to 1.5 ml microcentrifuge tube. The cell lysate was subjected to 15 
minutes rotation on an orbital shaker at 4°C. Centrifugation at 13,000 x g for 15 
minutes allowed the collection of clear cell lysate as the supernatant. The extracted 
protein lysate was kept at -80°C for storage and thawed on ice before usage. 
3.5.2 Quantification of protein samples 
Protein concentration of extracted cell lysate was analyzed with bichoninic 
acid (BCA) assay. Protein concentration of cell lysate and standard proteins samples 
were measured, in which, 3 ^il of sample was mixed with 200 fil of assay reagent on 
a flat bottom 96-well plate. After incubating the mixture in each well at 37°C for 30 
minutes, the absorbance was measured by a microplate reader (Model 3550, 
BIO-RAD) at wavelength 540 nm. A standard bovine serum albumin (BSA) curve 
was obtained by using 0, 0.15625, 0.3125, 0.625, 1.25, 2.5, 5 and 10 mg/ml BSA to 
determine the protein concentration of samples. 
3.5.3 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed to separate the cellular proteins according to their electrophoretic mobility 
_ which was determined by the molecular weight. SDS-polyacrylamide gel was set to 
12-15% depending on the protein target of interest. Cell lysate of equal amount and 
volume (30 |Lig) were mixed with 6X SDS gel loading buffer and subjected to boiling 
for 10 minutes before loading into the gel. Pre-stained SeeBlue rainbow marker 
• (Invitrogen) (6 |il) was loaded in parallel as a standard molecular weight marker. The 
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gel was run at 150-180 volts for 1-1.5 hours. 
3.5.4 Western blot 
After electrophoresis, the stacking gel was removed and the running gel was 
briefly rinsed with reverse osmosis water. The running gel was then equilibrated in 
transfer buffer for 3 minutes. During the equilibration, a piece of Immobilon™-P 
Transfer Membrane was fixed with 100% methanol for 15 seconds and then 
equilibrated in transfer buffer. Two sets of 3 M M Whatman chromatography papers 
(Kents, UK) were soaked in transfer buffer. Transfer was performed with the running 
gel and the transfer membrane placed in between two sets of 3 pieces of 
chromatography papers. Air bubbles were excluded using a roller. The electroblot 
transfer was performed at 12 volts for 50 minutes on a Trans-blot®SD semi-dry 
transfer cell (BIO-RAD). 
After transfer, the membrane was incubated in 10% blotting milk in I X TEST 
buffer with constant gentle shaking for an hour to block the non-specific binding 
sites of antibody. Appropriate primary antibody was added directly to the blotting 
solution and incubated with constant shaking at 4°C overnight. After primary 
antibody binding, the membrane was briefly rinsed with I X TEST washing buffer 
and then washed for three times with 10 minutes each with constant shaking. 
Appropriate secondary antibody was added to 10% milk in I X TBST and incubated 
for 1 hour at room temperature with gentle shaking. After the antibody binding, the 
membrane was washed for three times with 10 minutes each with constant shaking. 
3.5.5 Western blot luminal detection 
Luminal detection solution was prepared by mixing equal amount Western 
LightningTM Chemiluminescence Reagent Plus Enhancing reagent and Oxidizing 
、reagent (Perki Elmer). The membrane was briefly rinsed in I X TBST washing buffer 
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and then briefly dried by touching the edge of the membrane against a paper towel. 
The membrane was then immersed in an inverted position in the luminal detection 
solution and allowed to stand for 1 minute. The membrane was then covered by a 
transparent film and placed in a film cassette. A sheet of X-ray film (Fujifilm) was 
placed into the film cassette in a dark room and allowed to expose for 10 seconds to 
2 minutes. The film was developed with a Kodak film developer. 
3.6 Gene expression 
3.6.1 Primer design 
Primers for real-time PCR were designed using Primer Express 3.0 (Applied 
Biosystems) that also allows for an easy design of compatible TaqMan probes, for 
use in real-time PCR or end-point PCR analyses. Basically, the primers were 
designed to flank 150-300 base pairs of the target gene sequence with an annealing 
temperature of 58-60°C. 
3.6.2 Cell transfection 
Transfection was performed with EGFP-tagged plasmids on 60 mm culture 
dishes as described in section 3.3.1. 
3.6.3 RNA extraction 
At 24 hours and 48 hours post-transfection, messenger RNA (mRNA) from cells 
was isolated by TRIzol® reagent (Invitrogen). Cells were washed with sterilized IX 
- PBS twice and 0.5 ml of TRIzol® reagent was added to each dish to lyse the cells. 
After 3 minutes incubation with TRIzol® reagent at room temperature, the cells were 
made to detach from the plate by gently tapping the edge of the plate. The cell lysate 
was transferred into a 1.5 ml micro-centrifuge tube. Then 150 |il ice-cool chloroform 
、was added to the cell lysate and the mixture was shaken vigorously. The mixture was 
CHAPTER 3 Research Methods 62 
then centrifuged at 14,000 x g at 4°C for 20 minutes. After centrifugation, 3 layers: a 
lower red phenol-chloroform layer, a white interphase layer and a colourless upper 
aqueous layer were obtained. The upper aqueous layer containing mRNA was 
transferred to a new 1.5 ml microcentrifuge tube and equal volume of 70% ethanol 
was added to increase the binding stability of RNA to the column membrane. The 
mixture was then transferred to an RNeasy spin column placed in a 2 ml collection 
tube. The column was then centrifuged at 9,000 x g for 15 seconds at 4°C. After 
centrifugation, the flow through was discarded. Then 700 |LI1 Buffer R W l was added 
to the RNeasy spin column and centrifuged at 9,000 x g for 15 seconds to wash the 
spin column. The flow through was removed completely and 500 |il Buffer RPE was 
added to the RNeasy spin column. The column was centrifuged at 9,000 x g for 15 
seconds at 4°C to wash the column again. After discarding the flow through, the 
column was washed again with 500|il Buffer RPE by centrifuge at 9,000 x g for 15 
seconds. The column was then put into a new 2 ml collection tube and centrifuge at 
at 9,000 for 15 seconds to remove the residual buffer. Finally, the column was placed 
on a new collection tube and the RNA sample was eluted with 25 |il of DEPC-treated 
water. Integrity of the RNA was examined on a 1% TAE agarose (Invitrogen) gel. 
DNase I was performed prior to reverse transcription in one 10 |j,l reaction with 2 ug 
RNA, according to the instruction of supplier. The purity of RNA was evaluated by 
the ratio of absorbance for RNA to protein at X=260 nm and 280 nm respectively 
which was measured using a UV-Vis spectrophotometer. 
3.6.4 Reverse Transcription for first strand complementary DNA (cDNA) 
Reverse transcription for first strand cDNA synthesis was carried out using the 
High-Capacity cDNA Transcription Kits (Applied Biosystems). A 10 mixture was 
、set up on ice with 2|il of lOX RT Random Primers, 0.8 ^il of 100 m M dNTP mix, 1 
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1^1 of MultiScribe Reverse Transcriptase and 1 |il of RNase Inhibitor and 
DEPC-treated water. To each 10 |LI1 of the reaction mixture, 2 |ig RNA in 10 [i\ 
volume was added and mixed well. Reverse transcription was carried out in a 
thermal cycler with 25°C for 10 minutes, 37。C for 2 hours and terminated with 
incubation at 85°C for 1 minute. Thenl |il of RNase H was added and incubated at 
3TC for 20 minutes. The first strand cDNA product was stored at 
3.6.5 Quantitative real-time PGR 
Quantitative real-time PGR with Power SYBR® Green PGR Master Mix 
(Applied Biosystem) was used to measure the mRNA expression of specific target 
genes in transfected cells. SYBR Green was a dye that can be bound to the minor 
groove of double stranded DNA which exhibited little fluorescence in solution but 
strong fluorescence when bound to DNA. When SYBR Green binds to the DNA, the 
intensity of fluorescent emissions increased in proportion, giving to an amplification 
curve from which the expression level of specific gene can be compared in separated 
samples. 
V 
Real-time PGR was performed in triplicate in a 20 [i\ reaction mixture of 1 \i\ of 
cDNA sample (about 0.0625ug), 2.5 |iM forward and reverse primer mix (Table 2.4), 
10 |il Power SYBR® Green PGR Master Mix (Applied Biosystem) and sterile nano 
pure water. A separate mixture for human glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) was included as an internal control for each trial for the 
target genes. The mixtures were loaded onto a 96-well PCR plate (ABI Prism, 
Applied Biosystem) and sealed. The PCR was performed on an ABI Fast 7500 
real-time PCR machine with standard profile of 1 cycle of 50°C for 2 minutes, 95°C 
for 10 minutes, 40 cycles of 95°C for 15 seconds, 60°C for 1 minute. Quantification 
of - gene expression was carried out using Fast 7500 SDS program with autoCt 
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settings. The threshold cycle number (Ct) value defines the number of cycles for 
reach the threshold was designated to the samples by auto-detection. After 
normalization with the endogeneous G3PDH control, the AACt value was calculated 
for the transfected cells with reference to the vector control. 
3.7 Establishment of Tet-On inducible stable cell-lines 
3.7.1 Subcloning of HBx gene into pTRE2 vector 
Three sets of primers were designated flanking the open reading frame (ORF) of 
HBxWt, HBxAC44, HBxAN60 genes. They were designated as TRE-HBx-F/ 
TRE-HBx-R, TRE-HBx-F/ TRE-HBxAC44-R and TRE-HBxAN60-F/ TRE-HBx-R 
respectively (Table 2.2 ). Cloning was performed as described in section 3.1. 
3.7.2 Construction of WRL68 Tet-On stable cell-lines 
1. Transfection of pTet-On vector into WRL68 cells 
WRL68 cells were seeded in T25 culture flask (Corning) with a confluence of 
70% the day before Transfection. Transfection of pTet-On plasmid (Clontech) was 
performed with Lipofectamine™ Reagent (Invitrogen) as described in 3.3.1. 
2. Selection of the transfected WRL68 by geneticin 
a. Determination of geneticin selection dosage 
WRL68 cells were seeded onto a 96-well plate with 2x10^^  per well. At 24 hours 
after seeding cells, cells were treated with neomycin analogue, geneticin (Invitorgen) 
. at concentration of 0, 100，200，400, 600，800 and 1000 |ig/ml. geneticin (50 mg/ml) 
was diluted with complete culture medium DMEM to 5 mg /ml. Further dilution was 
performed to obtain the desirable concentration. The diluted geneticin was freshly 
prepared at each of the experiments. At 48 hours post-treatment, MTT proliferation 
assay was performed to determine the cell viability. 
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MTT assay is a quantitative colourimetric assay for the determination of cell 
survival and proliferation (Masmann, 1983). It employs tetrazolium salts, MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) as a substrate in 
measuring the activities of dehydrogenase enzymes in viable cells (Pagliacci et al, 
1993). In viable cells, the tetrazolium ring of the pale yellow MTT will be cleaved to 
purple formazan products. The absorbance of the purple product colour could be 
measured with an ELISA plate reader which served as an indirect way to determine 
the viability of cell population. 
Each well was washed with 100 |il I X PBS twice before adding 100 |j,l MTT 
solution (3 mg/ml in PBS). The plates were then incubated for another 2 hours at 
37°C，5% CO2. When the incubation was finished, 50 \i\ 10% SDS solution was 
added to each well to lyse the cells. The plate was gently shaken to mix the solutions. 
The plate was then placed in a 70°C oven for 15 min to dry up the SDS. At the end of 
incubation, 100 fil DMSO was added to each well. The plate was left at room 
temperature for 10 minutes to allow the complete dissolution of the formazan 
products. The absorbance at 540 nm was measured using a microplate reader 
(BIO-RAD, model 3550). 
b. Selection of stable clones 
At 48 hours post-transfection, cells were selected using geneticin. For the 
selection process, 600 |ig/ml geneticin was added to the culture medium. The 
selection process was continued for 3 weeks. After 3 weeks of selection, the 
concentration of geneticin was kept at 350 [ng/ml. 
3. Single clone isolation 
The geneticin-resistant cells were seeded onto a PALM petric dish at a number 
of 5x10^ per dish. After 24 hours, single cells were cut by the PALM machine and 
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reseeded onto a 96-well plate and supplied with 50 fil complete selection medium. 
The cells were cultured at 37®C, 5% CO2 for 2 weeks until cell colonies appeared. 
During the enrichment, selection medium was changed for every three days and 
maintained at 100 [i\ medium per well. Each single colony was transferred to two 
well on a 24-well plate for further enrichment. These cells were designated as 
WRL/tet-on clones. 
4. Determination of highly inducible clones with luciferase assay 
To determine the induction level of tet-on vector in the geneticin-resistant stable 
clones, a transient transfection with luciferase report gene in pTRE vector was 
performed. WRL-tet-on cells were seeded onto a 24-well plate with 6 wells of 3 xlO"^  
cells per well for each clone. After 24 hours, 0.4 |ig pTRE-Luc was transfected into 
cells in four of the wells using the LipofectAMINE PLUS Reagent as described in 
section 3.3.1. An untransfected control in duplicate was included to determine the 
background luciferase level. At 24 hours post-transfection, 400 ng/ml doxycycline 
(USB) in culture medium was added into two of the pTRE-Luc transfected wells as 
V 
well as to the untransfected doxycycline background control duplicates (Fig. 3.2). 
The cells were allowed to incubate for further 48 hours. The luciferase expression 
level of doxycycline-treated or untreated cells was assayed by using the 
Dual-Luciferase® Reporter (DLR®) Assay System (Promega). Cells were lysed 100 
\i\ IX Passive Lysis Buffer (PLB) which was formulated to minimize background 
autoluminescence. The cells were transferred to a 1.5 ml microcentrifuge tube using 
a cell scraper and allowed to shake on an orbital shaker at 4°C for 15 minutes to lyse 
the cells. Clear lysate was obtained after centrifugation at 14,000 r.p.m. for 10 
minutes. Quantification of protein lysate was performed as described in section 3.5.2. 
The luciferase activity was measured by mixing 5 |ig of protein lysate from each 
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sample to 100 \x\ Luciferase Assay Buffer (LAR) II from the kit transferred 
immediately into a glass tube. The mixture was allowed to incubate for 10 seconds at 
room temperature. The luminescence signal was measured by Lumat LB9501 
(Berthold). 
⑷ Induction Uninduced Background 
sample control control 
Luc. Transfection + + -
Dox. Induction + - + 
f •：膨 N 
H ^ N 
、、...、、"》•..、--、. ..、. 、..•；：• 
k 遍 歡 」 
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Figure 3.2 A schematic presentation of the set-up for doxycycline induction, (a) 
Two set of cell duplicated were transfected with pTRE2-Luc while one set of cells 
were untransfected. At 24 hours after seeding the cells, 400 ng/ml doxycyline was 
added to a set of transfected cells as well as the untransfected cells to estimate the 
background luciferase level, (b) Formulae used for calculating the induction ratio. 
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3.7.3 Construction of WRL68/Tet-On HBx and mutants expression cell-lines 
1. Transfection of pTRE-HBx Plasmid 
WRL68/Tet-On cells were seeded in T25 culture flask (Coming) with a level of 
70% confluence the day before Transfection. Transfection of pTRE2-HBxWt, 
pTRE2-HBxAC44 and pTRE2-HBxAN60 was performed with LipofectAMINE 
PLUS™ Reagent (Invitrogen) as described in 3.3.1. 
2. Selection of transfected cells by hygromycin 
a. Determination of hygromycin selection dosage 
WRL/Tet-On stable cells were seeded onto a 96-well plate with 2x10. per well. 
At 24 hours after seeding cells, cells were treated with hygromycin (Invitrogen) at 
concentrations of 0，50, 100，200, 300, 400 and 500 |ig/ml. hygromycin (50 mg/ml) 
was diluted with complete culture medium DMEM to 5 mg/ml. Further dilution was 
performed to obtain the desirable concentration. The diluted hygromycin was freshly 
prepared for each experiment. MTT assay was performed at 48 hours 
post-transfection as described in section 3.7.2. 
b. Selection of stable clones 
At 48 hours post-transfection, cells were selected using hygromycin. For the 
selection process, 300 fig/ml hygromycin was added to the culture medium. The 
selection process was continued for 3 weeks. After 3 weeks of selection, the 
concentration of hygromycin was kept at 200 fig/ml. 
3. Second Single Clone Isolation 
The hygromycin-resistant cells were trypsinized and diluted to 10 cells/ml. To 
each well on a 96-well plate, 50 diluted cell suspension was added. The cells were 
cultured at 37°C, 5% CO2 for overnight for cell adherence before adding 50 \i\ extra 
selective medium. The cells were further incubated for 2 weeks until cell colonies 
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appeared. During the enrichment, selection medium was changed every three days 
and maintained at 100 \il medium per well. Twenty colonies were trypsinized and 
transferred to 24-well plates for further enrichment of cell number. When the cells 
have reaches 90% confluence and transferred to larger containers. These cells were 
kept as monoclones in the enrichment process. They were designated as 
WRL/TOn/HBx, WRL/TOn/XAC or WRL/TOn/XAN clones. 
3.7.4 Characterization of Tet-On gene expression monoclones 
1. Induction 
Each clone of WRL/TOn/HBx, WRL/TOn/XAC or WRL/TOn/XAN were 
counted and seeded into 2 wells on a 6-well plate at 2x10^ per well before the day of 
induction. On the day of induction, 400 ng/ml doxycydine (USB) was prepared in a 
culture hood by diluting a doxycydine solution stock (50 mg/ml) into culture 
medium. To one well of each cell-line, 2 ml of doxycydine induction medium was 
added while 2 ml complete medium without doxycydine was added to the 
corresponding control well. 
2. Reverse transcription PCR 
Reverse Transcription PCR (RT-PCR) was performed to determine the expression 
of target gene in the selected tet-on monoclones. 
a. RNA extraction 
RNA extraction from monoclonal tet-on cell-lines was performed as described 
in section 3.6.3. 
b. First strand cDNA synthesis 
First strand cDNA synthesis for the transcripts was performed as described in 
section 3.6.4. 
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c. Polymerase chain reaction (PCR) 
Amplification of HBxWt, HBxAC44 and HBxAN60 transcripts were performed 
with gene specific primers as described in section 3.1.7. 
3. Cell growth pattern determination 
The growth curves of doxycycline-induced cells and uninduced cells were 
constructed by cell counting for subsequent fours days after induction. It was plotted 
as cell counts against the day(s) after induction. 
3.8 Statistical analyses 
Results were obtained from at least three sets of independent experiments. 
Statistical analyses were performed with SPSS V. 14.0 for Windows program. 
Student's t-test was used for group comparisons unless specified. All comparisons 
were made two-sided, and a p value <0.05 (two tailed) was considered as significant. 
Each datum point was expressed as mean 土 standard deviation unless specified. 
V 
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CHAPTER 4 
Study on mitochondria targeting 
Summary 
This chapter describes the results on subcellular localization of wild-type HBx 
and HBx mutants. In general, wild-type HBx was found to locate in the mitochondria 
whereas deleting the C-terminus abrogated such localization. A short key sequence 
of seven amino acids was mapped at the C-terminus which was essential but not 
sufficient for sustaining the mitochondrial localization. Through site-directed 
mutagenesis, the amino acid 115 of HBx was identified to be the key amino acid for 
mitochondria targeting. 
Cells are divided into different compartments which contain different proteins 
that coordinate with each other to maintain the normal cellular functions. Thus, 
knowing the subcellular localization of a protein will be the first step to predict the 
possible roles of a protein in a cell. 
4.1 Establishment of pEGFP-Cl-HBx and mutants constructs 
Polymerase chain reaction (PCR) was performed to amplify the wild-type HBx 
gene HBxWt, C-terminus truncated mutant HBxAC44 and N-terminus truncated 
mutant HBxAN60 as described in section 3.1.1. The template used for PCR belongs 
‘ to HBx subtype adw2, genotype A (Fig. 4.1a). The PCR products were expected with 
490 bp, 358 bp and 313 bp respectively with the addition of GC clamp and restriction 
sites to the gene sequences (Fig 4.1b). These fragments were digested and subcloned 
into pEGFP-Cl vector which would express the subcloned HBx gene at the 
、C-terminal of an enhanced green fluorescent protein (EGFP). The constructs were 
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sequenced in order to ensure that there was no nucleotide replacement or frame shift 
errors in the cloned genes. A no-template control (NTC) was included in each 
reaction to ensure that there was no template contamination in the PGR. 
(a) 
10 20 30 40 50 60 
HBxWt M A A R L Y C Q L D PSRDVLCLRP VGAESRGRPL AGPLGTLSSP SPSAVPADHG AHLSLRGLPV 
HBxAC44 M A A R L Y C Q L D PSRDVLCLRP VGAESRGRPL AGPLGTLSSP SPSAVPADHG AHLSLRGLPV 
HBxAN60 
70 80 90 100 110 120 
HBxWt CAFSSAGPCA LRFTSARCME TTVNAHQILP KVLHKRTLGL PAMSTTDLEA Y F K D C V F K D W 
HBxAC44 CAFSSAGPCA LRFTSARCME TTVNAHQILP KVLHKRTLGL PAMSTTDLEA 
HBxAN60 CAFSSAGPCA LRFTSARCME TTVNAHQILP KVLHKRTLGL PAMSTTDLEA Y F K D C V F K D W 
130 140 150 154 
HBxWt EELGEEIRLK VFVLGGCRHK LVCAPAPCNF FTSA 
HBxAC44 
H BxAN60 EELGEEIRLK VFVLGGCRHK LVCAPAPCNF FTSA 
(b) 
M 490 bp 
Figure 4.1 Amplification of HBxWt , HBxAC44 and HBxAN60 from PCR. (a) 
Protein sequence alignment of HBxWt, HBxAC44 and HBxAN60. The truncated 
region was presented as broken lines. (b)The PCR products were analyzed on a 2% 
TAE agarose gel. Lane 1: M-lOO bp DNA ladder; Lane 3，5 and 7: PCR products of 
HBxWt, HBxAC44 and HBxAN60 with size of 490 bp, 358 bp and 313 bp 
respectively; Lane 2, 4 and 6: No-template control (NTC) reaction of PCR. No band 
was observed in these control reactions. 
CHAPTER 4 Study on mitochondria targeting 73 
4.2 Transactivation C-terminus domain is essential for granular 
localization 
The HBxWt, HBxAC44 and HBxAN60 were successfully subcloned into the 
pEGFP-Cl vector. The pEGFP-HBx, pEGFP-HBxAC44 and pEGFP-HBxAN60 
constructs were transfected into WRL68 cells, a human hepatocyte cell-line and 
HepG2 cells, a human hepatocarcinoma cell-line, in parallel with a pEGFP-Cl vector 
control. The transfected cells were stained with Hoechst 33342 for cell nucleus at 24 
hours post-transfection. Under the fluorescence microscope, the EGFP expressed 
from the pEGFP-Cl vector control distributed throughout the cytoplasm and very 
likely the nucleus of the cells as well in WRL68 (Fig. 4.2). The EGFP-HBx fusion 
protein was found to localize as perinuclear granules. Truncating the N-terminus of 
the HBx gene did not alter the subcellular localization as the expression of 
EGFP-HBxAN60 also resulted in similar granular distribution to EGFP-HBxWt. 
However, such subcellular localization was abrogated when the C-terminus was 
deleted. The EGFP-HBxAC44 fusion protein distributed in a similar pattern of EGFP 
protein alone, that it could be found throughout the cytoplasm and the nucleus. 
Similar localization patterns of HBxWt, HBxAC44 and HBxAN60 distribution were 
observed in HepG2 cells (Fig. 4.3). EGFP-HBxWt and EGFP-HBxAN60 were 
located as granules near the nucleus while HBxAC44 and EGFP were dispersed in 
the cytoplasm. These suggested that distribution of these fusion proteins was not 
- cell-line specific. 
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EGFP Hoechst 33342 images 
• • • 
• • • 
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Figure 4.2 C-terminal truncation abrogates granular localization of EGFP-
HBxWt fusion protein in WRL68 cells. Subcellular localization of EGFP-HBx, 
EGFP-HBxAC44 and EGFP-HBxAN60 in WRL68 cells were visualized under a 
fluorescence microscope. The GFP signal of the fusion proteins and the nucleus are 
shown in the left and middle panel respectively. The right panel shows the 
superimposed image of the GFP and nucleus, (a) pEGFP-Cl control expressed EGFP 
that was distributed throughout the cytoplasm. (b)(d) EGFP-HBxAN60 fusion 
protein retained the mitochondrial localization of EGFP-HBxWt, resulted in granular 
structure near the nucleus, (c) EGFP-HBxAC44 abrogated the granular distribution 
ofEGFP-HBxWt fusion protein and it was distributed throughout the cytoplasm. 
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, 、 EGFP Hoechst 33342 images 
； • • • 
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Figure 4.3 C-terminal truncation abrogates the granular localization of 
EGFP-HBxWt in a non-cell-line specific manner. HepG2 cells were transfected 
with different EGFP-constructs. (a) EGFP-Cl vector control (b) EGFP-HBxWt 
fusion protein (c) EGFP-HBxAC44 fusion protein (d) EGFP-HBxAN60 fusion 
protein. The distribution was similar to that in WRL68 which showed that the 
distribution of these fusion proteins was not restricted to WRL68 cells. 
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4.3 Wild-type HBx localizes in mitochondria 
The subcellular localization in WRL68 cells was determined using mitochondria 
staining or mitochondrial protein co-transfection. At 24 hours post-transfection, cells 
were stained with MitoTracker Red for the mitochondria and with Hoechst 33342 for 
the nucleus. The EGFP-HBx fusion (green) was found to localize in perinucleus 
granules and overlapped with Mitotracker Red (red) which specifically stained the 
mitochondria and the overlapped areas were shown as yellow spots (Fig. 4.4). The 
localization in mitochondria was further confirmed by co-transfecting the WRL68 
cells with pEGFP-HBx together with a pDsRed2-Mito vector which expressed a 
mitochondrial targeting sequence from subunit VIII of human cytochrome c oxidase. 
The EGFP-HBx fusion was found to colocalize with the mitochondrial marker 
protein (Fig. 4.5). The EGFP protein, however, did not show specific colocalization 
with mitotracker red or the cytochrome c oxidase. These results suggested that the 
subcellular localization of HBx was associated with the cytoplasmic mitochondria 
within WRL68 cells. 、 
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Figure 4.4 Subcellular localization of wild-type HBx in mitochondria in WRL68 
cell-line. Wild-type HBx was expressed in pEGFP-Cl vector which produced a 
EGFP-HBx fusion protein. The cell nucleus was stained by Hoechst 33342 in blue, 
(a) The cell mitochondria were stained using Mitotracker Red in red which was 
found to overlap with EGFP-HBx fusion protein, as shown in the superimposed 
image, (b) EGFP from pEGFP-Cl vector control did not overlap with the 
Mitotracker Red specifically. 
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Figure 4.5 HBx protein overlaps with mitochondria targeting cytochrome c 
‘ oxidase in WRL68. (a) pEGFP-Cl-HBx was co-transfected with pDsRed2-Mito 
vector which expressed a mitochondria targeting protein cytochrome c oxidase 
fragment. The green signal from EGFP-HBx was found to be overlapped with the 
signal of cytochrome c oxidase, (b) EGFP from vector control did not overlap with 
the positive control protein cytochrome oxidase at specific spots. 
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4.4 C-terminal transactivation domain is sufficient for mitochondria 
targeting 
As described in section 4.2 and section 4.3, deleting the C-terminus of HBx 
abrogated the mitochondrial targeting and that apparently the C-terminus was 
necessary for the subcellular localization. In this part, we tested out if the C-terminus 
alone was enough for the mitochondrial distribution. The wild-type HBx gene was 
divided into 3 fragments, the N-terminus HBx 1-60 which covered the 1-60 amino 
acids, the central region HBx61-110 of the 61-110 amino acids and the C-terminus 
HBxlll-154 ofthe 111-154 amino acids, according to Wang X.W. et al., 1994. These 
3 fragments were subcloned into pEGFP-Cl vector which were then expressed in 
WRL68 cells. At 24 hours post-transfection, cells were stained with MitoTracker and 
Hoechst 33342 before observation under the fluorescence microscope. Fluorescence 
microscopy shown that neither the HBx 1-60 alone nor HBx61-110 alone was enough 
for the mitochondrial localization (Fig. 4.6). The fusion proteins were found to 
distribute in the cytoplasm in a non-organelle specific manner. Unlike these two 
fragments, HBxlll-154 fusion distributed in perinuclear granular structures which 
overlapped with the MitoTracker Red. These results suggested that only the 
C-terminus of HBx was sufficient for the mitochondrial localization. 
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Figure 4.6 The C-terminus 111-154 amino acids of HBx are sufficient for 
mitochondrial localization in WRL68 . (a) Wild-type HBx was divided into 3 
fragments including the N-terminus HBx 1-60, the central region HBx61-110 and the 
C-terminus HBxl 11-154. They were subcloned into pEGFP-Cl. (b) EGFP constructs 
- were transfected into WRL68 cells. The expressed EGFP-HBx 1-60 (i) and 
EGFP-HBx61-110 (ii) fusion proteins were distributed throughout the cytoplasm 
whereas the EGFP-HBxl 11-154 (C-terminus only) (iii) was located to the 
mitochondria that it overlapped with the Mitotracker red signal. 
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4.5 Mapping of the HBx region crucial for mitochondria targeting 
To identify the key sequence for the mitochondria targeting, various C-terminal 
truncation mutants were generated with deletion of 10 to 37 amino acids named 
HBx AC 10, HBxAC20, HBxAC30 and HBxAC37. Expression of EGFP-fusion 
protein of these mutants in WRL68 still gave rise to mitochondrial distribution and 
that the EGFP signal overlapped with Mitotracker Red. Thus, we speculated that the 
key region should lie within HBxl 11-117 which contributed to the distinct 
localization of HBxAC37 and HBxAC44 (Fig. 4.7). 
V 
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EGFP Fusion Hoechst 33342 Mitotracker Superimposed 
protein Nucleus red images 
• • • • 
Figure 4.7 HBxll l-117 is responsible for subcellular localization in WRL68 . 
Various C-terminal 
truncation mutants were subcloned into pEGFP-Cl vectors. 
HBxAC44 gave nonspecific localization as described in previous parts. In contrast, 
HBx AC 10, HBxAC20, HBxAC30 and HBxAC37 were distributed in mitochondria 
that the fusion protein overlapped with Mitotracker Red. 
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4.6 The 111-117 amino acid region in HBx does not work as a signal 
peptide 
The key amino acids for subcellular localization were mapped to be 
HBxlll-117. However, these seven amino acids YFKDCVF were not sufficient to 
guide the EGFP to the mitochondria. Linking 111-117 YFKDCVF to EGFP 
(EGFP-7Sp) did not alter the distribution of EGFP in WRL68 cells (Fig. 4.8). Five 
amino acids before the 111-117 sequence were added to this short sequence, making 
the EGFP to include amino acids of HBxl06-117 (EGFP-5+7Sp). Similar result of 
cellular distribution was given by this longer fragment. In that way, we suggested 
that the 111-117 or 106-117 amino acids do not work like a universal signal peptide 
for determining subcellular localization. 
、 
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H BxWt M A A R L Y C Q L D PSRDVLCLRP VGAESRGRPL AGPLGTLSSP SPSAVPADHG AHLSLRGLPV 
HBxTSp 
HBx5+7Sp 
70 80 90 100 110 120 
HBxWt CAFSSAGPCA LRFTSARCME TTVNAHQILP KVLHKRTLGL PAMSTTDLEA Y F K D C V F K D W 
HBx7Sp YFKDCVF 
HBx5+7Sp TDLEA YFKDCVF 
130 140 150 154 
H BxWt EELGEEIRLK VFVLGGCRHK LVCAPAPCNF FTSA 
HBxTSp 
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(b) EGFP Fusion Hoechst 33342 Superimposed 
Protein Nucleus images 
• • • 
Figure 4.8 Localization of EGFP-HBxll l-117 and EGFP-HBxl06-117 in 
W R L 6 8 cells, (a) The 111-117 and 106-117 fragment of HBx were subcloned into 
the pEGFP-Cl vector, (b) WRL68 cells were transfected with a pEGFP-Cl vector (i) 
in parallel with the EGFP-HBx7Sp (EGFP-HBxlll-117) (ii) and EGFP-HBx5+7Sp 
(HBx 106-117) (iii). All these fragments distributed throughout the cytoplasm. 
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4.7 Site-directed mutagenesis identifies the key amino acid at 115 in 
HBx for mitochondrial localization 
As the key sequence for localization was mapped to amino acid 111-117, we 
performed site-directed mutagenesis to mutate these amino acids in EGFP-HBx 
construct to alanine one by one. Mutants generated were named as HBxY l l lA , 
HBxF112A, HBxKl lSA, HBxD lHA , HBxC115A and HBxV116A (Fig. 4.9). The 
fluorescence images for WRL68 cells transfected with these mutants were compared 
to that ofHBxWt. Compared to wild-type HBx (HBxWt) (i), mutation at residue 115 
(vi, HBxCl lSA) from cysteine to alanine altered the protein subcellular localization 
whereas the other mutants did not (ii-v, vii). The mutant HBxC115A was distributed 
in the cytoplasm without specific sub-organelle localization. The mutants 
HBxY l l lA , HBxF112A, HBxK113A, HBxD lMA and HBxV116A，however, 
remained in a similar distribution to that of HBxWt. HBxF117A was not included in 
this part after several times of failure in making this mutant. 
CHAPTER 4 Study on mitochondria targeting 86 
a ) Residues 111 112 113 114 115 116 \y\ 
’ Amino acids Y | F | K | D | C V ， 
Nucleotides 
HBxWt T A C T T C A A A G A C T G T G T G 
H B x Y l l l A Q c f f l T T C A A A G A C T G T G T G 
HBxF112A T A c p c ^ 
HBxK113A T A C T T C § C | | | G A C T G T G T G 
H B x D l M A T A C T T C A A A ^ C ^ T G T G T G 
H B x C l l S A T A C T T C A A A G A C G ] C | | I G T G 
HBxV116A T A C T T C A A A G A c | t G 
• • • 
• • • 
Figure 4.9 Site-directed mutation of the amino acid 115 residue from cysteine to 
alanine alters the subcellular localization of HBx protein in W R L 6 8 cells. Single 
point mutations were generated for amino acid residue 111 to 116. (a) The sequence 
of mutants carrying single point mutation to alanine (nucleotide GCT) from 111 to 
116 a.a. respectively, (b) Fluorescence images for various mutants carried by 
pEGFP-Cl and expressed in WRL68 cells. Compared to wild-type HBx (HBxWt) (i), 
mutation at residue 115 (vi, HBxC115A) from cysteine to alanine altered the protein 
subcellular localization whereas the other mutants did not (ii-v, vii). 
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CHAPTER 5 
Cell proliferation and regulation 
Summary 
This chapter describes the effect of HBxWt and its mutants on cell cycle profiles 
and cell proliferation. In brief, HBxWt and HBxAC44 caused an increase in S-phase 
distribution as found in cell cycle analysis using flow cytometry while HBxlll-154 
(C-terminus) decreased S-phase distribution. HBxC155A, first caused a decrease in 
S-phase, followed by an increase. The induction effect of DNA synthesis by HBxWt 
and HBxAC44 was further demonstrated using BrdU cell proliferation assays. The 
cellular level of cell cycle proteins/genes changes upon HBx variants expression 
were determined to investigate the regulation mechanism on cell cycle. HBxWt was 
shown to increase cyclin A and E level while it repressedp2raficipi andp27_ mRNA 
expression. HBxAC44 decreased CDK2 protein level while up-regulating p21、阳•^zapi 
andp27k如 expression. 、 
Cancer may be thought as a biological phenomenon which is characterized by 
deregulated cell growth. There are strong evidences suggesting that increased 
proliferative activity is causally linked to carcinogenesis and tumour progression 
during which cells are exposed to a high risk of mutagenesis. Oncogenic viruses are 
thought to induce cell proliferation to compensate the extensive cell disruption 
caused by the viral proteins. Wild-type HBx has long been suggested to affect cell 
proliferation, with evidence on induction or inhibition. To elucidate the contribution 
of mutations to virus-induced cell growth intervention, we studied the cell cycle 
patterns and the mechanisms of carcinogenesis using cells expressing wild-type HBx 
or various HBx mutants. 
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5.1 Alteration of S-phase distribution in cell cycle 
Cell cycle profiles of WRL68 after transfection with EGFP constructs were 
analyzed using flow cytometry techniques. The seeded cells were first synchronized 
by incubating at serum-free culture medium for 24 hours before transfection. These 
EGFP constructs were then transfected into the starved cells. The transfection 
efficiency may be much lower than that in normal cases as the pre-transfection 
synchronization makes transfection somewhat more difficult. Twenty-four hours, 
though may not be long enough, was thus taken to achieve a balance between 
synchronization and decrease in transfection efficiency. Cell gating further allows the 
selection of those successfully transfected cells, though not plenty, for cell cycle 
analysis. The cell cycle pattern at 24 hours and 48 hours after serum enrichment were 
analyzed (Fig. 5.1 and 5.2). We made use of the cell gating strategies to gate the cells 
with successful expression EGFP-fusion protein for cell cycle analysis to compensate 
the low transfection efficiency in transient transfection (Chu et al, 1999). 
When compared to the EGFP-Cl vector control, expression of HBxWt and 
HBxAC44 both resulted in a mild decrease in GQ/GI phase and G2/M phase but a 
significant increase in S-phase at 24 and 48 hours. In contrast, the point mutant 
HBxC115A caused an increase in GQ/GI and G2/M phase but a drastic decrease in 
S-phase at 24 hours but the effect was not obvious at 48 hours. The C-terminus 
fragment mutant HBxl 11-154 gave similar results compared to that of HBxC115A as 
it caused an increase in GQ/GI and G2/M phase but a decrease in S-phase at 24 hours. 
The changes also became unobvious at 48 hours. 
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(b) PE-A (Propidum Iodide) 
% distribution of cells in cell cycle 24 hrs post-transfection ( * « =幻 
Samples HasmidDNA GO/Gl S G2/M 
i. Vector EGFP-Cl 61.22+3.19 18.26+3.98 22.03+1.14 
ii. HBxWt EGFP-HBxWt 57.70+1.12 26.12+2.06 17.04+1.72 
iii. HBxAC44 EGFP-HBxAC44 58.83+4.12 28.65+1.76 14.48+4.86 
iv. HBxC l lSA EGFP-HBxC115A 68.48+2.42 13.33+4.43 21.33+1.92 
V. HBxlll-154 EGFP-HBxl 11-154 70.94+1.87 8.91+2.94 21.16+1.52 
*Note: Data from three sets of independent samples and experiments 
Figure 5.1 Cell cycle profiles of WRL68 successfully transfected with HBxWt 
and mutants at 24 hours post-transfection. WRL68 cells were transfected with 1.6 
|xg EGFP recombinant plasmids in 60mm dishes. Cells with successful expression of 
EGFP-fusion protein were gated for cell cycle analysis, (a) Cell cycle distribution of 
cells transfected with EGFP constructs, (i) Vector control; (ii) HBxWt; (iii) 
HBxAC44; (iv) HBxCllSA; (v) HBxlll-154. (b) Summary of % distribution of 
cells in cell cycle. 
CHAPTER 5 Cell proliferation and regulation 90 
⑷ Vector j 
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(b) PE-A (Propidum Iodide) 
% distribution of cells in cell cycle 48 hrs post-transfection (*n=3) 
Samples H a s m i d D N A G O / G l S G2/M 
、 
i. Vector EGFP-Cl 58.85+4.13 19.97+0.59 21.81+4.15 
ii. HBxWt EGFP-HBxWt 57.78+1.07 25.02+2.16 16.56+3.65 
iii. HBxAC44 EGFP-HBxAC44 52.47+1.89 29.15+2.95 18.25+3.42 
iv. HBxCl lS A EGFP-HBxC115A 62.11+4.60 22.14+3.46 15.48+0.25 
V. H B x l l l - 1 5 4 EGFP-HBxl 11-154 59.90+1.92 20.06+1.53 1 9 . 3 9 + 1 . 8 1 
*Note: Data from three sets of independent samples and experiments 
Figure 5.2 Cell cycle profiles of WRL68 successfully transfected with HBxWt 
and mutants at 48 hours post-transfection. WRL68 cells were transfected with 1.6 
jig EGFP recombinant plasmids in 60 mm dishes. Cells with successful expression of 
EGFP-fusion protein were gated for cell cycle analysis, (a) Cell cycle distribution of 
cells transfected with HBx variants, (i) Vector control; (ii) HBxWt; (iii) HBxAC44; 
(iv) HBxC115A; (V) HBxlll-154. (b) Summary of % distribution of cells in cell 
cycle. 
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S-phase is the stage when cells replicate their chromosomal DNA. In our study, 
expression of HBxWt caused a significant increase in S-phase distribution at both 24 
and 48 hours (Fig. 5.3). C-terminus deleted HBxAC44 mutant caused a significantly 
greater increase in S-phase than that caused by HBxWt. The C-terminus fragment 
HBxl 11-154 caused a significant decrease in the S-phase with reference to both the 
vectors and HBxWt; that it seemingly was contributing to the higher increase in 
S-phase when that region was deleted in HBxAC44. 
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Figure 5.3 Summary of S-phase distribution of WRL68 successfully expressed 
EGFP-fusion proteins, obtained from flow cytometry. At 24 hours 
post-transfection, HBxWt and HBxAC44 caused a significant increase in S-phase. In 
contrast, HBxCllSA and HBxl 11-154 also caused a drastic drop in S-phase 
‘ distribution. At 48 hours post-transfection, HBxWt and HBxAC44 still caused a 
significant increase in S-phase. However, HBxC115A and HBxl 11-154 did not cause 
significant changes to S-phase distribution. 
P-value annotation: 
* p< 0.05 with reference to vector control; + <0.05 with reference to HBxWt, for 
three sets of independent samples and experiments. 
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5.2 Analysis of DNA synthesis using BrdU proliferation ELISA 
To confirm the increase in DNA synthesis in cells transfected with various 
mutants, BrdU proliferation assay was performed. This ELISA is designed as a 
colourimetric method to quantify the incorporation of thymidine analogue 
5-bromo-2‘-deoxyuridine (BrdU) into newly synthesized DNA. The incorporated 
BrdU can be detected with the corresponding antibody conjugates. The BrdU 
incorporation was analyzed at 24 and 48 hours transfecting WRL68 cells with 
EGFP-Cl vector and various HBx (Fig. 5.4). Expression of EGFP-Cl vector control 
did not cause a significant change in BrdU incorporation as compared to those of the 
mock transfection at both 24 and 48 hours that EGFP did not induce cells to 
proliferate faster. At 24 hours post-transfection, expression of HBxWt resulted in 
109.4%+3.4% BrdU incorporation when compared to the vector control while 
HBxAC44 caused 114.4%±5.9% BrdU incorporation. Point mutated HBxC115A 
resulted in 112.5%±9.6% BrdU incorporation. At 48 hours, HBxWt resulted in 
110.6%土3.50/0 while HBxAC44 caused 125.4%±17.1% BrdU incorporation. 
HBxC115A also resulted in an increase of proliferation with 114.3%+0.4% BrdU 
incorporation. 
HBxWt and HBxAC44 gave consistent results to that of flow cytometry, 
suggesting that the full length wild-type HBx has a proliferative effect on WRL68 
through increasing DNA synthesis at both 24 and 48 hours. In contrast, the point 
‘ mutated mutant HBxC115A was shown to decrease S-phase in flow cytometry at 24 
hours but a slight increase at 48 hours. The BrdU assay further suggested that the 
HBxCl lSA also has a proliferative effect at both time points. Since this assay was 
performed in a transient transfection system in which the expression level of the 
wild-type and HBxAC44 mutant might be different, we did not intend to compare the 
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degree of BrdU incorporation among the HBx variants. 
(a) 
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EGFP-Cl EGFP-HBxWt EGFP-HBxAC44 EGFP-HBxCl 15A 
24 hours 101.6%土1.80/0 100%±0.0% 109.4%±3.4% 114.4%±5.9% 112.5%±9.6% 
p-value 0.126 — � 0.001 0.003 0.043 
48 hours 101.3%±2.2% 100.0%±0.0% 110.6%±3.5% 125.4%±17.1% 114.3%±0.3% 
p-value 0.280 — 0.002 0.027 0.000 
Figure 5.4 DNA synthesis quantification using BrdU incorporation ELISA. 
WRL68 cells were transiently transfected with 0.03 ^ig/well EGFP-Cl, EGFP-HBx, 
EGFP-HBxAC44 and EGFP-HBxC115A in parallel with a mock transfection control 
on a 96-well plate. The % BrdU incorporation was calculated with reference to mock 
‘ transfection. (a) Vector control did not show significant changes to the mock 
transfection at both 24 and 48 hours. HBxWt, HBxAC44 and HBxCl lSA all caused 
an increase of BrdU incorporation at both time points, when compared to the vector. 
(b) Summary of % BrdU incorporation assay at 24 hours and 48 hours. 
P-value annotation: 
Independent student's t-test was performed for each group of data with reference to 
the vector control. * p<0.05, for four sets of independent samples and experiments. 
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5.3 Differential molecular regulation of cell cycle 
To investigate the molecular regulation of cell cycle and thus the cell 
proliferation in WRL68 cells, the cellular level of several cycle proteins were 
determined. Upon expression of different HBx variants in parallel with the vector 
control and mock transfection control, the cyclin A and E level as well as cyclin 
dependent kinase 2 (CDK2) was detected with the respective antibodies. Detection of 
HBx variants with anti-GFP antibody showed that all the EGFP-tagged fusion 
proteins were successfully expressed except for HBxC115A (Fig. 5.5). The 
HBxC l l SA however, was detected at mRNA expression level (Fig. 5.8). Therefore, 
the molecular changes caused by HBxC l l SA will not be discussed in this section. 
24 hours 48 hours 
2 ^ 5 ^ 广 《n — ^ in ^ 
CJ — • CJ — • 
o « CO m m g o 8 CO m cq eg 
S > a g EC X S > a g x g 
HBxWt— ^ m ^ m m m n m i ^ g 
冊 111-154 
* Representative figure from three sets independent samples and experiments. 
Figure 5.5 Expression of wild-type HBx and its mutants in WRL68 cells. 
Detection of HBx variants with anti-GFP antibody showed that all the EGFP-tagged 
‘ fusion proteins were successfiilly expressed except HBxC l lSA . The GFP tag adds 
approximately 27 kDa to the target protein. 
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The Western blot results were analyzed with ImageJ program which quantifies 
the relative intensity of the bans. Cell cycle protein cyclin A was slightly increased 
with HBxWt expression when compared to the vector at both 24 hours and 48 hours 
post-transfection (Fig. 5.6). Although cyclin A seemed to be increased upon 
expression of HBxAC44 and the C-terminus fragment HBxl 11-154 expression at 24 
hours post-transfection, similar change was not observed at 48 hours. The results also 
showed that HBxWt could increase the expression of cyclin E at both 24 and 48 
hours post-transfection. HBxAC44 and HBxl 11-154，however, did not result in an 
obvious change to the cellular level of cyclin E. 
(a) 24 hours 48 hours 
5 < 3 < ；^ 
^ Z ^ 2 S - -r 
I i 1 i £ 1 l i l i e s 
S > K E X S > K JC X S 
WB i r ^ = = = n 
(54kDa) i ^ m m n m i m 
(42kDa) ^ • • • • I H H H I 
(b)i 
Cyclin A • 24 hours • 48 hours 
0 .00 z m l 
•1.50 — ~ 
！.00 T -ri— 
- o .50 :S-mm-ir i 丄 
2 厂 W^T^ FIT 
.00 ——|—_——•——^——-I - J 
• . 5 � - _ t _ l i _ t 1 1 a 
^ .00 _ • _ • _ _h i , \ I _ _ _ _ k I _ _ t i j l j 
Mock Vector HBx HBxAC44 HBxCllSA HBxl 11-154 
Transfectk)n(s) 
CHAPTER 5 Cell proliferation and regulation 96 
ii 
Cyclin E • 24 hours • 48 hours 
fl O r\A — _ . ^rrrz r ： ：^^ 二 
0 Z . U U I --“… “ 
1 i 
1 . 5 0 - - \ 
H 
di -I- I 1 -r 1 
Z T r f i 士 T T 工 I 
® 1.00 「： ^丄 I— I—I 丄 「 ] 「_^"[" P I t i 
mm 丄 这 丄 ，1 丄 
« 0 . 5 0 丄 丄 1 
1 i 
占 0.00 丨 I U I I I I I I I U I I I I • I 丨 
Mock Vector HBx HBxAC44 HBxCllSA HBxl l l-
154 
Transfection(s) 
Figure 5.6 Alteration of cellular cyclin A and E protein level by wild-type HBx 
and mutants. Upon expression of different HBx and mutants in parallel with the 
vector control and mock transfection control, the cyclin A and E levels as well as 
CDK2 in WRL68 cell lysate were detected with respective antibodies, (a) Western 
blot results, (b) Quantification of the results of Western blot, i. Cyclin A; ii. Cyclin E. 
Cyclin A and E were slightly increased upon HBxWt expression when compared to 
that of the vector control at both time point post-transfection. HBxAC44 and 
HBxl 11-154 seemed to increase at cyclin A level at 24 hours post-transfection by not 
at 48 hours. No change to the cyclin E was observed for both time points upon 
expression of HBxAC44 and HBxlll-154. 
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Apart from the detection of cyclin A and E, the level of CDK2 was also 
determined. As shown in figure 5.7, HBxWt decreased CDK2 expression slightly at 
both time points. The CDK2 was drastically decreased upon expression of HBxAC44 
or HBxl 11-154 at both 24 hours and 48 hours. 
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Fhgure 5.7 Alteration of cyclm-dependent kinase 2 (CDK2) expression by 
HBxWt and mutants, (a) Western blot results, (b) Quantification of the results from 
- Western blot. HBxWt slightly decreased the level of CDK2. In contrast, HBxAC44 
and HBxl 11-154 caused an obvious decrease in CDK2 expression compared to that 
of HBxWt 
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5.4 Regulation of the mRNA expression levels of cyclin-dependent 
kinases inhibitors and 
To further investigate the regulation mechanism on cell cycle pattern, the 
mRNA expression level of cyclin-dependent kinase inhibitors (CDKI) p2iwa£^ cipi and 
p27kiPi were determined. As described in section 5.3, cyclin A and E were increased 
by HBxWt while CDK2 was slightly decreased. On the other hand, CDK2 was 
drastically decreased by HBxAC44 and HBxlll-154 while cyclin A and E were not 
consistently altered. These results may be implying different mechanisms of 
regulation by HBxWt and HBxAC44. WRL68 cells were transiently transfected with 
HBxWt, HBxAC44 and HBxCllSA for the study of this part. HBxlll-154 was not 
included in this section as we are more interested in studying the HBx mutants 
instead of the fragment only. S-phase regulators cyclin A and E are tightly regulated 
by two CDK inhibitor proteins p2iwaf/cipi and which when diminished, 
stimulate CDK2-cyclin E complex activity that cooperates with other cycle protein 
complex to activate the expression of S-phase proteins such as cyclin A. Expression 
of CDKI proteins and in cells expressing HBx mutants or vectors 
were studied using real-time PGR. At 48 hours after transiently transfecting the 
recombinant plasmids, the mRNA was extracted from the cells and converted into 
complementary DNA (cDNA) through reverse transcription. The expression of target 
HBx genes was detected using reverse transcription PGR (Fig. 5.8). 
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Figure 5.8 Expression of transfected genes in WRL68 at 48 hours after 
transfection. The expression of target genes in three batches of cDNA samples was 
detected using reverse-transcription PCR. All the transfected vector or HBx variants 
was expressed successfully. 
Real-time PCR using Power SYBR Green Master Mix showed that expression 
of both p2iw««^cipi 肪d were significant altered by HBxWt and its mutant (Fig. 
5.9). The results were analyzed and presented as fold change compared to the vector 
control. The up-regulated genes were presented as positive while down-regulated 
ones as negative. 
Wild-type HBxWt was found to repress the mRNA expression of p21 樣 i p i ^ d 
p27k时 significantly to 1.45土0.16 and 1.77±0.24 fold respectively. In contrast, 
HBxAC44 significantly up-regulated p21 疏 i P ! and at 1.88土0.19 and 
2.62+0.13 fold respectively. However, HBxC l l SAd i d not cause a significant change 
to the mRNA expression of both genes with 1.10+0.14 fold down-regulation for 
p21 感 p i and 1.14土0.15 fold up-regulation for p 2 7 _ . 
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Figure 5.9 HBx variants exert different effect on and p27*^Pi m R N A 
expression. WRL68 cells were transiently transfected with various HBx variants in 
parallel with a pEGFP-Cl vector. At 48 hours after transfection, HBxWt was found 
to repress pSl^f鄉丨 and mRNA expression of 1.45±0.16 and 1.77土0.24 fold 
respectively. In contrast, HBxAC44 caused an increase in mRNA expression for both 
p2iwaf/cipi 肌d p 2 7 _ at 1.88±0.19 and 2.62±0.13 fold respectively. However, 
HBxCl lSA did not cause a significant change to the mRNA expression of both 
genes. 
P-value annotation: 
*p<0.05 with reference to the vector control for three sets of independent samples 
and experiments. 





This chapter describes the transactivation activity of HBx variants on mRNA 
expression of several oncogenes/ proto-oncogenes and their activity on stimulating 
the Ras/Raf/MARK pathway. In this chapter, we aimed to study the regulation 
mechanism 
ofpin^zcipi by HBxWt and its mutants. The results from real-time PCR 
showed that when p2r^af/cipi 狄以^  down-regulated, wild-type p53 was up-regulated or 
vice versa. Study on the Ras/Raf/MARK pathway showed that all the HBx fusion 
variants could stimulate the ERKl/2 phosphorylation. Inhibition of the MEK kinase 
which blocked the phosphorylation of ERK resulted in opposite effect on altering the 
mRNA expression of p2广"•^乂鄉！ “nd、wild-type p53 when compared to the case when 
MEK was not inhibited. Furthermore, expression study on three oncogenes/ 
proto-oncogene showed that HBxWt, HBxAC44 and HBxCllSA regulated the mRNA 
expression of two ras family genes and c-myc differently. 
6.1 Determination of p53-dependency of expression 
Wild-type p53 (p53Wt) is a tumour suppressor protein and responses to various 
forms of cellular stress, including DNA damage, oncogene activation and hypoxia, to 
trigger cell cycle arrest and/ or apoptosis (Ko and Prives, 1996). The universal 
CDK-cyclin complexes inhibitor described in chapter 5 is also a DNA 
damage responding protein. It is known to be regulated in a p5 3-dependent or 
p53-independent manner. In this section, we determined if the p2iwaf/cipi repression 
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or up-regulation was dependent on the expression level of p53Wt. Upon transient 
transfection and expression of HBx variants in WRL68 cells, the tumour suppressor 
gene p53Wt was studied using real-time PGR. Expression of HBxWt significantly 
but mildly up-regulated the expression of p53Wt gene at 48 hours after transfection 
by 1.34±0.16 fold (Fig. 6.1). In contrast, HBxAC44 and HBxCl lSA caused similar 
suppression on p53Wt mRNA expression as they down-regulated p53Wt by 
2.17土0.07 and 1.41 土0 .16 fold respectively. 
In combination with that described in section 5.4，HBxWt up-regulated p53Wt 
expression while it suppressed expression. In contrast, HBxAC44 
suppressed p53Wt expression while up-regulating p2iwaf/cipi expression. Point 
mutated variant HBxC115A down-regulated p53Wt expression while causing an 
insignificant change to expression. 
V 
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Figure 6.1 Effect on the mRNA expression of wild-type p53 by HBx variants at 
48 hours after transient transfection in WRL68 . The expression level of p53 was 
converted to fold changes with reference to that of EGFP-Cl vector control. HBxWt 
significantly but mildly up-regulated p53Wt mRNA expression by 1.34+0.16 fold. In 
contrast, HBxAC44 significant down-regulated the p53Wt by 2.17+0.07 fold. 
HBxCl lSA also resulted in a significant but mild down-regulation of p53Wt 
expression level by 1.41+0.16 fold. 
P-value annotation: 
* p<0.05 from three sets of individual samples and experiments. 
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6.2 Ras/Raf/MAPK pathway activation by HBx variants 
In the previous chapter, we have determined the mRNA expression level of 
p2iwaf/cipi which was repressed by HBxWt, up-regulated by HBxAC44 and not 
changed by HBxC115A. Besides the p53 inducible pathway, p2iwaf/cipi has been 
reported to be regulated through the Raf-l/MEK/ERK pathways (Beier et al, 1999). 
Furthermore, activation of the Ras/Raf/MEK/ERK by HBx has been shown to 
increase cell proliferation by deregulation of cell cycle checkpoint proteins (Benn et 
al, 1995; Doria et al., 1995). To investigate the potential regulation of pir^^^'P^ 
expression through the Ras/Raf 1 /MEK/ERX pathway, we applied antibodies that 
specifically blotted the phosphorylated ERKl and ERX2 to the lysate from cells 
transfected with different HBx variants. Moreover, we studied the potential 
phosphorylation activation role of HBx variants by inhibition strategy in which 
MEK inhibitor PD98059 was used to block the phosphorylation of ERKl and 
ERK2. 
6.2.1 ERKl /2 phosphorylation by HBx variants 
WRL68 cells were transfected with HBxWt, HBxAC44 and HBxC115A 
recombinant EGFP-plasmids in parallel with an EGFP vector control. The level of 
phosphorylated ERK l (pERKl , 44 kDa) and ERK2 (pERK2, 42 kDa) were 
examined at different time points after transfection (replenishment of 10% serum 
supplemented medium). Equal amount of 30 |ig protein was loaded into each well 
onto a 12% protein gel. (3-actin was included as the loading control as shown in 
figure 6.2. Results showed that the total ERKl and ERK2 were more or less constant 
in amount in samples from different time points, (a) Interesting, unlike the sustained 
level detected at 48 hours post-transfection as described in the previous chapter, 
HBxWt was detected at 5 hours post-transfection which persisted till T=10 hours but 
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Note: Representative figure from two sets of independent samples and experiments. 
Figure 6.2 ERKl/2 phosphorylation by HBx variants. WRL68 cells were 
transfected with HBxWt, HBxAC44 and HBxCllSA in parallel with EGFP-Cl 
vector control. Equal amount of 30 jig protein was loaded into each well of a 12% 
protein gel. The level of phosphorylated ERKl (44 kDa) and ERK2 (42 kDa) were 
examined at different time points after transfection (replenishment of 10% serum 
supplemented medium) using Western blot. (3-actin was blotted as the loading 
control which did not vary significantly. Total ERKl and ERK2 were found more or 
less constant at different time points after transfection. (a) H B x W t was detected at 5 
hours post-transfection which persisted till T=10hours. (b) (c) (d) HBxAC44, 
HBxCllSA and EGFP protein were detected at T=20 hours which persisted at T=44 
hours. All the three H B x variants and the vector caused a decrease level of 
, pERXl/2 at T=5 hours followed by an increase at T=10 hours. 
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failed to be detected at T=20 hours onwards, (b) (c) (d) HBxAC44, HBxCllSA and 
EGFP protein were detected at T=20 hours which persisted at T=44 hours. The total 
ERKl and ERK2 did not change upon expression of various fusion proteins. All the 
three HBx variants and the vector caused a decrease in the level of pERKl/2 at T=5 
hours. The level of pERKl and pERK2 were strongly increased by T=10 hours, 
when the target protein started to be detected. These results further showed that 
HBxAC44 and HBxC115A activated the phosphorylation of ERKl and ERK2 for a 
longer period of time compared to that of HBxWt and vector control i.e. T=44 hours. 
However, we found that the vector control EGFP protein also resulted in a similar 
activation showing that EGFP alone was capable in activating E R K phosphorylation, 
which makes the interpretation complicated. This is consistent with the findings of 
Chin et al in a recently published paper (Chin et al., 2007). This may imply that the 
EGFP recombinant plasmids are not a good system for studying E R K pathway 
activation at T=10 hours. 
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6.2.2 ERK inhibition blocks the regulation effect on p53Wt and pZ^af/dpi 
PD98059 is cell-permeable chemical inhibitor of M A P kinase kinase (MEK). It 
inhibits phosphorylation of E R K by M E K and thus blocks the phosphorylation 
activity of E R K on the downstream proteins. PD98059 was used at 20 ^M, the 
suggested IC50 from the supplier. It was added together with 10% serum-medium at 
the step of medium replenishment in transfection. After 24 hours inhibition, the 
m R N A was isolated from the cell and converted into cDNA. The m R N A expression 
level of wild-type p53 (p53Wt) and in W R L 6 8 cells were analyzed using 
real-time PCR. 
Results showed that upon M E K inhibition, H B x W t up-regulated p2iwaf/dpi 
while down-regulating p53Wt m R N A expression (Fig. 6.3). The opposite effect was 
observed for HBxAC44 which slightly down-regulated expression and 
slightly up-regulated p53Wt expression. For HBxC115A, was slightly 
up-regulated while p53Wt was repressed. In combination of the results in chapter 5 
and section 6.1, the alteration effect on m R N A expression of and p53Wt by 
、 
HBx variants was abrogated or reverted with the addition of the M E K inhibitor. It 
implies that the Ras/Raf/MAPK pathway may be responsible for p53Wt mediated 
p2iwaf/cipi repression. Alternatively, m R N A expression itself may be 
regulated through this pathway. However, this experiment was only performed once 
so that it needs to be replicated before a firm conclusion can be drawn. 
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Figure 6.3 Effect of HBx variants on the mRNA expression levels of wild-type 
p53 and 卩2广》[如卩1 after MEK inhibition. The m R N A expression level of 
p2iwaf/cipi 肌d p53Wt win W R L 6 8 cells ere determined after 24 hours M E K 
inhibition with PD98059 (20 ^iM). Results showed that both H B x W t and 
HBxCllSA up-regulated and down-regulated p53Wt. HBxAC44 slightly 
down-regulated while up-regulating p53Wt. 
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6.3 Transactivation activity on oncogenes/ proto-oncogenes 
The transactivation activity of HBx variants on gene expression was further 
studied using real-time P C R techniques. In hepatocarcinogenesis, H B x may not act 
as an oncogene but cooperate with many activated cellular oncogenes(s) in 
hepatocarcinogenesis. Thus in this section, we determined the m R N A expression 
level of a well-known oncogene, c-myc; and two genes from the Ras family, that 
were previously reported by our group to be up-regulated by H B x W t (Ng et al., 
2004). 
6.3.1 Effect on c-myc (NM—002467) mRNA expression 
Expression of c-myc gene in normal cells is tightly regulated by growth factors 
or extracellular matrix contacts as well as by cellular signals like those found in 
different stages of the cell cycle. Normally cells do not express c-myc at a high level 
but when it is abnormally over-expressed in cells it turns on an apoptosis cascade. In 
contrast to such tight regulation in normal cells, which only express the gene when 
cells are actively dividing, cancer cells may over-express this gene in an uncontrolled 
manner. C-myc gene was suggested to promote cell proliferation, development of 
liver lesions and thus genomic instability (Terradillos et al., 1997). It has also been 
found to increase cyclin D expression and thus sequesters to accelerate cells 
through Gl/S transition of the cell cycle in an indirect way which also involves an 
elevation of inactive glycogen synthase kinase-3-beta (GSK3p) (Dieth et al., 1998). 
‘ C-myc was found to be over-expressed in breast cancers, colon cancers and many 
other human cancers. In massive gene expression profiling study for H C C , several 
c-—c-regulated genes were identified (lizuka et al., 2006). It has also reported to 
inhibit p53-induced apoptosis which is a step leading to cancer development 
(Ceballos et al.，2005). The relationship between H B x W t and c-myc has been widely 
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described. C-myc is frequently amplified in liver tumours which are caused by 
hepatitis virus infection (Transy et al, 1992). Some suggests HBx itself is largely 
non-oncogenic but in combined expression of c-myc, the risk of 
hepatocarcinogenesis is increased (Terradillos et al., 1997). 
The alteration of c-myc m R N A expression level was determined in cells 
over-expressing HBxWt, in parallel with HBxAC44, HBxCllSA and a EGFP vector 
control to investigate the differential effect of these HBx variants at 48 hours 
post-transfection (Fig. 6.4). The relative m R N A expression level was calculated 
using the vector control as a reference. Upon expression of HBxWt, the level of 
c-myc gene was not significantly changed (-1.18土0.16). HBxAC44 significantly 
up-regulated the c-myc expression by 1.94±0.75 fold whereas HBxC115A 
down-regulated c-myc by 2.44±0.16 fold. 
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Figure 6.4 Alteration of mRNA expression of c-myc gene by HBx variants. 
W R L 6 8 cells were transiently transfected with various HBx variants. The c-myc 
expression level was determined at 48 hours post-transfection and presented as fold 
changes when compared to that of the vector control. Upon expression of HBxWt, 
the level of c-myc gene was not significantly changed (-1.18+0.16). HBxAC44 
significantly up-regulated the c-myc m R N A expression by 1.94土0.75 fold whereas 
HBxC115A down-regulated c-myc by 2.44+0.16 fold. 
P-value annotation: 
* p<0.05 from three sets of independent samples and experiments. 
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6.3.2 Effect on RhoC (NM_017744) and Rabl4 (NM一016322) mRNA 
expression 
The interest in studying the expression of RhoC and Rabl4 initiated from the 
results of our previous research on HBx using a Tet-On inducible cell-line that stably 
expresses wild-type H B x (Ng et aL, 2004). Massive differential gene expression 
profiling, using gene chip microarray led to the discovery of several genes (including 
RhoC and Rabl4) that were significantly up-regulated. In this section, we compared 
the expression level of these two genes in cells transfected with H B x W t to those 
expressed in HBxAC44 or HBxC 115 A transfected cells. 
Both RhoC and Rabl4 were classified as Ras-oncogenes which is a superfamily 
including GTP-binding proteins. This superfamily can be divided into at least five 
families: the Ras, Rho, Rab, Sarl/Arf, and Ran families (Takai et al., 2001). Both 
Rho and Rab family are Ras-related, small guanosine triphosphatases (GTPases) 
which commonly adopt a mechanism called the guanosine triphosphate (GTP)/ 
guanosine diphosphate (GDP) cycle that defines the active or inactive state of the 
enzymes (Oxford et al., 2003). Ras superfamily regulates a wide variety of cellular 
functions in which they also take the role to determine the time for initiation and 
termination of a cell response (Takai et al., 2001). Rho GTPase may be involved in 
transcription regulation, cell cycle control, maintaining the transformed phenotype 
and metastasis (Aspenstrom et al.’ 1999; Van Aelst and D'Souza-Schorey, 1997; del 
- Peso et al.’ 1997; Clark et al, 2000). The regulation of transcription by Rho family is 
unlikely via the extracellular signal-regulated kinase (ERK) pathway (Frost et al., 
1996). Nevertheless, the Rho family is able to induce the JNK pathway activation 
(Teramoto et al., 1996). Rho is even involved in the regulation of glucose transport 
、 which is an early cellular response to growth factor and is essential for cell 
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proliferation (Standaert et al, 1998). RhoGTPase is often over-expressed in various 
kinds of tumours (Fritz et al, 1999). The Rho family contains three prototypic 
members, RhoA, RhoB and RhoC with different regulation effect and subcellular 
localization (Sah et al., 2000). 
In this study, the expression level of RhoC and Rabl4 were analyzed at 48 hours 
after transient transfection. The expression levels of the genes were presented as fold 
expression relative to the vector control. H B x W t and HBxAC44 up-regulated RhoC 
significantly by 1.79±0.28 and 1.89土0.08 fold respectively. In contrast, HBxCllSA 
significantly but mildly down-regulates RhoC expression by. 1.29+0.008 fold (Fig. 
6.5). 
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Figure 6.5 Alteration of mRNA expression of RhoC in WRL68 upon HBx 
variants expression. At 48 hours after transient transfection, the expression level of 
RhoC was determined and presented as fold of expression. H B x W t and HBxAC44 
up-regulated RhoC significantly at 1.79+0.28 and 1.89土0.08 respectively. In contrast, 
HBxCllSA significantly but mildly down-regulated RhoC by 1.29+0.08 fold. 
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Rab GTPase also regulates a number of cellular processes such as vesicular 
membrane transport and tumour progression (Bucci et al, 1992; Pei et al.，2002). 
The Rab protein at their active state is essential in controlling the targeting and fusion 
of transport vesicles to appropriate acceptor membrane (Zerial and McBride, 2001). 
Thus, it is believed that the alteration of Rab protein expression is related to the 
occurrence of cancer. Our results showed that H B x W t down-regulated Rab 14 by 
1.3 8土0.46 fold whereas HBxAC44 and HBxC115A up-regulated Rab 14 by 
1.27+0.31 and 1.49+0.42 respectively. However, in three sets of independent samples 
and experiments, no significance of the data was found (Fig. 6.6). 
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Figure 6.6 Alteration ofmRNA expression of Rab 14 in WRL68 upon HBx 
‘ variants expression. The expression level of Rab 14 was determined at 48 hours 
after transient transfection and presented as fold expression. H B x W t down-regulated 
Rab 14 at 1.38+0.46 fold whereas HBxAC44 and HBxC115A up-regulated Rabl4 at 
1.27土0.31 and 1.49+0.42 respectively. However, in three sets of independent samples 
and experiments, no significance of the data was found, i.e. the p-value of these 
, results are >0.05. 
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CHAPTER 7 
Construction of Tet-On inducible cell-lines 
Summary 
This chapter describes the progress of Tet-On inducible cell-lines establishment. 
Several WRL68 based Tet-On cell-line were constructed. The clone with highest 
induction response was selected for establishment of Tet-On/Gene inducible cell-line, 
including cells expressing HBxWt, HBxAC44 and HBxAN60. Until this stage, only 
Tet-On/HBxAC44 was successfully constructed which was named as TOXDCl. The 
induction profile, growth curves as well as the expression patterns of its cellular 
• p2 i�vaf/cipi 狄它沈 determined as the early characterization of this cell-line. 
In studying the function a protein by over-expressing it, the low transfection 
efficiency is a problem that could be encountered. In our project, the transfection 
efficiency of EGFP-recombinant plasmids was estimated to be 5-10% (data not 
shown). Apart from lipofectamine-PLUS transfection reagent, another reagent called 
GeneJuice® was also tried. However, it did not improve the situation that the 
transfection efficiency remained low. In Chapter 5, we have described the method of 
using cell gating in a flow cytometer to select the cells successfully express 
EGFP-tagged recombinant proteins to eliminate the problem of low transfection 
efficiency. However, this strategy was only applicable to techniques where cell 
“ gating is possible. Cell sorting is an alternative for cell gating, however, it usually 
takes a long time and a large population of the early sorted cells will die. The main 
drawback of transient transfection is that the effect of different HBx variants was 
underestimated. Moreover, different transfection or expression level among the 
、 variants makes the comparison unfair. In view of these problems, we constructed 
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Stable monoclonal cell-lines such that each cell in the pool stably expresses the target 
variants at a similar level. Viral proteins have been reported to induce programmed 
cell death that makes the stable cell selection difficult. To avoid selecting the strong, 
apoptosis-resistant cells while the viral protein is continuously being expressed, we 
adopted the Tet-On system in which the expression of the viral protein is tightly 
regulated by a doxycycline-responsive vector. Without the addition of doxycycline, 
the viral gene remains silent. When doxycycline is applied to the Tet-On cells, the 
target viral gene can be turned on within a very short period of time, in our case, less 
than 24 hours. 
7.1 Establishment of WRL/Tet-On monoclonal cell-lines 
7.1.1 Determination of geneticin selection dosage 
As different cell-lines respond differently to geneticin, a selection antibiotic of 
Tet-On plasmid, the optimal selection dosage for W R L 6 8 cell-line was determined 
using M T T assay. M T T assay is a colourimetric assay which reflects the relative 
amount of viable cells. W R L 6 8 were seeded on a 96-well plate with 5 well repeats. A 
serial dosage of geneticin of 0, 200, 400，600，800, 1000 jig/ml in medium was added 
to the cells the next day after seeding cells. M T T cell viability assay was performed 
at 48 hours after treatment and the results were presented as % viability with 
reference to the untreated control (geneticin: 0 pig/ml) (Fig. 7.1). A trend-line was 
- added to outline the general cell viability pattern. The IC50 of geneticin was 
determined as the 50% viability of the untreated control and was found to be 650 
|j,g/ml. This dosage was used to select the W R L 6 8 successfully transfected with 
Tet-On plasmids. These stable clones were then named as WRL/TOn clones. 
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Figure 7.1 Determination of the selection dosage of geneticin for WRL68 cells 
transfected with a Tet-On vector. W R L 6 8 were seeded on a 96-well plate with 5 
well repeats. A serial dosage of geneticin of 0, 200，400, 600，800，1000 i^g/ml in 
medium was added to the cells the next day after seeding the cells. M T T cell viability 
assay was performed at 48 hours after treatment and the results analyzed with 
reference to the untreated control (geneticin= 0 ng/ml). The IC50 of geneticin was 
determined as the 50% viability dt the untreated control and was found to be 650 
昭/ml. 
V 
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7.1.2 Selection of the best WRL/TOn clone using luciferase assay 
Twenty clones of stable WRL/TOn cell-lines were isolated and allowed to be 
grown up for cell assays. A pTRE2-Luc plasmid which contains a firefly luciferase 
protein sequence was transfected into different clones that survived eventually. An 
untransfected control was included to determine the background luciferase activity as 
described in chapter 3. At 24 hours after transfection, the transfected cells were 
induced with 400 ng/ml doxycycline. An uninduced control was included to 
determine the reference luciferase activity. At 48 hours after induction, protein lysate 
was collected and quantified using B C A assay. The luciferase activity was measured 
with 5 |ig cell lysate. The relative induction ratio was calculated with reference to the 
uninduced control after normalization using the background control as shown in 
figure 7.2, WRL/TOn clone 8 (C8) showed the greatest relative luciferase ratio and it 
was selected for establishment of stable WRL/TOn/gene cell-lines. 
V 
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Figure 7.2 Relative luciferase activity ratio of doxycycline induced WRL/TOn 
cell-line to the uninduced control. The WRL/TOn cells were transfected with 
pTRE2-Luc. Doxycycline (400 ng/ml) was added to the cell-lines at 24 hours 
post-transfection. The protein lysate was collected at 48 hours after induction and 
quantified using B C A assay. The luciferase activity was measured with 5 |ig cell 
lysate. The relative induction ratio was calculated with reference to the uninduced 
control after normalization using the background control. 
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7.2 Establishment of inducible WRL/TOn/Gene monoclonal 
cell-lines 
7.2.1 Determination of hygromycin selection dosage 
The dosage for hygromycin to select the cells with pTK-Hyg plasmids was 
determined prior to construction of WRL/TOn/gene cell-lines. Stable WRL/TOn 
clone 8 (C8) cells were seeded on a 96-well plate with 5 well repeats. A serial dosage 
of hygromycin B of 0，100，200, 300, 400 and 600 |ig/ml in medium was added to the 
cells the next day after seeding cells. M T T cell viability assay was performed at 48 
hours after treatment and the results were analyzed with reference to the untreated 
control (hygromycin B = 0 fxg/ml) (Fig. 7.3). The IC50 was determined as the 50% 
viability of the untreated control and was found to be 320 |ig/ml approximately. Thus, 
we adopted the dosage of 350 p,g/ml hygromycin B in the cell selection process. 
V 
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Figure 7.3 Determination of the selection dosage of hygromycin for WRL/TOn 
transfected with pTRE2-gene plasmids. Stable WRL/TOn cells were seeded on a 
96-well plate with 5 well repeats. A serial dosage of hygromycin B of 0，100, 200, 
300，400 and 600 |xg/ml in medium was added to the cells the next day after seeding 
cells. M T T cell viability assay was performed at 48 hours after treatment and the 
results analyzed with reference to the untreated control (hygromycin B= 0 ug/ml). 
The IC50 was determined as the 50% viability of the untreated control and was found 
to be about 320 ^ ig/ml. 、 
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7.2.2 Selection of positive WRL/TOn/Gene clones with viral genes 
The pTRE2-gene plasmid which contains the H B x variants was co-transfected 
with pTK-Hyg plasmid which contains a hygromycin resistant gene, at 3:1 ratio into 
WRL/TOn cells. At 48 hours post-transfection, 350 (xg/ml hygromycin B was added 
to select for pTK-Hyg positive clones, which should contain the whole pTRE2-gene 
plasmids. The selection process was continued for 3 weeks, the resistant clones were 
maintained at 350 |j,g/ml of geneticin and 200 |j.g/ml of hygromycin B. 
For each WRL/TOn/Gene transfection, 40 monoclones were isolated. However, 
among the isolated clones, only few survived. After enrichment to certain number of 
cells, doxycycline induction was performed to determine the inducibility of cells as 
well as to identify the successful constructed clones. Monoclonal cells were seeded 
onto a 35 m m culture dish. Doxycycline-induced or uninduced treatment was 
performed at 24 hours after seeding. The m R N A was isolated from the cells at 24 
hours and 48 hours after induction. Reverse transcription P C R was performed with 
34 cycles of reactions. Figure 7.4(a) shows the target viral genes amplified from the 
、 
c D N A of different WRL/TOn clones, (i) TOn/HBxWt clone 1 gave bands for both 
induction and uninduced treatment at both 24 hours and 48 hours. Clone 2，however, 
did not give rise to a band of the appropriate size (-500 bp), (ii) TOn/HBxAC44 
clone 1 gave a band of about 350 bp for doxycycline-induced treatment at both 24 
hours and 48 hours. No band was observed for uninduced treatment. However, clone 
, 2 did not give rise to any bands for both induced and uninduced treatment at 24 hours, 
(iii) TOn/HBxAN60 clone 1 gave bands of correct size 300 bp) at both time points 
for both induced and uninduced treatment. Similar results were shown by clones at 
24 hours that bands were observed for both treatments. Clone 3 and 4, however, did 
. not give any target bands. The detection of viral genes expression in the uninduced 
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control might be due to the deletion of the rTetR response promoter when the pTRE 
response plasmid was integrated into the cell genome, leading to leakage of 
expression even without induction. In view of this problem, we suggest pre-digestion 
of the plasmid containing the target genes at site upstream of the TRE promoter to 
aid its integration into the host genome, so as to decrease the chance of random 
integration at undesirable sites on the plasmid. 
From the induction pattern, TOn/HBxAC44 (b) was selected for further analysis 
while the other clones will be continued to be studied in the future. 
WRL/TOn/HBxAC44 was renamed as TOXDCl for simplicity of description. 
V 
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Fig 7.4 Induction test of on WRL/TOn/Gene monoclones. Cells were induced 
with 400 ng/ml doxycycline or uninduced at 24 hours after seeding onto a 35 m m 
culture dish. The m R N A was isolated from the cells at 24 hours and 48 hours after 
induction, (a) (i) Two clones CI and C2 for TOn/HBx were analyzed. Clone 1 gave 
a band of correct size (-500 bp) for both induced and uninduced samples at 24 and 
48 hours. Clone 2 did not give any P C R product at 24 hours, (ii) For 
TOn/HBxAC44, clone 1 gave a strong clear band upon doxycycline induction but 
not in uninduced control at both 24 and 48 hours. Clone 2 did not give a band at 
- about 350 bp for both induced and uninduced treatment, (iii) For TOn/HBxAN60, 
clone 1 gave bands for both treatments at 24 and 48 hours with correct size of about 
300 bp. Clone 2 also gave bands for both treatments at 24 hours. In contrast, C3 and 
C4 did not give bands for both treatments at 48 hours, (b) Induction pattern of 
TOn/HBxAC44 was extracted and edited. TOn/HBxAC44 stably expressed the 
-truncated H B x mutant upon doxycycline induction at 24 and 48 hours after 
induction. 
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7.3 Characterization of TOXDCl cell-line 
7.3.1 Cell morphology 
In this part of study, some basic properties of T O X D C l which stably expresses 
HBxAC44 upon doxycycline induction were characterized. To start with, the cell 
proliferation effect and 卩 2 产 _ 
expression was studied and compared with those 
observed for the transient transfection in the previous parts showing HBxAC44 
induced cell proliferation and up-regulated 卩 2 1 碰 叩 1 m R N A expression. 
Doxycycline induced Uninduced 
TOn/HBxAC44-Clone 1 
(TOXDCl) 
Figure 7.5 Cell images of doxycycline-induced or uninduced TOn/HBxAC44 
(TOXDCl) at 24 hours after the treatment. Addition of doxycycline (400ng/ ml) 
did not cause obvious changes in the morphology of the cell-line expressing 
HBxAC44. 
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7.3.2 Growth pattern of TOXDCl 
Microscopy with cell images showed that the morphology of T O X D C l 
remained similar upon 24 hours doxycycline induction (Fig. 7.5). No cell death was 
observed. The growth curves for T O X D C l induced and uninduced treatments were 
constructed (Fig. 7.6). The same number of T O X D C l cells was seeded onto 35 m m 
culture dishes and 400 ng/ml doxycycline was added at 24 hours into one set of cells. 
Cell number was counted for both induced and uninduced treatments for the 
subsequent 4 days after induction and presented as % cell number with reference to 
day 1 after induction. Upon doxycycline induction, the curve growth shifted up 
when compared to the uninduced control, implying for a greater proliferation of the 
cells. 
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Figure 7.6 Growth curves of TOXDCl of induced and uninduced treatment over 
four days induction with doxycycline. The growth curve of the induced and 
uninduced cells was determined by counting the total cell number on four subsequent 
days after doxycycline (400 ng/ml) induction. The results were presented as the 
percentage of cells compared to that of day one. The doxycycline induced cells was 
found to grow faster and gave a curve that shifted up when compared to that of the 
uninduced control. 
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7.3.3 HBxAC44 induced pZr'^^""^ m R N A expression 
The induction and expression pattern of the target HBxAC44 was studied for 4 
days after induction by 400 ng/ml doxycycline (Fig. 7.7). In the induction process, 
induction medium was replaced every two days. From day 1 to day 3, HBxAC44 
m R N A was detected upon induction but not for the uninduced control. On day 4, the 
HBxAC44 m R N A was not detected even with doxycycline (400 ng/ml) induction. 
The expression level of 卩 2 广 — 1 — s determined using RT-PCR. Results showed 
that p21 柳fZcipi expression was up-regulated with doxycycline induction, i.e. with 
HBxAC44 expression, from day 1 to day 3. When there was expression of 
HBxAC44, the was up-regulated. The expression level of p^ a^f/cipi 
remains more or less the same on day 4, which may be due to the low expression 
level of HBxAC44. A housekeeping gene G3PDH was included as the internal 
control. Western blot was not used as the commercially available anti-HBx 
antibodies could not be used to detect HBxAC44 as the antibody usually target at the 
C-terminus which was deleted in this case. 
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Figure 7.7 Study on mRNA expression in TOXDCl upon doxycycline 
induction. Expression of the target HBxAC44 in T O X D C l was detected upon 
doxycycline (400ng/ ml) induction from day 1 to 3 but not on day 4. Expression level 
of p2iw豪pi was increased when HBxAC44 was expressed. A house keeping gene 
G 3 P D H was included as the internal control. 
V 
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7.3.4 Doxycycline-concentration-dependent expression of HBxAC44 in 
TOXDCl 
In the previous section, we found that the expression level of HBxAC44 upon 
induction with 400 ng/ml doxycydine was very low, that after 28 cycles of PCR 
cycles, the bands were weakly detected by EtBr on the agarose gel. Thereby, we 
analyzed the expression of the HBxAC44 in T O X D C l cells upon induction with 
different concentration of doxycydine. After treating with different concentration of 
doxycydine for 48 hours, the expression level of HBxAC44 was determined using 
real-time PCR. Our results showed that, the expression level of HBxAC44 was 
dependent on the concentration of doxycydine that with a higher concentration of 
doxycydine, a greater expression level of HBxAC44 was measured. 
fl 6.00 
1 5.00 B — 
• 
S 4.00 • 
3 3.00 、 H — 
< 2.14 • 
I 0.00 • • • • • W - J B -
0.00 0.25 0.50 0.75 1.00 1.50 2.00 
Doxycydine (ug/ml) 
Figure 7.8 Concentration-dependent induction on HBxAC44 expression by 
doxycydine. T O X D C l cells of a fixed number were induced with doxycydine at 
different concentrations for 48 hours. Real-time P C R was performed to examine the 
expression level of HBxAC44. The expression of HBxAC44 was found to be 
positively dependent on the concentration of doxycydine added. 
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CHAPTER 8 
Discussion 
8.1 Selection of model 
8.1.1 Selection of cell models 
In the present study, human liver cell-line W R L 6 8 was chosen as the cell model 
for most of the studies. First of all, it is of human and liver origin that is the natural 
target of human HBV. Moreover, it is derived from a normal liver. Carcinogenesis is 
a process of multi-steps of molecular changes in normal cells that eventually 
contribute to the final physiological alterations that present the cancer markers or 
morphology. Cancer cell-lines like HepG2 or Hep3B which have already present the 
cancer morphology, are not chosen for this study due to this reason. 
Using W R L 6 8 cell-line has another advantage that it possesses the wild-type 
p53 gene. Many studies indicated that different roles of H B x in carcinogenesis are 
mediated by the wild-type p53. Thereby, to study the effect of H B x in transformation 
or cellular pathways, a cell model with a wild-type p53 should be taken. HepG2, 
though has a wild-type p53, was derived from natural human hepatoblastoma 
(adenoma) in which many cellular pathways may have been inactivated. Hep3B is 
not a good model, too, as its p53 gene is thought to be truncated or absent. It is 
neither suitable to be used as a negative control in p53 related study as it contains the 
H B V integrants that may interfere with the exogenous H B V genes transfected into it 
(Ahn et al, 2002). 
However, there are some limitations in using W R L 6 8 as the model to study liver 
oncogenesis. Some W R L 6 8 cells contain part of human papilloma viral (HPV) D N A 
sequences that may interfere with the effect of H B x herein studied (information from 
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ATCC). Therefore, selection of liver-derived cells using biomarkers is necessary for 
future stuies on hepatocarcinogenesis if this cell-line is used as the model. In view of 
the potential tumourigenecity, in our previous study on HBx, we used liver cell-line 
A M L 1 2 in spite of its mouse origin, for construction of an H B x Tet-On inducible 
cell-line. This cell-line over-expresses growth factor TNF which sustains the 
immortal property of the cells. It was used because it does not have tumourigenecity. 
In the current project, we constructed Tet-On cells from W R L 6 8 cell-line for three 
different H B x variants including the wild-type HBx. The two Tet-On cell-lines on 
HBx from W R L 6 8 and A M L 1 2 may also serve as a comparison tool for the effect of 
HBx on different mammals. 
8.1.2 Selection of truncation mutant 
In project, the majority of the cell assays were performed with H B x W t and 
HBxAC44. It has been reported to be clinically relevant to H C C . Other truncations 
mutants lacking 10, 20 or 30 a.a. may also promote tumourigenicity in a way, if not 
impossible, much more than that by HBxAC44. As described by Tu et al. in 2001, 
HBx mutants with 20-34 a.a. deletion at the carboxy-terminus abrogated some 
biological functions of wild-type H B x such as growth inhibition and transforming 
inhibition. As described in chapter 4, C-terminal truncation mutants ranging from 
HBxAlO to HBxAC37 localized in a similar way as wild-type H B x and that they all 
targeted to the mitochondria. Truncation mutant HBxAC44 lacking carboxy-terminal 
44 a.a. residues, however, showed discrete subcellular localization in both W R L 6 8 
and HepG2 cells. In addition, as we speculate that the C-terminus is important in 
determining the biological functions of HBx, a wild-type H B x and a mutant with the 
removal of the whole C-terminus would be the best targets to be used in a 
comparison study like this one. 
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8.2 Differential sub-cellular localization of HBx and its variants 
Using fluorescence microscopy, we demonstrated that EGFP-tagged wild-type 
HBx of genotype A, adw2 subtype was located in the mitochondria as indicated by 
co-localization with cytochrome c oxidase and mitotracker red. Such localization was 
independent of whether N-terminus 1-60 residues were present or deleted. On the 
other hand, we found that the transactivation sequence in the C-terminus domain was 
essential and indispensable for mitochondrial localization. The C-terminal sequence 
(HBxlll-154) of 44 amino acids long was sufficient for the mitochondrial targeting. 
Therefore, when this sequence was deleted, HBxAC44 dispersed in the cytoplasm. 
The EGFP vector control gave green signals that dispersed in the cytoplasm without 
specific organelle distributions. 
8.2.1 Mechanisms of mitochondria targeting 
The subcellular localization of H B x has previously been studied by several 
groups of investigators including ourselves. The results showed that H B x was 
predominantly localized in the cytoplasm (Rahmani et al., 2000; Shirakata et al., 
2003), while some suggested that H B x localized in the nucleus (Dandri et al.’ 1998; 
Henkler et al, 2001; Hoare et al., 2001). The dynamic distribution of H B x could be 
important to the multiple functions of HBx at different stages of the H B V life cycle. 
Indeed, a group shows that HBx is shuttled between the cytoplasm and the nucleus 
through a Crm-1 dependent nuclear export pathway. H B x also takes the role of 
sequestering Crm-1 in the cytoplasm and helps to enhance N F - k B localization into 
the nucleus (Forgues et al., 2001). Increasing evidence from immuno-fluorescence 
microscopy and subcellular fractionation techniques further confirms that H B x 
locates at mitochondria, or it causes the mitochondria to aggregates at the perinuclear 
.space in a p53 independent manner. Such mitochondrial aggregation is caused by the 
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HBx-mediated modulation of the microtubule network as HBx activates the p38 
M A P K pathway to contribute to the increase in microtubule-dependent dynein 
activity (Kim et al., 2007). 
Various deletion mutants of HBx have been studied by other research groups. 
However, none of these reports show that there is a crucial amino acid for 
mitochondrial targeting. In 2003，the 68-117 amino acid residues of HBx were 
suggested as the mitochondrial targeting sequence (Shirakada et al, 2003). In this 
study, we demonstrated for the first time that the C-terminus (44 amino acids) itself 
was sufficient for such subcellular localization. Through systematic deletion of 
various length of the C-terminus, we further mapped out a crucial short region of 7 
amino acids (111-117) for mitochondrial targeting. Such short sequence of 7 amino 
acids (HBxlll-117) however, was not sufficient to work as a signal sequence to 
bring the non-mitochondrial proteins to the mitochondria. Adding extra 5 
neighbouring amino acids to this short oligonucleotide sequence did not aid in 
working as a signal sequence. However, from site-directed mutagenesis we found 
that the key amino acid for subcellular localization was HBxll5 cysteine. When 
HBxll5 cysteine was mutated to alanine, the mutant HBxC115A failed to target to 
the mitochondria. Indeed, many disulphide bonds were assigned to HBx in an E. coli 
expression system that eight of the total nine cysteine residues were linked. Cysll5 
of HBx was assigned to link with its Cysl7 at the N-terminus (Gupta et al, 1995). 
Taken together, we proposed that mitochondrial targeting is a result of interaction 
between the central sequence and C-terminal 111-117, of which very likely the 115 
cysteine is responsible for the interaction. 
The cysteine residues in HBx, however, are found to be not required for its 
interaction with AU-rich R N A oligonucelotides and human p53 in vitro. When all or 
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some of the cysteine were mutated to serine, the mutant H B x was still able to interact 
with p53 protein just as full-length wild type H B x (Rui et al, 2005; Moura et al., 
2005). Although these studies suggested that the cysteine residues are of minor 
importance of in R N A and p53 binding, we speculate the cysteine residue at HBxll5 
has an indispensable role in interacting with mitochondrial proteins, as demonstrated 
in our results. 
Viral proteins coded in the host cells are imported into the mitochondria through 
several cytosolic factors. These proteins usually contained a mitochondrial targeting 
sequence (MTS)，defined as sequences sufficient to target proteins and peptides to 
mitochondria. They are usually of 20-40 amino acids long, with abundant positive 
charges and hydroxylated residues forming amphipathic-helices in membranes 
(Neupert et al., 1997). In our project, the M T S of H B x was found to include seven 
essential amino acid residues (HB111YFKDCVF117). These amino acids were not 
all positively charged which may be the reason why it is not sufficient for 
mitochondrial targeting. 
8.2.2 Mitochondria as site of HBx-induced apoptosis 
Mitochondria are the key organelles that orchestrate the apoptotic responses. 
Mitochondrial proteins encoded by the host cell's nuclear D N A are synthesized in the 
cytoplasm and then imported into mitochondria. Protein sorting to mitochondria is 
achieved by several cytosolic factors and mitochondrial translocation machines, 
which ensure their correct targeting to the appropriate sub-mitochondrial 
compartment (Neupert et al., 1997). The exact compartmentation of H B x is still a 
matter of debate. As H B x has been shown to colocalize and interact with a 
mitochondrial outer porin protein called human voltage-dependent anion channel, 
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H V D A C 3 , the mitochondrial membrane has been thought to be the site for HBx 
distribution (Rahmani et al.’ 2000). The localization in mitochondria is consistent 
with the role of H B x to potentiate apoptosis as mitochondria are the site of apoptosis 
initiation. Indeed, viral proteins are thought to induce apoptosis for its survival in the 
host cells. Usually at the beginning of the life cycle of virus, the viral proteins 
suppress the cell-autonomous antiviral apoptotic response and thereby allow the 
virus to replicate before its host cell dies. This is supported by the absence of 
cytochrome c release from cells expressing mitochondrial-associated HBx. A survival 
protein Raf-1 which protects cells from stress-mediated apoptosis was stimulated by 
HBx to translocate to the mitochondria which reinforces the anti-apoptotic program 
in infected hepatocytes (Chen and Siddiqui, 2007). It may also be mediated by 
up-regulation of other survival proteins that promote hepatocellular growth and 
survival (Tufan et al., 2002). At later stages of infection when the viruses are still 
replicating, viruses may induce apoptosis of the infected cells in order to increase 
viral spread or subverting the host's immune response (Benedicts et al, 2002). It is 
thought to be a cell-mediated (although virus-induced) process as H B V is not lytic. 
HBx locates in mitochondria and induces a decrease mitochondrial potential and 
increase intracellular reactive oxygen species (ROS), thereby induces cell death 
(Shirakata et al., 1998; Waris et al., 2001). Nevertheless, we speculate that the 
localization in mitochondria does not necessarily link to apoptosis in all cases as 
apoptosis, from the virus point of view, is at no good and contradict to its role in 
hepatocarcinogenesis. 
8.2.3 Stimulation of calcium release from mitochondria by wild-type HBx 
Another possibility of mitochondria targeting by wild-type H B x is to trigger 
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calcium release from the mitochondria. The localization of wild type H B x (HBxWt) 
in mitochondria, as found in this study, has been shown to elevate the [Ca^ '^ ]cyt as 
demonstrated by using recombinant aequorin probes and Fura2-AM dye (Oh et al, 
2003). Such increased [Ca^ ]^cyt activates proline rich tyrosine kinase 2 (Pyk2) and 
focal adhesion kinase (FAK), and in turn the H B V replication (Bouchard et al, 2001 
and 2006). Increasing [Ca^ ]^cyt artificially actually can replace such induction effect 
by HBx. Furthermore, blocking the mitochondrial channels with calcium drugs 
CGP37157 that targets on Na+/Ca2+ exchanger and cyclosporin A (CsA) that inhibits 
permeability transition pore (PTP) opening reduces H B V replication. The association 
between mitochondrial localization and calcium has been demonstrated to viral 
replication so far, but not yet on apoptosis and other cellular pathways such as E R K 
(Chami et al, 2006). 
The HBxAC44 does not target to the mitochondria; that we speculate that this 
mutant adopts a mechanism which is different from that of wild-type H B x to induce 
cellular changes. It is thus more interesting to ask that why does the same virus adopt 
different mechanisms in hepatocarcinogenesis if the truncation is a virus-generated 
process? The answer may be revealed in some of the following discussions. 
8.3 Cell cycle distribution profiling and its regulations 
8.3.1 Cell cycle pattern and cell proliferation 
To construct the relatedness between subcellular localization and cell cycle 
modulation, we analyzed the cell cycle pattern of cells expressing different H B x 
variants. Deregulation of cell cycle pattern is an observable cellular change in the 
early process of tumourigenesis. W e employed the flow cytometry techniques for the 
-cell cycle study as described in Chu et al., 1999. In our system, the cells duplex were 
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excluded before the analysis. Synchronization was performed prior to the analysis to 
lock the cells at the Go phase. The cells with EGFP fusion were gated when the green 
fluorescence emitted was detected by the lasers. This overcomes the problem of low 
transfection efficiency in transient transfections. From the cell counts shown by the 
flow cytometer, we estimated that the transfection efficiency was less than 10% (data 
not shown). Cell gating allowed the cell cycle analysis on cells that successfully 
expressed the fusion proteins but not untransfected cells. Using GFP signal gating is 
further benefited by the fact that GFP and propidium iodide (PI), the dye used for 
staining D N A , both absorb wavelength at 488 nm but emit fluorescence at distinct 
wavelength. This allowed for the simultaneous identification and cell cycle analysis 
of GFP-positive populations. To prevent GFP leach from the cells, we adopted an 
optimized fixation protocol with a low concentration of paraformaldehyde thereby 
permits fair analysis of the cell cycle (Chu et al., 1999). 
Our results in cell cycle and proliferation showed that HBxWt and HBxAC44 
caused a drastic increase in S-phase accompanied by a mild decrease in G q / G i and 
G2/M phases at both 24 hours and 48 hours after transfection. The stimulation of 
S-phase increase was apparently independent on their subcellular localization. It is 
neither dependent on the presence of the C-terminus. As revealed by the result of 
BrdU proliferation assay, both HBxWt and HBxAC44 caused an increase in D N A 
synthesis at both 24 and 48 hours after transient transfection, which was in 
consistency with the results from the cell cycle study that the S-phase was increased. 
In contrast, the C-terminus fragment (HBxlll-154) caused the S-phase to decrease, 
which was probably linked to a decrease in D N A synthesis. In combination of that 
for HBxWt and HBxAC44, the C-terminus seemingly was acting as an inhibitory 
domain while the N-terminus and central sequence acted as stimulating sequences. 
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HBxWt contained the full sequence thus its effect on cell cycle was the combined 
results from both stimulation and inhibition. The C-terminus truncated mutant 
HBxAC44, because lacks the inhibitory domain, caused a greater increase in cell 
proliferation. Murakami firstly suggested the idea of the regulation effect by one 
terminus on the other in 1994. They showed the deleting the N-terminal 1-50 amino 
acids fragment increase H B x transactivation transcription function. Another group 
also reported that the N-terminal amino acid 1 -20 could suppress the transactivation 
function of H B x (Misra et al., 2004). Such negative regulation is likely to be a 
mutual regulation that the C-terminus may also regulate the effect of the N-terminus, 
and even the central region. 
The point mutated variant HBxCllSA has the 115 cysteine residue replaced by 
alanine and did not locate in mitochondria. It caused an increase in S-phase at 48 
hours after transfection. In BrdU proliferation assay, it caused an increase in D N A 
synthesis at both time points. The HBxC115A mutant, though has a C-terminus, has 
the key amino acid mutated to make the C-terminus non-functional from the view of 
subcellular localization, thereby we speculate that it works like the HBxAC44 mutant 
that it also acts as a cell proliferation activator like HBxAC44. Nevertheless, the 
point to note is that in BrdU assay, transient transfection was performed and cell 
selection of successfully transfected cells was not possible. Thus, the result of BrdU 
shown in this part is an under-estimation of about 90% as the transfection efficiency 
is estimated to be 10%. 
8.3.2 Differential cell cycle molecular pathway activation 
Eukaryotic cell cycle is tightly regulated and catalyzed by cyclin-dependent 
kinase (CDK), which as the name suggests, is activated by cyclins. Emergence of 
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cells from G q / G i phase into S-phase involves sequential activation of CDK2-cyclin E 
complexes followed by formation of active CDK2-cyclin A complexes (Benn et al., 
1995). During the Gi/S transition, the Gi phase regulating cyclin D binds to and 
activates C D K 4 and CDK6. This activates cyclin E in turn activates C D K 2 and the 
complexes cause cells to proceed into S-phase. The C D K 2 then forms complexes 
with cyclin A which sustain the S-phase for D N A synthesis. CDK-cyclin complex 
assembly and enzymatic activity are regulated by a number of small proteins termed 
C D K inhibitors (CDKI). They include structurally and functionally distinct members 
Cip/Kip family that comprises p2iwaf/cipi，p^ ykipi ^ nd pST'^ '^ l They are all able to 
bind to and inhibit the activity of most CDK-cyclin complexes with different efficacy 
(Ilyin et al, 2002). 
Because deregulation of cell cycle can happen due to the changes in activities of 
these complexes, we tested out whether wild type HBx and the mutants regulated 
these proteins in a similar pattern to cause cells to proliferate. As demonstrated in 
chapter 5, our data showed that HBxWt enhances cell proliferation by increasing the 
expression of cyclin A and cyclin E at the protein level. In spite of a slight decrease 
in CDK2，the elevated level of cyclin E may potentiate an increased CDK2-cylin E 
activity and cause cells to enter the S-phase more rapidly. The higher level of cyclin 
A helps to sustain the S-phase for a longer time and thereby elevated the level of 
D N A synthesis. The elevated CDK2-cyclin A or CDK2-cyclin E complexes may be 
mediated through a repressed C D K 2 inhibitors p2raf/cipi ^ nd expression as 
demonstrated in our real-time PCR results. In 2006, Mukherji also demonstrated that 
wild type HBx can directly bind to CDK2-cyclin A/E complexes and potentiate 
C D K 2 activity, coupled with an increase in proliferation. The interaction site on HBx 
was suggested to lie on amino acid 85-119, thus mutants without this region did not 
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interact with CDK2-cyclinA/E complexes. In our project, we found that the 
C-terminal truncated mutant HBxAC44 (HBxl-110) markedly decreased the CDK2 
protein level while the cyclin A and E were not obviously altered except for an 
increase in cyclin A at 24 hours post-transfection. Interestingly, the CDK2 inhibitors 
p2iwaf/cipi and p27k'Pi are found to be up-regulated which may be the reason for a 
repressed C D K 2 level. These suggest for a possible alternative pathway on cell cycle 
regulation by these two mutants when compared to the wild-type HBx. Nevertheless, 
despite the decreased C D K 2 level, cells with over-expressed HBxAC44 showed a 
longer time distribution in S-phase and more D N A synthesis. The up-regulation of 
p2|waf/cipi was also suggested to be involved in cell proliferation in which its dual 
effect on repression or promotion was determined by its cellular concentration 
(Glaise et al, 1998). A higher level of p2iwaf7cipi ^ ^^ associate with an increased level 
of cyclin D, as demonstrated by Ilyin P. in 2003. Such up-regulation by HBx is 
mediated By N F - K B / BC13 complex through KB sites of the cyclin D1 promoter (Park 
et al, 2006). The could play a positive role in adult hepatocytes by 
promoting CDK4-cyclin D1 or CDK6-cyclin D1 assembly and target them to the 
nucleus, as shown in the fibroblasts (LaBaer et al., 1997). In our current study, we 
found that HBxAC44 was able to up-regulate 口2广—'p!，making us to believe that the 
CDK4-cyclin D1 or CDK6-cyclin D1 complexes could be activated at the same time. 
In addition, HBxAC44 transactivates whose function is sequestered by the 
elevated CDK4-cyclin D1 or CDK6-cyclin D1 activity. Thus the downstream protein 
CDK2-cyclin A/E is up-regulated (Ilyin et al., 2003). As C D K 2 is a kinase, one 
should keep in mind that its activity determines its function more than merely its 
m R N A expression. In order to elucidate the overall mechanism of a decreased CDK2 
level that is related to increased cell proliferation, measurement of the kinase activity 
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should be performed for a holistic picture on the cell cycle regulation. A higher 
CDK2 activity is anticipated, in spite of the low expression C D K 2 level. 
We also demonstrated that the C-terminus of HBx alone could suppress S-phase 
distribution, with a decreased C D K 2 expression. Therefore, the effect of HBxWt 
should be a result of combined effect of the activation on cyclin A/E and suppression 
on CDK2. This may help to explain the proliferative/ anti-proliferative effects of 
HBx and that cyclin A/E or CDK2 levels are in a dilemma for determining the net 
effect on cell cycle. Despite the failure of detection at the protein level, the 
expression of HBxC115A was detected at the m R N A level. The GFP-HBxC115A, 
however, was observed under a fluorescence microscope as previously described in 
Chapter 4. The failure of its detection on Western blot may be due to the low protein 
expression level of this protein so that it is beyond the detection limit of Western blot. 
It may also be due to its high susceptibility to degradation by proteases or a low 
transfection efficiency. Another possible reason is due to the shorter half-life of 
HBxC115A protein. Nevertheless, the expression conditions of this mutant should be 
further optimized. 
The differential effect of HBxWt on repression of and HBxAC44 
up-regulation is one of the multi-steps in HBx-mediated cellular changes. Apart from 
the direct difference of the absence of C-terminus in HBxAC44, these variants may 
have caused complex activation of pathways, leading to the final results on cell cycle 
protein regulations. 
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8.4 Ras/Raf/MAPK mediated transactivation by HBxWt and its 
mutants 
8.4.1 p53-mediated expression 
W e tested if the regulation of expression was affected by the level 
wild-type p53 (p53Wt) present in the p53-positive W R L 6 8 cell-lines. The results 
showed that H B x W t up-regulated p53Wt expression and decreased the expression of 
the downstream p2iwafzcipi HBxAC44, however, works in an opposite way that it 
down-regulated p53Wt and elevated the 卩21柳【允1卩1. Taken together, the C-terminus 
may potentiate p53Wt up-regulation and thus negatively regulates p2iwaf/cipi 
expression. 
Regulation of p2iwaf/cipi expression has been demonstrated in several studies, 
which may play an important role in hepatocarcinogenesis. H B x suppresses 
p2iwaf/cipi transcription in a p53-dependent manner, as demonstrated in p53-positive 
HepG2 cells (Kwun and Jang, 2004). In addition, H B x can repress p^ l^ af/dpi ^ 
p53-independent pathway possibly by modulation of a transcription factor spl 
activity (Ahn et al, 2001). In contrast, some reported that promoter 
activity can be activated and thus a higher transcription of 卩21柳"。1卩1 via 
p53-mediated pathway which prolongs G i ^ S transition in human hepatocyte cells 
(Han et al, 2002; Park et al, 2000). The dual effects of H B x on p2iwaf/cipi ^ ^^ 
dependent on the status of p53 that wild-type, truncated or absence of p53 result in 
. different effects (Ahn et al., 2002). Our results show that the C-terminus is 
responsible for p2严i^ cipi 
repression. In addition, we also showed that the C-terminus 
is important for up-regulation of p53Wt expression as observed for HBxWt. Apart 
from the alteration of p53Wt expression, H B x may interfere with the functions of 
、 • p53 through indirect binding. The C-terminus (111-154) region of H B x is necessary 
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for in vitro binding to p53 which may explain the direct interaction and suppression 
on p53 by this region (Wang et al., 1994). HBx binds to p53 and blocks its 
tumour-suppressive activity and thus p53 fails to interact with specific D N A 
sequence adjacent to functionally important cellular genes such as waf-cipl (Elmore 
et al., 1994). The retention of p53 in the cytoplasm by H B x was suggested to via the 
interaction of the transcriptional activation domain of H B x and the C-terminal region 
of p53 (Takada et al., 1997). The attempt by the cells to stop inappropriate 
proliferation caused by H B x is therefore blocked, and this may contribute to part of 
the mechanism whereby H B x promotes progression of cells into S-phase. It servers 
an early step in hepatocarcinogenesis as HBx cause the loss of function of 
endogeneous p53 (Ueda et al.’ 1995). Interestingly, the inactivation of H B x on p53 is 
restricted to the wild-type p53. It may also be an alterative explanation on the 
contradictory results of H B x and p53 mediated cellular changes reported in various 
cell-systems, ranging from p53-positive HepG2, to p53-negative Hep3B (Ahn et al., 
2002). Wild-type 53 has been reported to complex with which is a growth 
inhibitor gene, to cause a decrease risk in H C C development. H B x has been 
hypothesized to interact with p53-p33丨NGib complexes to counteract with their 
apoptotic effect thus causes cells to proliferate (Zhu et al., 2005). 
8.4.2 ERK-mediated p2raf/cipi and wild-type p53 mRNA expression 
regulation 
It has been well accepted that H B x is involved the Ras/Raf/MAPK pathway 
alteration to regulate target genes expression by regulating different transcription 
factors. The activation of this pathway has been linked to the accelerated entry of 
cells into S-phase with H B x expression (Benn and Schneider, 1995). The 
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transformation activity of HBx is also found to be the results of activating this 
pathway (Tarn et al., 2001). W e noticed that HBx and HBxAC44 altered several 
genes expression and we speculated that it could be mediated via the 
Ras/Raf/MAPK/ERK pathway. W e thereby examined the ERKl/2 and 
phosphorylated E R K 1/2 level in lysate of cells transfected with the HBx variants. 
However, we found that the EGFP(GFP)-tag system is not a good choice for studying 
this pathway as the E R K 1/2 were markedly activated to phosphorylate by EGFP 
alone at T=10 hours, making it difficult if not impossible to interpret the results on 
HBx-EGFP fusion protein and HBxAC44-EGFP fusion protein. EGFP alone has long 
been accepted as a fluorescence tag that is rather useful in locating a protein 
distribution in cells or for identification of specific types of cells in a largely mixed 
population. It has been reported to induce IL-6 expression that its roles in affecting 
cellular functions are worth more attention (Mak et al, 2007). Recently, another 
report on H B V also showed that activation ofpERK by EGFP tag in Huh 7 and P M H 
(Chin et al, 2007). Nevertheless, we did not find any difference for cells expression 
EGFP in cell cycle analysis, cell proliferation and cycle protein expression in which 
the gene expression levels were calculated with reference to the EGFP control. 
Neither do other groups found any effects of EGFP in up-regulate cell cycle genes or 
oncogenes. These suggest that EGFP seemingly is only affecting specific proteins 
such as ERK. 
Due to the ambiguous results on E R K phosphorylation by H B x variants, we 
sought to study the M A P K - M E K pathway activation by negative inhibition. W e used 
a M E K inhibitor PD98059 to block the phosphorylation of E R K by M E K and to 
examine if expression of wild-type p53 or p2iwaf/cipi changes. Our results showed 
that when E R K phosphorylation is inhibited, H B x W t failed to repress 卩2广&价ipi 
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expression or to up-regulate p53Wt expression. On the other hand, HBxAC44 failed 
to up-regulate 卩21碰。丨口1 or to down-regulate p53Wt. Similar results were found in 
HBxCllSA expressed cells. Thereby, we predicted that both p53Wt and 
transcription regulation are mediated via the Ras/Raf/MAPK pathway. The increase 
in p53 represses the downstream p21, or vice versa. Nevertheless, we do not rule out 
the possibility that pir^ '^'''^ ^ is directly regulated through the M A P K pathway as 
PD98059 blocks ERK-mediated p53 and Taken together the results from 
the two parts, we still predict that both HBxWt and HBxAC44 are capable to activate 
the Ras/Raf/MAPK/ERK pathway. Actually only part of HBx (residue 58-119) is 
sufficient to activate the M A P Kinase pathway, as shown in mouse liver (Nijharar et 
al., 2001). Here we further showed that the 111-119 amino acid residues may be 
dispensable, that is the whole C-terminus is not needed in the M A P Kinase pathway 
activation. 
A potential feedback loop was also proposed for the repression of by 
HBx via the Ras/Raf/MEK/ERK pathway in which the HBx itself is phosphorylated 
by E R K 1/2 (Noh et al., 2004) (Figure 8.1). Nevertheless, it is possible that the 
contribution of ras-signaling pathway is not rate-limiting. As HBx is capable to 
activate PI3K, N F K B , AP-1, JAK/STAT, p-catenin, etc., it is also possible that these 
pathways also play an important role on HBx-mediated p53 and p2iwa位cipi 
expression. 
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(a)i ^ ^ ^ ^ Cell-line: “ ^ ^ ^ ^ Cell-line: 
I S S ^ WRL68 麵 
HB 僅 、 、 广 _ 2 _ ^ M 
J r MEK + PD98059 一 沪 M E K + 
J v PO4 J v (POJ (not done) 
p53 0 T P53 暴 T ^ 
p21 I P53 I mRNA P21 P53 tr 
A • mRNA 
(b) Cell-line: 
、 H e p 3 B 
H B x W t ^ 
、 E R K l / 2 
PO4 ^ 
p 2 1 I Transcription 
(Noh et al., 2004) 
Figure 8.1 A schematic presentation of HBx-mediated p21 洲f^ Pi and p53Wt 
expression changes via ERKl/2 phosphorylation, (a) i. Both H B x W t and 
HBxAC44 can activate the phosphorylation of ERKl/2 to alter the m R N A 
expression of 卩2广咖口1 and p53. HBxAC44 seems to sustain the phosphorylated 
ERKl/2 for a longer time than that of HBxWt. ii. Addition of M E K inhibitor 
PD98059 blocks the phosphorylation of ERKl/2 by H B x W t and HBxAC44, 
causing opposite alteration of and p53 m R N A expression, (b) A 
feedback loop of phosphorylation was proposed in 2004 in which H B x was 
suggested to be phosphorylated by ERKl/2 and then it caused a repression of 
p2iwaf/cipi transcription. 
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8.4.3 Regulation of oncogenes/ proto-oncogenes expression 
HBx was been reported to transactivate enormous cellular pathways, thus lead 
to the pathogenesis of liver diseases. Apart from the tumour suppressor protein p53, 
we also studied the m R N A expression level of two genes from the ras family, namely 
RhoC and Rabl4. These two genes were previously shown by our group to be 
regulated by wild-type HBx, which may be the early markers of HBV-mediated 
tumourigenecity (Ng et al, 2004). C-myc oncogene is also frequently reported to be 
associated with H B x although the detailed roles of c-myc in HBx-mediated cellular 
changes are unknown. HBx is able to influence the expression of both 
extra-chromosomal transfected c-myc regulatory and endogenous c-myc gene 
(Balsano et al, 1991). These three genes are strongly linked to cancer development 
including HBV-mediated H C C . The effects of H B x on them are thought to be to the 
transactivation effect of this viral protein. Thus, here we investigated, as part of this 
project, the differential effect of H B x W t and HBxAC44, that without one of the 
transactivation domain at the C-terminus, on RhoC, Rabl4 and c-myc expression. 
C-myc 
Our results showed that in cells transiently expressed H B x W t c-myc expression 
was not altered. However, expression of HBxAC44 caused a significant higher level 
of c-myc expression. C-myc over-expression is greatly associated with a higher 
frequency of H C C , suggesting that its over-expression may be a central feature of 
hepatocarcinogenesis. Such association was observed in ground squirrels naturally 
infected by G S H V and in woodchuck H B V hosts. Such up-regulation of c-myc 
over-expression is unlikely to be dependent on the transactivation activity of 
wild-type HBV, as c-myc was up-regulated by our C-terminal deleted mutant 
HBxAC44. Our results are consistent with the clinical finding that the integrated 
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H B V viral sequences are accompanied with an increased c-myc expression in liver 
tumour tissues from more than 400 chronic H B V carriers. The role of c-myc in liver 
oncogenesis is further addressed with co-over-expression of H B x and c-myc in 
transgenic mice. Elevated c-myc expression induces oncogenesis mediated by HBx 
which on its own does not have a direct pathological effect (Terradillos et al., 1997). 
Hepatocarcinogenesis is a multi-steps process of genes and pathway alteration. In our 
transient transfection system, up-regulation of c-myc expression by the clinically 
relevant HBxAC44 truncation mutant at just 48 hours after transfection suggests that 
c-myc over-expression may also act as an early marker that signals for a higher risk 
of tumour development. In addition, over-expression of c-myc can suppress 
p53-mediate apoptosis by up-regulating chaperon expression (Ceballos et al, 2005). 
Specially, HBxC115A caused a down-regulation on c-myc to more than two fold. It is 
probably due to the altered transactivation function of this mutation at amino acid 
115，which thus interferes with the c-myc regulation pathways. To obtain a clear 
picture on c-myc function, phosphorylated c-myc protein may be the next target for 
study. A recent study showed that, in proliferating hepatocytes, an increase 
phosphorylated c-myc level was detected although the total c-myc remained 
unchanged. 
RhoC 
Regarding the RhoC expression, both H B x W t and HBxAC44 were shown to 
up-regulate RhoC in transient expression systems. This implies that the 
transactivation C-terminus is dispensable for inducing RhoC over expression. RhoC 
has been closely associated with different tumours, such as breast carcinoma, lung 
cancer, colon cancers and pancreatic adenocarcinoma (Fritz et al., 1998; Suwa et al, 
.1998). Up-regulation of RhoC by H B x implies that H B x W t and HBxAC44 may 
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contribute to metastasis. Our result matches with the claim that the C-terminus 
deleted HBxC44 mutant retains the ability to induce carcinogenesis. RhoC and 
Rabl4 are over-expressed in hepatoma cells as previously demonstrated in our group 
(data not shown). Rho gene was found to be involved in the vascular invasiveness of 
HCC. The RhoC protein mediates the effect of extracellular stimuli on actin 
cytoskeleton rearrangement and cell migration (Clark et al., 2000). Such 
cytoskeleton arrangement is often observed in invasive carcinoma which lacks an 
adherent junction that causes the cancer cells to migrate from one site to another 
(Schmitz et aL, 2000). The disruption of cell adhesion has been reported for H C C 
which is mediated by HBx. Such disruption of adhesion serves as the first step of 
tumour spreading. 
Rabl4 
In our experiments, we did not find any expression alteration on Rabl4 by HBx 
and its mutants although we have previously showed that Rabl4 is up-regulated by 
HBxWt at three days after its expression. Such discrepancy may be due to different 
time points of study used in both projects. 
8.5 General discussions on differential effects of HBxWt and 
HBxAC44 
In summary of the results, we speculate that the C-terminus fragment (111-154) 
- of H B x is generally responsible for the mitochondrial localization, D N A synthesis 
suppression and transactivation, which is probably also responsible for viral-induced 
apoptosis responses at the appropriate time of the viral life cycle. The N-terminus 
and the central region however are responsible for stimulation of D N A synthesis and 
、 “part of the transactivation activity and possibly for stimulating cell survival. These 
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two regions probably have anti-apoptotic effects. 
Wild-type HBx (HBxWt) consists of the full-length sequence whose 
contribution to the cell cycle pattern and D N A synthesis is the net effect of the 
stimulating and suppression effect of various regions. This may be the explanation 
for the contradictory results on apoptosis and cell proliferation. HBxAC44 which has 
the C-terminus deleted suppresses apoptosis and stimulates cell cycle progression, 
which are the hallmarks of carcinogenesis. 
The mechanisms by which HBxWt and HBxAC44 exert their functions on 
cellular changes are proposed and outline in Figure 8.2. The wild-type HBx 
stimulates M E K which phosphorylates the downstream ERKs to upregulate p53. The 
upregulated p53 then suppress the p21 expression. On the other hand, the CDKI 
proteins p21 and p27 are down-regulated by HBxWt through the same MEK/ERKs 
pathway. As a result, cyclin A and E are upregulated and cells are stimulated to 
proliferate. The HBxWt also cause an upregulation of RhoC which may contribute to 
the metastasis of cancer cells. 
The HBxAC44 also stimulates M E K which brings forth to the phosphorylation 
of ERKs, resulting in an upregulation p53 and a repression of p21. The p21 and p27, 
however, is upregulated by HBxAC44. Thus, the cellular C D K level decreases. 
However, cells are stimulated to proliferate probably via another pathway which 
involves c-myc and cyclin Dl. The c-myc oncogene is upregulated which in turn 
results in an increased level of cyclin Dl. The elevated cyclin Dl causes 
destabilization of p27 that p27 degrades at a faster rate than in normal cells. The 
CDK2 activity thus increases and leads to faster cell proliferation. The HBxAC44 
also upregulates RhoC expression and may contribute to cell metastasis. 
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Figure 8.2 Schematic presentations of the major findings on the functions of 
HBxWt and HBxAC44 in this project. The major findings are indicated in solid 
arrows or bars while some proposed function of these H B x variants are indicated as 
broken lines. 
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As summarized in Figure 8.3, carcinogenesis basically involved the stimulation 
of cell proliferation by altering the expression of host genes. Genome instability 
happens due to viral gene integration and accumulation of mutations. A destruction 
of tumour suppressor genes such as p53 or/and activation of oncogenes/ 
proto-oncogenes such as c-myc and RhoC is often shown in both in vitro and in vivo. 
In this thesis, the effects of H B x W t and H B x A C 4 4 in carcinogenesis are described 
which are consistent with the commonly agreed molecular changes in carcinogenesis 
and that observed in vivo. 
Carcinogenesis is HBxWt HBx A C44 In vivo 
often associated 
WI^ I This thesis I 
Genome instability ^ ^ (not done) (not done) viral 
U Integration 
Accumulation of (not done) (not done) ^ ^ 
mutations — 
Cell proliferation 介 介 介 • 
J I •• IJ .J 11 
Tumor suppressor |~] [~| |~| 
e.g. p53Wt ^ U V 
.. 、 
Activation of oncogenes 
e.g. c-myc 介 • 介 
^―‘ —I L-J 
e.g. RhoC • 介 介 合 
Figure 8.3 Summary on the process of carcinogenesis and the findings in this 
project. The cellular and molecular changes in carcinogenesis are schematically 
described. This thesis also describes some of these changes for both H B x W t and 
HBx A C44 which are consistent with the commonly accepted changes in 
carcinogenesis and that observed in vivo. 
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8.6 Establishment of Tet-On/HBxAC44 cell-line TOXDCl 
As described in the previous sections of this chapter, there were lots of potential 
problems in using the transient expression system. Although EGFP seems to be a 
solution for cell selection to reduce the effect of low transfection efficiency, the 
EGFP is suspected to regulate some cellular functions on its own. Establishing stable 
cell-lines is commonly adopted in studying specific gene's functions on cells. 
However, it is not a good choice for studying a viral gene especially for HBx, which 
has long been suggested to be an apoptosis inducer. In the process of establishing 
stable cell-lines, stronger cells that can counteract the apoptotic effect of viral protein 
may be selected as a result. Alternatively, these transfected cells may proliferate very 
fast and in effect to lower the copy number of viral gene so as to reduce the toxicity. 
Despite continuous selection which can retain the vector containing the viral gene, 
the cellular response upon such viral protein expression tends to eliminate the viral 
gene. Thereafter, usually after several passages of cells, the viral gene is eliminated 
or retained at a low copy number. This is a continuous process that makes the cells 
、 
assays results difficult to be reproduced. 
The Tet-On system allows controlled gene expression with a 
doxycycline-dependent promoter. W e have successfully established a Tet-On cell-line 
that stably expresses HBxAC44, which is named as TOXDCl. Some basic 
characterization assays were performed. The doxycycline induced TOXDCl has a 
similar morphology to the uninduced TOXDCl cells. No apoptosis was observed 
after fours days of induction. Upon doxycycline induction, T O X D C l expresses 
HBxAC44 m R N A which was detected with RT-PCR. Growth curves show that with 
the HBxAC44 expression, the TOXDCl-doxycycline cells grow at a faster rate than 
the uninduced T O X D C l cells which is consistent with the results of the transiently 
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transfected cells. To confirm the results found in transient transfection system, we 
further analyzed the expression pattern of The m R N A 
expression increased when HBxAC44 was expressed. These results are consistent 
with the data in previous chapters in which the results of the transient transfection 
system are described. 
In the process of constructing the inducible cell-lines, several problems were 
encountered such as the lower survival rate of single cells isolated and the loss of the 
Tet-On responsive element. These results in few clones eventually are available. In 
the project, only one clone TOXDCl was successfully constructed. The potential 
artifacts generated by an only clone due to the clone-clone variations, however is 
overcome by the inducibility of the cell-line that the uninduced cells could serve as 
the control in the context of cell backgound. 
8.7 Conclusions 
Wild-type HBx has been extensively studied for its function in 
V 
hepatocarcinogenesis. In this study, we compared the potential differential functions 
between wild-type HBx and the clinically relevant C-terminus truncated mutant 
HBxAC44 for several representative cellular functions of HBx. W e have successfully 
demonstrated that the C-terminus of HBx is crucial for its mitochondrial targeting 
with an essential short region of seven amino acids 111YFKDCVF117 in which the 
Cysll5 is important in determining the subcellular localization. 
W e have also shown that wild-type HBx, HBxAC44 and the point mutant 
HBxCllSA have a cell proliferative effect in WRL68 cell-lines with an increase in 
S-phase distribution. A consistent D N A synthesis has been revealed using BrdU 
. -incorporation ELISA. The effect of these viral genes on cell proliferation and D N A 
CHAPTER 8 Discussion 155 
synthesis is independent of the subcellular localization. The study of the underlying 
molecular regulation of cell cycle shows that wild-type H B x and HBxAC44 adopt 
different mechanisms in contributing to the cell cycle alteration. In brief, wild-type 
HBx increases cellular cyclin A and cyclin E level, with a corresponding decrease in 
C D K inhibitors p2iwaf/cipi ^^^ m R N A expression. In contrast, C-terminus 
truncated mutant HBxAC44 has a more complex regulation on cell cycle that it 
causes a decrease in C D K 2 level and an elevated level of and 
expression. The C-terminus fragment HBxlll-154 on its own is able to decrease the 
cellular level of CDK2, which may function as a suppression domain for cell 
proliferation in wild-type HBx. 
The differential regulation of p21 柳f^ pi expression may be mediated through the 
wild-type p53 (p53Wt) dependent pathway. Our results indicated that wild-type HBx 
up-regulates the expression of p53 and down-regulates p2iwa"cipi expression. In 
contrast, HBxAC44 down-regulates p53Wt which explains the up-regulation of 
p2iwaf/cipi m R N A expression. Alternatively, and p53Wt may be regulated 
V 
by Ras/Raf/MAP kinase pathway in parallel. The H B x constructs have been shown to 
potentiate the phosphorylation extracellular-signal-regulated kinases (ERKs). 
Inhibition of E R K phosphorylation further confirms such speculation as the 
HBx-mediated and p53Wt expression alteration is reverted upon addition 
of the phosphorylation inhibitor. 
Apart from the above findings, we have also constructed a Tet-On monoclonal 
cell-line T O X D C l which stably expresses HBxAC44. This cell-line serves as an 
excellent tool for studying this truncated H B x mutant. Upon the expression of 
HBxAC44, as turned on by induction with doxycycline, the induced T O X D C l cells 
.grow faster than the uninduced T O X D C l cells. Up-regulation of is 
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observed in parallel with an increase in HBxAC44 expression. Furthermore, we have 
also shown that the expression HBxAC44 is constantly dependent on the 
concentration of doxycycline inducer. This opens the door for a more comprehensive 
study on this clinically relevant mutant. It is particularly important as in reality the 
HBV-infected tissues express HBx integrants with different viral load and will 
certainly contribute to different outcomes. 
、 
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8.8 Future Prospects 
In this study, several differential functions between wild-type HBx and 
truncated mutant HBxAC44 were discovered, and these findings shed new light to 
future studies on these two variants. 
8.8.1 From mitochondria targeting to calcium signaling 
In resting cells, free cytosolic calcium ([Ca^ J^cyt) is very low of about 100 nM. It 
is primary maintained by activation of calcium transporters that either release 
calcium cross the plasma membrane to the extracellular environment or uptake of 
calcium into intracellular organelles (Carafoli et al, 2001). Mitochondria accumulate 
calcium via the uniporter (UP) upon physiological stimulation (Csordas et al, 1996). 
Calcium extrusion is achieved via the NaVCa^^ exchanger and the H+ZCa〗. exchanger. 
As discussed in section 8.2, it is worth while to study if the profound roles of HBxWt 
in cells are linked to calcium release from the mitochondria. Besides, HBxAC44 does 
not locate in mitochondria but seemingly has the same tumourigenic effect. It may 
V 
work in a different modulation manner from that of HBxWt, which is also worth 
attention. In studying the mitochondrial calcium migration, a dye that specifically 
binds to mitochondrial calcium can be used. An indirect method to study the 
mitochondrial calcium release or uptake can be made with different drugs that 
inactivate the calcium channels, as shown in figure 8.4. HBxAC44 may stimulate the 
calcium signaling at the frontline in that it directly stimulates cytosolic calcium 
elevation. Future work should also focus on identifying the targets of this truncation 
mutant. 
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Figure 8.4 Calcium drugs can be used to block mitochondrial calcium channels. 
Ruthenium red inhibits the uniporter (UP), thus blocks the calcium intake into the 
mitochondria. 
CGD37157 blocks the NaVCa^^ exchanger and H+/Ca2+ exchanger and 
reduces calcium release into the cytosol. Cyclosporin A inhibits the permeability 
transporter pores and prevents calcium extrusion from the mitochondria. 
8.8.2 Construction of a complete cell cycle regulation pathway 
As demonstrated in our study, H B x W t and HBxAC44 regulate the cell cycle 
cyclins, cyclin-dependent kinases (CDKs) and C D K inhibitors (CDKI) differently, 
though both of them have the same cell proliferative effect. To understand more 
about the regulation of cell cycle at different phases including the Go/Gi and G2/M 
phases, cycle regulators such as cyclin Dl, CDK4/ C D K 6 and C D C 2 expression 
should be detected. Furthermore, the activity of the kinases can be measured instead 
of merely studying their protein expression. Apart from the cell cycle proteins, in our 
study, we failed to detect the point mutant HBxCllSA in transient expression 
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systems (though we could detect the GFP-fusion under a fluorescence microscopy 
and at the m R N A level), thus its expression conditions should be further optimized. 
The effect of this point mutant on cell cycle alteration thus can be studied in depth in 
the future. 
8.8.3 Elucidation of the transcriptional transactivation regulation 
As wild-type p53 and c-myc are found to be differentially expressed upon 
expression of H B x W t and HBxAC44, we are interested to see if the elevated/ 
decreased expression level of these two genes aids the viral gene in inducing 
tumourigenecity. In vitro colony formation assays can be performed to study the 
potential synergetic effect of p53 and c-myc in causing cancers. Furthermore, the 
potential wild-type p53 dependency for transcription can be further studied 
by over-expressing the viral genes in wild-type p53 null cells, such as Saos cells. 
Undoubtedly, the regulation of Ras/Raf/MAPK/ERK pathway should be studied 
in depth by adopting another expression system without GFP, in order to elucidate 
V 
the potential activation of this pathway by the viral genes. Both activation and 
inhibition strategies can be applied. 
Besides, the transcription of the oncogenes/ proto-oncogenes which were 
studied in this project should be elucidated by measuring their promoter activities. 
This will give a clear idea on the overall regulation of m R N A expression. 
8.8.4 To make the best use of the Tet-On stable cell-line TOXDCl 
As shown in chapter 7, we have successfully constructed a monoclonal 
inducible Tet-On cell-line T O X D C l that stably expresses HBxAC44 without any 
tags or extra sequences. First of all, works on identifying stable clones on HBxWt 
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and HBxAN60 expression will be continued. In addition, many studies on T O X D C 1 
can be carried out. On the one hand, it can be used for further studies on the linkage 
between this mutant viral gene and the molecular mechanisms revealed in the 
transient transfection system. On the other hand, it can also be used for both in vitro 
and in vivo tumourigeneicity studies. Moreover, we are interested to study the 
potential metastasis effect of HBxAC44 as it up-regulates the m R N A expression of a 
metastasis responsible gene RhoC. It can be used in vitro for studying cell 
invasiveness or in vivo by locating the HBxAC44-expressing T O X D C 1 cells using 
nano fluorescence particle in mice that can be later detected using special lasers that 
can pass through the skin of the mice. 
8.8.5 Study with other carboxy-terminal truncation mutants 
As described in section 8.1.1, truncation mutants with deletions of various 
carboxy-terminal a.a. residues may contribute equally, or perhaps more importantly 
to hepatocarcinogenesis, which is still unknown to current knowledge. It will be of 
、 
great clinical impact if these naturally occurring truncation mutants could be studied 
in depth in the future. 
8.8.6 In vivo study 
In this thesis, the differential functions of wild-type H B x and a C-terminal 
deleted mutant HBxAC44 in vitro were described. However, the molecular changes 
herein described may only reflect those happen in W R L 6 8 or HepG2 cells. It is 
important to carry out an in vivo study to show if the same molecular changes happen 
in patients with chronic liver disease or hepatocarcinogenesis. 
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In summary, there could be an enormous amount of work that can be carried out 
to further studies on the differential roles between HBxWt and HBxAC44. W e have 
successfully shown some of their potential differences and we ought to study them 
more extensively with the goal towards understanding hepatocarcinogenesis more 
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